The Regulation of spinal neurogenesis by PTPγ by Hashemi, HM
  
 
The Regulation of Spinal Neurogenesis by PTP!  
 
 
 
 
 
 
 
 
Hamid Hashemi 
 
 
 
 
 
 
A thesis submitted in partial fulfilment of the requirements of 
University College London 
for the award of the degree Doctor of Philosophy 
 
 
 
 
 
 
Neural Development Unit, Institute of Child Health 
& Great Ormond Street Hospital for Children 
 
 
 
 
 
 
 
 Declaration 
 
 
 
‘I, Hamid Hashemi confirm that the work presented in this thesis is my 
own. Where information has been derived from other sources, I confirm 
that this has been indicated in this thesis.’ 
 
 
HAMID HASHEMI Electronic Copy 
_________________________ 
 
 i 
Abstract 
 
RPTPs have striking patterns of expression within the neural tube; raising interesting 
questions as to their role in the development of this structure. PTP! expression is initially 
observed in the first born neurons and this expression domain progressively expands to the 
lateral motor columns and intermediate zone of differentiating neurons. Short hairpin 
encoding RNAi constructs were generated against PTP!, which effectively knocked down 
this gene in vitro and in ovo. Analysis of silenced embryos through neuronal markers 
presented a range of phenotypes. The most striking was a dorsoventral truncation of the 
neural tube arising from a loss of LIM-HD expressing cells not observed among controls. 
During the onset of neurogenesis, a loss of Lim1/2/3, Islet1/2, and Mnr2/Hb9 positive cells 
was observed. At later stages, Islet1/2 cells showed no such sustained effect essentially 
recovering. A further heterotopic phenotype was observed with mislocated neurons located 
ectopically in the ventricular lumen, that were Islet1/2 and Nkx2.2 positive but never 
Lim1/2/3.  The targeted regions showed a significant decrease in apoptosis suggesting 
newly born neurons were dying before reaching their pool specific domains. A reduction in 
the proliferative capacity in the ependymal zone demonstrated by Histone3 activity. Over 
expression of PTP! showed a similar reduction in LIM-HD expression however no overall 
change in S-Phase was observed yet cells at M Phase were reduced with no apoptosis 
detected through Caspase3 activity. The data suggests PTP! silencing may result in a 
failure of Lim1/2/3 cells to reach their final destinations and acquire LIM-HD identities, 
implicating this gene in the development of inter and motor neuron populations. 
Preliminary RNAi experiments against PTP" show a reduction in LIM-HD fated cells and 
a triggering of the apoptosis programme along with a reduction in number of mitotically 
active cells. This is consistent with a potential role for PTPs during neurogenesis and the 
birth of the first neuronal populations in the neural tube. 
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Chapter 1:  Introduction 
 
 
Within the early embryo, as the ball of multipotent cells called the blastula takes form 
during gastrulation, cell to cell interactions between the ectodermal cap and the 
underlying mesoderm give rise to all of the bodies cells. As gastrulation proceeds, a 
carefully choreographed movement of cells within the embryo’s three germ layers 
establishes the beginnings of a body axis that leads to the formation of the nervous 
system.  In the following sections, the development of the neural tube will be 
discussed as well as the transcription factors involved in this process. This will be 
followed by an introduction into the genes involved in neuronal differentiation and 
finally the impact of Receptor Protein Tyrosine Phosphatases (PTPs) on neuronal 
populations during and following neurogenesis will be discussed. Following this, the 
aims of the thesis will be addressed within the context of the spinal cord to better 
understand the role of PTPs within the spinal cord region during neurogenesis. 
 
1.1   Neural Induction and development of neural progenitors. 
 
The nervous system of animals has its origins within a distinct region of the dorsal 
ectoderm, where interactions between these ectodermal cells, the mesendoderm and 
‘organiser centres’ confer a neural fate of cells within this region through neural 
induction. These ectodermal cells are in fact neural by default where the presence of 
neural inducing factors block an overriding inhibitory signal through activin receptors 
that initially presides over the ectoderm. This maintains an epidermal fate within the 
ectodermal cells (Spemann, 1938; Waddington, 1933; Hemmati-Brivanlou & Melton, 
1994). 
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Once neural induction is initiated, the neural ectodermal cells thicken to form the 
neural plate with a conferred anteroposterior identity along a neuroaxis, providing an 
anterior end that gives rise to the brain and the posterior end that culminates in the 
spinal cord.  As this process of neurulation proceeds, the neural plate rapidly elongates 
and cell interactions convert a predominantly cuboidal morphology of epithelial cells 
into a pseudo-stratified arrangement. Through signals from cells residing outside of the 
neural plate, along the notochord in higher vertebrates, the neural plate bends at its 
midline through apical narrowing and basal widening of the cells along the 
presumptive floor plate, creating a hinge where the neural plate folds upwards. The 
neural folds elevate further through convergence-extension movements within the 
neural plate and overlying ectoderm (Schoenwolf et al, 1988; Catala et al, 1996).  
 
Along the prospective spinal cord region running the anteroposterior length of the 
neural plate, the notochord and floor plate are intimately associated. Further bends 
occur in the neural folds as secondary hinge points form dorsally along its mediolateral 
aspect on both sides. This has the effect of encapsulating the neural plate whereby the 
edges of the neural fold at the margins of the neural plate fuse along the dorsal 
midline, forming the roof plate and creating the distinctive enclosed keyhole 
appearance of the neural tube under the overlying epidermis. At this point the shape of 
the neural tube changes further through cell movements as the neural tube readies itself 
for neurogenesis and cell proliferation (Schoenwolf & Alvarez, 1992; Smith & 
Schoenwolf, 1997; Nurse, 2000). 
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1.1.1 Neural Inducers and their genetic interactions. 
 
Classical studies in Xenopus led to the discovery of factors driving the induction of 
neural genes within dorsal lip tissues. These were Noggin, Chordin and Follistatin and 
were all found to be sufficient in driving neural fate of tissues in ectopic locations. 
These studies led to the realisation that activin signals inhibit ectodermal cells from 
developing a neural fate. Induction of neuronal development therefore occurs through 
inhibition of the activin-like TGF-! family signals through signals emanating from the 
organiser centres, such as Follistatin, supporting the ‘neural default’ state of early 
ectodermal tissues. (Lamb et al, 1993; Smith et al, 1993; De Robertis & Sasai, 1996; 
Hemmati-Brivanlou & Melton, 1994). 
 
Early experiments in Drosophila found a homologue to Xenopous Chordin called the 
Short gastrulating gene (Sog). Sog loss of function experiments revealed an expansion 
of epidermal fate within tissues along with a reduction in neurogenic regions, and 
further ectopic expression of Sog resulted in the formation of ectopic neural tissue (De 
Robertis & Sasai, 1996). Sog was found to interact with the Decapentaplegic (Dpp) 
gene that is a TGF-! related protein similar to Bone Morphogenic Protein (BMP) in 
vertebrates. The BMP receptor consist of Type I and Type II subunits, whereby the 
Type II subunit acts as a Kinase phosphorylating serine/threonine amino acids on the 
Type I subunit. This results in further phosphorylation of R-SMADs, which once 
phosphorylated, form complexes with co-SMADs that enter the nucleus; activating the 
transcription of target genes via BMP response elements in target gene promoter 
regions.  
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BMPs are expressed dorsally in the neural tube acting in this domain, furthermore Sog 
and Dpp antagonise each other’s action and display opposing phenotypes with Dpp 
mutants showing an expansion of neurogenic regions at the expense of epidermis. 
Classical studies in Xenopous have shown a conservation of neural induction function 
demonstrated in earlier Drosophila studies whereby recombinant BMP4 expression 
suppressed chordin/noggin/folloistatin induced neural induction in animal caps. This 
implicates the antagonisation of BMP signals as the driver of neural induction and 
furthermore, expression of a truncated activin receptor blocked the endogenous BMP4 
signals (Wilson & Hemmati-Brivalou, 1995; Piccolo et al, 1996; McMahon et al, 
1998). 
 
Neural induction in the chick embryo occurs prior to gastrulation and members of the 
Fibroblast Growth factor family (FGF) of genes have been implicated as potent neural 
inducers. Blocking of this FGF signal by inhibitors, namely SU5402 was shown to 
prevent the initiation of early phase neural induction (Streit et al, 2000). Further 
studies in the ascidian embryo showed that Chordin and Follistatin were by themselves 
not sufficient to drive neural induction and that FGF signals were critical here as in the 
chick embryo (Bertrand et al, 2003; Delaune et al, 2005). Downstream components of 
the BMP pathway, SMADs were further shown to be inhibited through 
phosphorylation resulting from FGF signalling (Pera et al, 2003).  
 
Looking at more detail at the convergence of BMP and FGF pathways reveals two 
transcription factors as key mediators of neural Induction. Zic1 and Zic3 are expressed 
in the region of the ectoderm fated to become the neural plate and are both required for 
the formation of the neural plate, and are induced by Noggin. When FGF signals are 
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inhibited, Zic3 expression is lost, however Zic1 expression remains unaffected, thus 
inhibition of BMP and activation of FGF signalling act in concert during the 
specification of the neural plate (Marchal et al, 2009).  
 
On the other hand, ectodermal BMP signals result in the activation of intracellular 
proteins that bring about the repression of Zic1, giving rise to epidermal tissue. Within 
the neural tube, once BMP signals are inhibited, the SMAD pathway is activated and 
Zic1 expression ensues. This, coupled with FGF signals, results in the activation of 
Zic3, together with Zic1 directing a neural fate through activation of downstream 
neural progenitor genes such as Sox2. Dominant negative Sox2 over expression 
resulted in a blockade of neural induction (Sasai, 2001). 
 
1.1.2 The development of progenitor cells and Notch signalling. 
 
Following the definition of the neurogenic regions by BMP/Dpp, the action of 
proneural genes are required for the correct formation of neural progenitor cells from 
the epidermis. The drosophila achaete/scute and the atonal genes encode !HLH 
transcription factors that bind specific E-box sequences in promoter regions of target 
genes thereby activating their transcription. Expression of Achaete/scute genes and 
consequent neuroblast formation is regulated by lateral inhibition through the Notch 
receptor and Delta ligand signalling. Notch is a transmembrane protein with cysteine 
rich EGF repeats that binds to its ligands Delta and Serrate. In drosophila, Notch 
signalling serves to regulate neuroblast formation with a low level of expression in 
neuroblasts and high levels of expression in epidermal cells. Notch loss of function 
results in more neurons differentiating in neurogenic regions, a similar phenotype to 
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Delta loss of function mutants (Pierfelice et al, 2011). Notch signalling enables an 
individual cell to maintain achaete-scute expression, and suppresses its own expression 
in neighbouring cells (Kopan & Ilagan, 2009).  
 
The production of the correct number and type of neurons is in part regulated by Notch 
activity, whereby during cell division a progenitor cell can give rise to either two 
progenitors or two neuronal cells, via symmetrical division, or a neuron and a 
progenitor through asymmetrical division. Studies in the brain reveal Notch signalling 
is required to maintain progenitor cells during neurogenesis whereby cells undergoing 
differentiation express Notch ligands, in turn activating notch signalling in 
neighbouring progenitor cells. This prevents their differentiation through lateral 
inhibition temporarily since the notch signal is then extinguished, resetting the 
potential of progenitors. (Gotz & Huttner, 2005; Louvi & Artavanis-Tsakonas, 2006).  
 
Previous studies have shown that Notch1, a homologue of the Drosophila Notch gene 
is concentrated basally in the dividing progenitor cells. The Notch1 protein is inherited 
asymmetrically in horizontal divisions whereas vertical cleavages distribute Notch1 
equally to the two daughter cells. Notch1 may then provide an instructive role within 
progenitor cells determining whether cell fates are the same or different (Chenn & 
McConnell, 1995; Donovan & Dyer 2005). These studies arguing for a role for 
asymmetric Notch in progenitor cells have been superseded by other studies contesting 
these findings (Fortini, 2009; Pierfelice et al, 2011). 
 
The current mechanism of Notch signalling involves the binding of Delta to Notch 
resulting in the proteolytic cleavage of the intracellular Notch domain by "-secretase, a 
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protease. The cleaved Notch fragment brings about nuclear transcriptional activation 
complex with Suppressor of Hairless (SuH) and Mastermind (MAM) proteins enabling 
the expression of downstream targets namely the !HLH Enhancer of Split genes. 
These genes repress Asc expression and blocks further neural differentiation along 
with down regulating delta expression (Pierfelice et al, 2011) (Figure 1.1 A). Initially 
all achaete-scute expressing cells have equal levels of Notch and Delta activity. When 
a cell expresses more achaete-scute, it activates the Delta promoter to produce more 
Delta protein that then activates Notch on neighbouring cells. This resulting in more 
Notch fragments binding to SuH that further joins Enhancer of Split in a 
transcriptional complex. This complex binds the N-box regulatory region in achaete 
gene to suppress its transcription thereby downregulating delta and forming a single 
neuroblast (Castro et al, 2005). 
 
Further studies have indicated that the onset of notch activity is a random event that 
governs progenitor fate, with Notch signalling occurring both before and after mitosis 
(Wilcock et al, 2007; Vilas-Boas et al, 2011). However this has been ruled out in more 
recent studies observing cells during normal neurogeneis where the establishment of 
apical polarity is crucial to this process (Das & Storey, 2012) (Figure 1.1 B). In this 
study, dividing cells with non-perpendicular cleavage planes are able to generate 
daughter cells through asymmetrically inheriting the apical Par protein complex. Par3 
specifically promotes the stem cell state of progenitors through Notch signalling. This 
complex is associated with dynein proteins and microtubule networks that contact the 
mitotic spindle (Zhong et al, 2008). This results in the basal daughter cell rapidly 
regrowing an apical process, re-establishing apical polarity. Loss of apical protein 
complex may serve to release the cells from the surface of the lumen.  
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Figure 1.1 (A) Scheme of Notch signalling between two adjacent cells. Arrowhead 
denotes the site of S2 ligand dependent processing. Grey arrow denotes site of S3 
cleavage by "-secretase as well as CBF1 mediated transcription of target genes in the 
nucleus. Ub – ubiquitin; PS – Presenilin. Taken from Pierfelice et al, 2011. (B) Cell 
movements during neurogenesis in the chick neural tube. Asymmetric divisions 
generate daughter cells inheriting apical (red) or basal (blue) cell poles. Upon division, 
apical daughters inherit the original apical complex (green) and the basal daughter 
inherits the basal process. The basal daughter makes new apical complex proteins 
(light blue) and extends a new apical process and elevates Notch signalling (grey). The 
apical daughter generates a new basal process, whilst down regulating apical proteins, 
evident as it commences apical process withdrawal during neuronal differentiation. 
The notch activated basal daughter cell that retains apico-basal polarity then goes on to 
divide again. Taken from Das & Storey, 2012. 
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In the neural tube as in the cortex, cells that inherit the apical component during 
division more often than not exit the cell cycle and become neurons. Therefore the 
basal daughter remains the progenitor daughter cell, and continues to function as a 
progenitor cell with inheritance of basal process a requirement for the maintenance of 
the neural stem cell state (Alexandre et al, 2010; Das & Storey, 2012). The model 
presented was that Notch signalling is differentially activated after apical-basal 
division indicating that mitotic spindle orientation influences Notch signalling. 
Increased levels of Notch in basal daughter cells reiterates their progenitor profile and 
indicates that asymmetric division results in a ‘cell intrinsic’ difference in ability of 
sibling cells or neighbouring cells to respond to Notch. Moreover basal daughter 
express Par3 and have active notch signalling while apical daughters, inherit Par3 but 
have no active Notch signals. The apical daughter then down regulates Par3 driving as 
differentiation proceeds (Das & Storey, 2012).  
 
1.1.3 Downstream of the Notch pathway in vertebrates. 
 
There are 4 Notch receptors in mammals, Notch1-4 that are activated by the Delta-like 
ligands Dll1, Dll3 and Dll4 and Jagged proteins, Jag1 and Jag2 on adjacent cells 
(Reviewed in Pierfelice at al, 2011). Delta and Serrate/Jagged proteins are further 
notch ligands that are expressed in complimentary domains within the ventricular zone 
(Myat et al, 1996). As described above, activation of the Notch receptor results in the 
intracellular Notch domain (NICD) being cleaved by Presenilin proteases Psen1/2 of 
the "-secretase complex. This NICD travels to the nucleus where it associates with 
CBF1 and mastermind-like (Maml) that then transcriptionally activate target genes. 
These Notch target genes include the Hes family, Hes1 and Hes5, and Hey genes that 
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encode inhibitory !HLH proteins that bring about the repression of proneural !HLH 
genes such as Ascl1 and Neurogenin1/2, two genes that promote neural differentiation. 
Therefore cells activated by Notch are inhibited from developing into differentiated 
neurons and reside in a stem cell state. Further targets of Notch signalling may be 
cyclinD1, p21, ErbB2 and GFAP to name a few although the mechanisms behind these 
remain unclear (Figure 1.1 A). 
 
Notch1 loss of function mice reveal a faster rate of differentiation of ventral spinal 
neurons with lower levels of Hes1 and Hes5 expression and higher levels of Mash1 
and Neurogenin1 and Neurogenin2 expression. There was also a reduction among 
multiple progenitor subtypes with marked increases in V0, V1 and especially 
Lim3/Chx10 positive V2 interneurons accompanied by a decrease in Lim3/Islet1 
positive motor neurons. This suggests Notch1 down regulation generates interneurons 
at the expense of motor neurons (Yang et al 2006). This compensatory effect is 
accompanied by a fusion of the ventral central spinal cord canal emanating from the 
floor plate perhaps through the loss of progenitor cells closest to the ventricles. 
Furthermore premature development of post mitotic neurons occurs that interconnect 
laterally, with Chx10 positive V2 neurons and Sim1 positive V3 neurons located more 
medially fusing together at the midline. Looking more closely, Notch 1 in the ventral 
spinal cord may serve to restrict the size of Lim3 positive progenitors through its 
action in progenitors. Within Lim3 population may then favour motor neuron 
development, yet the mechanism is unclear and may involve LIM-NLI tetramer 
complexes (Yang et al 2006).  
 
 12 
The notch pathway genes and proneural transcription factors are expressed in 
progenitors and differentiating neurons (Bertrand et al, 2002). The proneural genes 
Mash1, Neurogenin and Olig1/2 maintain progenitor cells by activating Dll1-3, which 
further activates notch receptors on dividing progenitor cells (Kageyama et al, 2008). 
The downstream expression of Hes1/Hes5 genes maintain cells as progenitors. 
Blocking the Notch receptor function results in premature neural differentiation 
(Nelson  et al, 2007). Over expressing Notch blocks the differentiation of progenitors 
to neurons, whereby they either stall or become glia. The progenitor pool is maintained 
if the cells express Dll, neurogenin and Hes1 equally. However, if a daughter cells has 
more neurogenin expression, this in turn stimulates the expression of Dll, activating 
Notch in the sister progenitor cell, which lowers its Dll expression. The daughter cell 
with higher neurogenin levels then terminates as a neuron. Therefore a change in the 
balance of Ngn or Hes1 levels in the Notch pathway results in an amplification of the 
surplus signal through feedback between the cells. Hes1 represses its own transcription 
resulting in a feedback loop that oscillates the level of Hes1 protein in each progenitor 
cell (Shimojo et al, 2008).  
 
The Hes1 oscillation results in counter oscillations of Ngn, and Dll gene activity in 
each cell whereby two neighbouring progenitor cells in contact cycle in opposite 
phases to each other. A second oscillation occurs during the progenitor expansion 
phase at Mitosis where Hes1 levels are high at S-phase but low entering M phase and 
G1 phase at the ventricular surface. Notch thus demethylates STAT3 binding site of 
the GFAP promoter enabling CNTF to activate this region (Namihira et al, 2009). 
Notch further induces NFIA, a glial promoting transcription factor during late 
astrocyte generation, repressing neurogenesis through Hes5 (Daneen et al, 2006). 
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1.2      Control of cell movements in the early neural tube. 
 
Cell movements within the neural tube are critical to the final location of neuronal 
subtypes, as demonstrated by studies on the distribution of motor neurons innervating 
the chick limb muscles and consequent columnar functional grouping of neurons 
(Landmesser, 1978; Landmesser, 2001; Hollyday & Hamburger, 1977; Hollyday, 
1980). Post mitotic daughter cells arising from ventricular zone neural progenitors, 
initially inhabit the midline ventricular zone either side of the lumen along distinct 
domains, and then migrate laterally and subsequently dorsoventrally along the neural 
tube (Leber & Sanes, 1995). The different combinations of transcription factors 
maintain regional properties and functionality during the migration of neuronal 
populations (Briscoe et al, 2000). 
 
Retroviral recombinant labelling of cells has shown a lateral displacement of cells 
within the ventricular zone, which becomes increasingly restricted into clonal groups, 
whilst initial migration is predominantly radial. Here radial stacking of progenitors in 
the ventricular zone and their migration occurs in spoke-like routes. Circumferential 
migration of neurons along axons and short distance dispersal of differentiating 
neurons, along with late migration of glia along white matter tracts also occurs (Leber 
& Sanes, 1995; Cepko et al, 1995) (Figure 1.2). 
 
Neuroepithelial radial glial cells are the first precursor cell types to develop in the 
spinal cord prior to the onset of neurogenesis. These cells are bipolar in morphology 
with both ventricular anchorage through apical adherens junctions with the lumen, and 
an elongated process with a conical pial end foot.  
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Figure 1.2 A Summary of the migratory patterns in dorsal (A) and ventral (B) chick 
spinal cord. (1) Cell mixing in the VZ  (2) Radial Stacking in the VZ (3) Radial 
migration into the IZ (4) Tangential migration (5) Dispersal of differentiated cells (6) 
Longitudinal migration of glia. FP-Floor Plate, IZ-Intermediate Zone, MC-Motor 
Column, MZ-Marginal Zone, RP-Roof Plate, VZ-Ventricular Zone. Taken from Leber 
& Sanes 1995. 
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The radial glial cell bodies lie predominantly in the ventricular zone and their bipolar 
morphology distinguishes them from the neuroepithelial cells within the cord (Rakic, 
1972; DeFelipe et al, 1988; Anthony et al, 2004). These radial glia ultimately give rise 
to all the different neuronal subtypes within the neural tube and a large majority 
develop into astrocytes at later stages of development. Post-mitotic pioneer neurons 
migrate along the radial glial fibre scaffold towards the pial surface and their fated 
pools (McDermott et al, 2005). 
 
1.2.1 Interkinetic Nuclear Migration. 
 
The nuclei of radial glial cells shuttle back and forth along the width of the ventricular 
zone as they undergo cell division. Once the daughter cells exit the cell cycle, they 
migrate radially and differentiate. Studies in the vertebrate retina and chick hindbrain 
have revealed that Interkinetic Nuclear Migration (INM) may have an impact on the 
fate of the daughter cells during cell division (Fujita, 1964; Fujita 2003; Guthrie et al, 
1991). Interkinetic nuclear migration as demonstrated in fish therefore drives nuclei to 
be exposed to proliferative versus differentiation signals (Frade, 2002; Gotz & Huttner, 
2005; Del Bene et al, 2008). During this nuclear migration, the nucleus shuttles 
through the cytoplasm during the cell cycle whereby M phase of mitosis, and 
consequent G phases occurs at the basal surface, respectively, and S phase where DNA 
synthesis occurs basally during asymmetric cell divisions (Jacobson, 1985).  
 
 
Studies of radial glia in the mammalian cerebral cortex have identified two distinct 
progenitor cell behaviours following cell division at the onset of neurogenesis. Firstly, 
a vertical symmetrical cleavage occurs whereby both daughter cells maintain contact 
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with the ventricular surface, which may serve to replenish the progenitor pool as radial 
glia. Secondly, horizontal asymmetrical cleavage occurs where one daughter cell re-
enters the cell cycle, and the other migrates radially as a post mitotic neuron 
undergoing differentiation. 
 
 
1.2.2 Radial glia and Laminins 
 
 
Asymmetrical cell divisions thus produce one progenitor cell and one neuron thereby 
replenishing the progenitor pool and producing differentiating neurons. Daughter cells 
that maintain both basal and apical adhesive junctions remain in the progenitor pool as 
radial glia (Chenn et al, 1998; Konno et al, 2008). The mechanisms behind how radial 
glia interact at adhesive junctions with the extracellular matrix of the spinal cord is 
only recently being elucidated.  Studies in the Medaka fish have suggested that 
Laminin signalling through the downstream Focal Adhesion Kinase (FAK) is required 
for planar cell division and interkinetic migration. This is possibly through an 
interaction between FAK and the dynein machinery, which is required for migration 
and movement (Tsuda et al, 2010).  
 
Laminins form key subunits of basement membranes structurally and also serve within 
signalling complexes with Integrins (Yurchenco et al, 2004).  In higher vertebrates 
during neurogenesis, laminin function was shown to be necessary for the correct 
positioning of cortical basement membranes. Loss of laminin function resulted in 
ectopic neuronal protrusions, yet laminin mutants are predominantly embryonic lethal 
(Halfter et al, 2002; Miner et al 2004). These early processes set the scene for 
neurogenesis in the neural tube and a complex patterning programme consequently 
ensues giving rise to neuronal populations at distinct locations in the spinal cord. 
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1.3  Neurogenesis and the cell cycle. 
 
During early growth of the neural tube, progenitor cells produce a large number of 
radial glial cells that are initially bipolar in morphology with one process attached to 
the central canal at the ventricular surface and the other connected to the outer, basal 
cell surface of the neural tube. The nuclei of these cells shuttle back and forth during 
the cell cycle, through Interkinetic Nuclear Migration. The nuclei move to the inner 
ventricular surface just prior to mitosis and divide into two daughter cells. The nuclei 
then move away during S-Phase (Norden et al, 2009).  
 
Astrocytes and oligodendrocytes also arise from the same cells that give rise to motor 
neurons highlighting the multipotency of the early ventricular zone progenitor cells, 
where neurons are generated first and then glial population follow (Leber et al, 1990; 
Tosney et al, 1995; Wilcock et al, 2007). Thus, multipotent progenitors in the neural 
tube can give rise to several lineages producing neurons, astrocytes and 
oligodendrocyte progenitors. However this multipotency gets restricted over time so 
that progenitors become committed to producing either neurons or glia and thus the 
potential of progenitor cells ultimately becomes restricted over time to unipotency. 
 
It is thought that phosphorylation signals are also required for the establishment of cell 
polarity, position and regulation of these precursor and daughter cells during 
neurogenesis. Phosphorylation through the action of a typical protein kinase C (Baye 
& Link, 2007), regulates cell polarity and influences the decision of progenitors to 
maintain stem-like properties or commit to a post-mitotic state.  
 
 19 
1.3.1 Cyclins as key components of the cell cycle. 
 
As development progresses, the number of new cells generated by progenitors 
decreases and the cells take longer to progress through the cell cycle. Cyclins are key 
components of cell cycle regulation and their expression coincides with the various 
stages on the cell cycle temporally. The cyclins associate with cyclin-dependent 
kinases (CDKs) resulting in their activation and consequent phosphorylation of key 
cell cycle proteins. Pairs of cyclins/cdk complexes regulate the different stages of the 
cell cycles and serve as start/stop ques. The progression through M Phase is controlled 
by Cyclin B and Cdk2 whilst the transition of G1 phase to S Phase is governed by 
Cyclin D and Cdk4 or Cdk6. Here Cyclin D causes cells to enter S phase by 
phosphorylation of Retinoblastoma protein (Rb), a tumour suppressor gene. Rb 
releases E2F that drives the transcription of target genes. Cdk inhibitors such as p27kip 
and p21 inhibit the cell cycle during mitosis in progenitor cells, causing exit of the cell 
cycle and differentiation of neurons and glia (Calegari et al, 2005).  
 
Ultimately FGF and EGF signals also play a role in the progression of G1 to S phase 
controlling cyclin D1 expression, with the Wnt pathway crucial for progenitor cell 
proliferation. Progenitor cells express receptors for specific mitogens and respond to 
their signals accordingly. EGF and FGF stimulate cell division by driving the 
expression of Cyclin D during S-phase. TGF-beta acts as stop signal for proliferating 
cells, through cell surface signalling and up regulation of p27kip. Further mechanisms 
act in concert to regulate cell cycle progression and generate the correct numbers of 
differentiated cells. Furthermore a shift occurs from a symmetric expansion phase of 
progenitor cell division to an asymmetric phase of cell division during neurogenesis. 
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As the cell cycle progression lengthens, progenitors gradually switch from producing 
further progenitor cells to producing differentiated neurons (Calegari et al, 2005). 
 
1.3.2 Control of cell cycle & Wnt signalling 
 
The overall regulation of cell cycle progression, cell proliferation and generation of 
neurons from neural tube progenitors are mediated in part by the Wnt family of 
secreted signalling proteins, related to the Drosophila Wingless gene, whose ligands 
bind to various Frizzled receptors on the cell surface and propagate a downstream 
signal (Nusse, 2001; Willert et al, 2003; Ohnuma & Harris; 2003). The Wnt pathway 
has been implicated in cell proliferation and adhesion, through various co-factors and 
structural adaptors proteins including dishevelled, !-catenin, and competitive cadherin 
dependent sequestration of !-catenin. These molecules transduce the signal from Wnt 
proteins, ultimately leading to !-catenin stabilisation and nuclear signalling. (Cadigan 
& Nusse, 1997; Jamora & Fuchs, 2002).  
 
Knockout studies of members of the Wnt family (Wilson et al, 2001), Wnt1, namely in 
mice show a deletion of the midbrain. Wnt3a loss of function reveals loss of the 
hippocampus. Double Wnt1/Wnt3a loss of function mice exhibit defects of the 
midbrain, hindbrain, and spinal ganglia indicating semi-redundant roles of these two 
genes in controlling the growth of the spinal cord as opposed to specification of 
regional fates (McMahon & Bradley, 1990; Ikeya et al, 1997). The ectopic expression 
of Wnt1 also results in a larger neural tube without affecting the pattering of precursor 
cells  (Dickinson et al, 1994). 
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Wnt1 and Wnt3a have been shown to act as mitogens by promoting proliferation and 
inhibiting the differentiation of progenitor populations of neurons. This is thought to 
occur via a gradient of Wnt activity, high dorsally, lower ventrally across the 
ventricular zone, initiated by Wnt genes expression in the dorsal midline of the spinal 
cord. Here the Wnt activity may affect the rate of proliferation and differentiation of 
precursor cells, while the dorsal TGF! and ventral Shh gradients would be involved in 
the patterning of distinct precursor identity (Megason & McMahon, 2002).  
 
McMahon and colleagues investigated the action of Wnt in the chick spinal cord and 
found that ectopic expression of Wnt1 resulted in a reduction of the number of 
differentiating neurons and increased rate of progenitor cell proliferation. Such 
mitogenic growth was greater at ventral regions with bulging of the ventricular zone. 
Furthermore this mitogenic effect was not observed amongst progenitors in the dorsal 
most region of the neural tube, yet elicits the greatest effect on the ventral most 
progenitor domains. The overall rate of proliferation in the neural tube following 
ectopic Wnt1 expression increased by 50% predominantly in the ventral region of the 
spinal cord through increasing the number of S-Phase cells and shortening the G1/G2 
phases of the cell cycle. This in turn reduced the differentiation of interneurons and 
motor neurons by over 50% without affecting the rate of apoptosis, demonstrating of 
role for Wnt1 in cell cycle progression and exit (Megason & McMahon, 2002). 
 
The transduction of Wnt signals is mediated by a number of factors, bringing about its 
action through the classical ‘canonical’ pathway where !-catenin is recruited and 
stabilised and initiates the binding of the TCF/Lef family of transcription factors that 
transcriptionally activate Wnt target genes (Nelson and Nusse, 2004) (Figure 1.3 A). 
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Figure 1.3 (A) Scheme of !-catenin in Wnt signalling and the cadherin complex. !-
Catenin exists as a cadherin-bound form that regulates adhesion This occurs in a 
complex with axin, APC, and GSK-3!, where it is phosphorylated and targeted for 
degradation by !-TrCP; or in the nucleus with TCF/LEF transcription factors. Wnt 
signalling, proceeding through Frizzled activates Dishevelled (Dsh), which results in 
uncoupling !-catenin from the degradation pathway and its entry into the nucleus, 
where it interacts with TCF/LEF to control transcription. Wnt protein can also interact 
with the Derailed receptor to control axon path finding. The Wnt pathway is also 
subject to extensive regulation and feedback control by extracellular factors that bind 
Wnt i.e. Wnt inhibitory factor (WIF) and Frizzled-related protein (FRP) or the 
coreceptor LRP (Dickkopf). Taken from Nelson & Nusse, 2004). (B) Regulation of the 
cadherin-catenin complex by the balance of tyrosine kinase and phosphatase activities. 
Cadherin binds p120 and !-catenin, which in turn binds "-catenin. The integrity of this 
complex is negatively regulated by phosphorylation of !-catenin by receptor tyrosine 
kinases (RTKs) and cytoplasmic tyrosine kinases (Fer, Fyn, Yes, and Src), which 
phosphorylate (red arrows) specific tyrosine residues in !-catenin (Y654, Y142), 
which leads to dissociation of the cadherin-catenin complex. Integrity of the cadherin-
catenin complex is positively regulated by !-catenin phosphorylation by casein kinase 
II, and dephosphorylation by protein tyrosine phosphatases that bind p120 and !-
catenin (green arrows). Changes in the phosphorylation state of !-catenin (bottom) 
affect cell-cell adhesion, cell migration, and the level of signalling !-catenin. 
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Megason and colleagues found that transfection of a dominant active form of !-catenin 
also resulted in an overgrowth phenotype similar to Wnt1 yet more pronounced, 
suggesting other factors may be involved downstream of Wnt and upstream of !-
catenin. The ectopic expression of Wnt1 or dominant active !-catenin was sufficient to 
reduce the differentiation of progenitors along the entire dorsoventral axis, blocking 
their differentiation without inducing apoptosis.  
 
Furthermore, ectopic dominant negative !-catenin expression resulted in an expansion 
of all progenitor domains evident by Pax6, Pax7 and Nkx2.2 yet precursor boundaries 
and domains were correctly patterned. Of the TCF/Lef family, TCF3 and TCF4 are 
expressed in neuronal precursor cells, ectopic expression of dominant negative TCF4 
that is unable to interact with !-catenin acts as a repressor of wnt pathway target genes 
and caused the cell autonomous blocking of the cell cycle prior to S-Phase without 
differentiation and therefore remaining stalled (Megason & McMahon, 2002). 
 
In the chick neural tube, only Wnt1 and Wnt3a demonstrate mitogenic activity and are 
expressed in dorsal midline cells, however Wnt3, Wnt4, Wnt7a, Wnt7b showed no 
such mitogenic properties and did not have any effect on the proliferation of precursor 
cells. Wnts elicit their responses through transcriptional targets to bring about 
regulation of the cell cycle. A key target is cyclin D1 (Nurse, 2000; Megason & 
McMahon, 2002). Cyclin D1 is expressed in the neural tube in a high dorsal to ventral 
gradient in mitotically active neural precursors, regulating the G1 exit of the cell cycle. 
In the early neural tube cyclin D1 expression is evident along the ventricular zone, 
however this expression gradient becomes restricted dorsally. Furthermore, dominant 
active !-catenin upregulates G1 phase cyclin D1 and cyclin D2 but not G2/Mphase 
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cyclins, cyclin A1 or cyclin B3 within precursor cells indicating the transcriptional 
regulation of cyclinD1 by Wnt signals to be a direct action.  
 
Ectopic expression of Wnt1 and Wnt3a also resulted in cyclinD1 up regulation, yet 
only in intermediate to ventral regions of the spinal cord as ventral cells have a 
stronger response to mitogenic wnt activity. Also, high levels of dominant negative 
TCF4 down regulated cyclin D1 expression. The ectopic expression of dominant 
negative cyclin D1 resulted in the formation of abortive complexes with G1 cyclin 
dependent kinases CDK4 and CDK6, causing a reduction in the expansion of 
progenitor populations without blocking the cell cycle, or abnormal expansion of 
progenitors. Dorsal midline wnts in the neural tube therefore serve to act as mitogens 
spatially and temporally (early progenitor expansion, later increased differentiation) on 
precursor populations, increasing their proliferative rate and decreasing the rate of 
proliferation through a gradient of activity from high dorsal to low ventral across the 
ventricular zone (Megason & McMahon, 2002). 
 
1.3.3 Cadherin-catenin functions in the neural tube  
 
The control of cell-cell adhesion is also important for neural tube growth and 
patterning. This is in part regulated by cadherins and catenin signalling. Cadherin 
signalling ultimately establishes adhesive contacts and to mobilise cells through the 
neural tube. Cadherin-based cell-cells contacts involve homodimerisation and 
consequent association with the cytoskeleton via actin clustering (Adams & Nelson, 
1998). Tyrosine phosphorylation of !-catenin in the Cadherin/Catenin complex plays 
an important role in its regulation (Anastasiadis & Reynolds, 2000) (Figure 1.3 B).  
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Interestingly, the binding of #-catenin to actin at the cytoplasmic end of the Cadherin 
receptor, through a !-catenin complex, involving p120 that binds with microtubules is 
also regulated by phosphorylation.  For our purposes we will focus on the type I 
Cadherins that include E-Cadherin and N-Cadherin and the Type II Cadherins that 
include MN-Cadherin (Shapiro & Colman, 1998). 
 
Serine/Threonine phosphorylation of !-catenin results in stabilization of the Cadherin 
complex, however tyrosine phosphorylation of !-catenin directly disrupts this complex 
making more !-catenin available to the cytoplasm (Roura et al, 1999). Furthermore, a 
few PTPs bind to p120 and reverse the phosphorylation of tyrosine, which stabilizes 
the cadherin complex and establishes adhesive contacts (Lilien et al, 2002; Nelson & 
Nusse, 2004) (Figure 1.3 B). 
 
Cadherins have also been shown to define and segregate pools of motor neurons 
during neurogenesis. The combined profiles of type II Cadherins that have been shown 
to define functional motor pools within the chick neural tube, namely the differential 
expression of individual members of the Cadherin family such as MN-Cadherin in the 
segregation of neuronal subsets within the motor columns and further segregation of 
neurons within each subdivision (Price et al, 2002).  The Cadherins are also critically 
implicated in maintaining adhesive contacts between cells in the epithelium, with 
intracellular links to the actin filament cytoskeleton (Harstock & Nelson, 2007; 
Halbleib et al, 2006).  As previously described, adherens junctions are located at the 
apical surface of the neuroepithelium and have many functions, namely cell adhesion, 
signalling, cytoskeletal regulation and transcriptional control. These junctions facilitate 
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the migration and dispersal of precursor and post mitotic cells and earlier transitional 
states of the epithelial cells (Yamada et al, 2005; Ferreri & Vincent, 2008)  
 
The birth of the first neurons during neurogenesis forms a critical milestone in the 
development of the spinal cord. Complex gene interactions generate distinct 
populations of neuronal subtypes through a combination of signalling factors whilst 
guidance molecules guide newly born cells to their resting places in the spinal cord. 
Here, cells project axons to their targets and begin building the complicated array of 
connections within the central nervous system. From a mere cluster of blastula cells 
giving rise to the a pseudo stratified epithelium, the neural tube folds and holds 
together our wiring, connecting our peripheral motor and sensory circuits ultimately to 
our brain (Jessell, 2000). What triggers the birth and temporal-spatial distribution of 
spinal neurons within the neural tube and what cues guide this development, arranging 
the distinct functional cohorts into refined patterns?  
 
1.4  Generating the anterior-posterior pattern of the neural tube 
 
The Hox family genes were first discovered in drosophila. The Anteroposterior axis 
was initially established through the distribution of Bicoid anteriorally and nanos 
posteriorly, establishing a framework for further segmentation of the embryo (Driever 
& Nusslein-Volhard, 1998). Hox function has been conserved from flies to vertebrates, 
however the mechanisms of patterning vary.  
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1.4.1 Retinoic acid and rostrocaudal polarity 
 
A major regulator of Hox gene expression has been identified as Retinoic Acid (RA), 
which permeates the cell membrane and binds a cytoplasmic retinoic acid receptor 
complex that moves to the nucleus to regulate the expression of target genes via 
‘Retinoic Acid Response Elements’ (RARE). RA expression proceeds through a 
gradient with anterior regions of the embryo possessing a ten fold greater 
concentration compared to posterior regions. Embryos treated with RA fail to develop 
heads and display an inhibition of anterior Hox gene expression (Durston et al, 1989).  
 
RA is able to induce Hox gene expression in embryonic stem cells with increasing 
concentrations of RA, resulting in the expression of more posterior Hox genes 
(Simeone et al, 1991). The source of RA is the overlying paraxial mesoderm which 
enzymatically synthesises RA that consequently diffuses into the neural tube in order 
to activate the correct expression of the Hox genes. In vertebrates, the neural inducers 
through the organiser centres produce, as described previously, 
Chordin/Noggin/Follistatin that transforms the neural tube to provide anterior brain 
characteristics, whilst caudal transforming features are brought about though the action 
of RA, Wnts, Hox and FGFs in synergy with BMP signalling (Nordstrom et al, 2006).  
 
1.4.2 FGF signalling and anteroposterior patterning. 
 
Along the rostrocaudal aspect of the neural tube, the Fibroblast growth factor genes 
(FGFs) and Retinoic Acid and expression profiles of the Hox transcription factors 
determine the pattern of neural progenitor cells and position along the length of the 
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spinal cord (Bel-Vialar et al, 2002; Dasen et al, 2003, Sockanathan et al, 2003). Many 
Hox genes ultimately work with other factors to determine motor neuron pool identity 
with a very ordered and restricted expression profile (Jungbluth et al, 1999; Briscoe & 
Wilkinson, 2004; Dasen et al, 2005).  
 
Progenitor cell culture experiments show that adding FGF drives their differentiation 
to neurons whilst those cultured with EGF, CNTF or BMP produced astrocytes. 
Progenitor cells cultured with PDGF produced oligodendrocytes (Ravin et al, 2008; 
Bonni et al, 1997; Raff et al, 1988). CNTF receptor activation causes phosphorylation 
of STAT3 that in its active form enters the nucleus and binds to specific sites in the 
promoter regions of GFAP and S100 genes. This direct transcriptional control is 
reinforced by BMP, where early progenitor cells remain unresponsive to CNTF and 
therefore few glia are produced at these stages. The DNA in promoter regions of 
GFAP is methylated in early progenitors blocking the binding of STAT3 and 
activation of GFAP function (Fan et al, 2005). 
 
The anteroposterior gradient of Wnt/!-catenin and further co-inhibition of Wnt/BMPs 
leads to the induction of anterior CNS characteristics. Mediators in the inhibition of the 
Wnt pathway include Cerberus, FrzB receptor that competes for Wnt thereby blocking 
its signal propagation and Dickkopf, which are all expressed in the organiser region 
(Kiecker & Niehrs, 2001). The FGF family of growth factors act in a dose dependent 
manner similar to the action of RA during neural induction. High FGF expression 
induces posteriorising genes of the Hox family such as FGF8 in the chick (Liu et al, 
2001; Maden et al, 2006).   
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1.5 Establishing dorsoventral polarity of the neural tube. 
 
 Dorsoventral polarity within the spinal cord occurs through a sequence of cell 
movements and formation of the ventral floor plate and dorsal roof plate. The sulcus 
limitans forms as a fissure along the length of the spinal cord dorsoventrally. Signals 
emanating from the notocord and other neural and non-neural tissues further develops 
and refines this axis.  
 
1.5.1   Shh and neural tube patterning 
 
A large number of transcription factors determine the DV patterning of the spinal cord 
during development (Tanabe & Jessell, 1996; Lumsden & Krumlauf, 1996; Goodman, 
1996). An initial pattern is established by Sonic Hedgehog (Shh) and Bone 
Morphongenic Protein (BMP) (Roelink et al, 1994; Roelink et al, 1995; McMahon et 
al, 1998). Along the dorsoventral aspect of the cord, the Shh gradient expression 
extends from the notochord and floor plate, decreasing dorsally resulting in progenitor 
cells generated in the ventricular zone of the neural tube, whilst BMP’s operate 
dorsally and in competition (Poh et al, 2002; Liem et al, 1995). 
 
Pax7, Olig 2 and Nkx2.2 are main players in this process and are expressed in well 
defined domains with Pax7 responding to lower levels of SHH, while Nkx2.2 to the 
highest levels of SHH ventrally. Shh loss of function embryos for example reveal a 
block in the development of all ventral cell types in the spinal cord, including motor 
neurons (Chiang et al, 1996). The Gli genes are implicated as transducers of the Shh 
signal and these are described in more detail in section1.6. (Figure 1.4 A & B). 
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Figure 1.4  (A) A scheme for spinal cord development in the chick. On the left is a 
diagram of the cross-regulatory interactions between Class I & II genes, which 
establish the cell fate domains at the corresponding levels of interacting pairs, where 
boundaries represent cross-repressive pairs. They act either side of the midline of the 
spinal cord to set up the progenitor domains p0 to p3 in the spinal cord scheme at the 
centre of the diagram against a decreasing Shh gradient from the ventral to the dorsal 
aspect of the spinal cord. These then gives rise to their corresponding cell fate domains 
V0 to V3, which by E5 express various differentiation factors, also listed in the table 
on the right against their cell fate domains. VZ-Ventricular zone. Adapted from Jessell, 
2000. (B) Molecular pathway for motor neuron development where Nkx6.1 
unconstrained by Irx3 and Nkx2.2 is sufficient to induce MNR2 expression, which 
then induces downstream transcription factors Lim3, Isl1/2 and HB9. MNR2 also auto-
activates its own expression consolidating progenitors toward a motor neuron fate.  
After Jessell, 2000.
AB
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1.5.2 Dorsal fate determination by BMPs 
 
The progressive restriction of neuronal fate within the spinal cord as development 
proceeds derives from many factors acting in concert to maintain the regional identity 
of neuronal progenitors through overlapping and restricted gene expression profiles. 
Members of the TGF! family namely the Bone Morphogenic Protein (BMP) genes act 
dorsally, originating from the roof plate in a graded manner within the neural tube 
alongside the ventral Shh signals. BMP loss of function mice (GDF-7) display a loss of 
the dorsal-most neural precursor cells in the neural tube (Lee et al, 1998).  
 
Further experiments have demonstrated a role for BMPs whose expression from the 
roof plate promotes, regulates and defines the expression domains of the Pax genes. 
The Pax 3/6/7 genes are expressed in a dose-dependent manner prior to cell 
differentiation within the dorsal and intermediate regions of the neural tube, promoting 
cell differentiation and !HLH gene expression. BMPs then serve to activate various 
homebox transcription factors that further define progenitor pools within the neural 
tube and alongside Wnt signals (Timmer et al, 2002; Lee et al, 2000; Zhuang & 
Stockanathan, 2006).  
 
Studies in the chick have shown that BMPs and Wnts function within separate 
pathways, with BMPs acting as morphogens during neural patterning whilst Wnts may 
act as mitogens during neural tube growth. BMPs may also regulate Wnt and homebox 
genes during a later phase of spinal cord specification and progenitor pool refinement 
(Chesnutt et al, 2004; Wine-Lee et al, 2004). 
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1.5.3   Wnt pathway and dorsoventral patterning. 
 
Wnts are secreted molecules that bind the Frizzled receptor, a membrane bound 
protein with seven transmembrane domains. A further component of the frizzled 
receptor is called LRP that presents as a single transmembrane strand. In the absence 
of binding of Wnt protein to Frizzled ,  !-catenin binds to a complex and causes the 
ubiquitination and ultimate degradation of !-catenin (Cadigan & Nusse, 1997; Polakis, 
2002). During the binding of Wnt to its receptor, a further protein, called dishevelled 
(Dsh) is activated, blocking the degradation of !-catenin and allowing its accumulation 
in the cell. This !-catenin then translocates into the nucleus forming a transcriptional 
activator complex with TCF/Lef, initiating the transcription of target genes (Reviewed 
in Nelson & Nusse, 2004).  
 
Furthermore, Wnt signals are thought to result in the accumulation of !-catenin in the 
cytoplasm, translocation into the nucleus and interaction with the transcription factor T 
cell Factor/Lymphoid Enhancer Factor  (TCF/LEF) that regulates gene expression. In 
the absence of Wnt signals, phosphorylation of !-catenin by CKI and Glycogen 
Synthase 3! (GSK3!) results in its degradation. Activation of Wnt leads to inhibition 
of GSK-3! and accumulation of cytoplasmic !-catenin thus providing a level of !-
catenin regulation within the cell (Polakis et al, 2002).  Wnt signals therefore not only 
affect proliferation but also affect Shh induced patterning to a certain degree (Briscoe 
& Novitch, 2008; Muroyama et al, 2002; Robertson et al, 2004). 
 
This sequence of events determines the expression of other transcription factors that 
establish the patterning of neural progenitor cells. Post mitotic daughter cells arising 
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from neural progenitor cells within the ventricular zone consequently follow a radial 
and tangential migration to end up in their transcription factor-specific domains 
creating diverse neural circuits (Briscoe & Novitch, 2008). Classical studies in the rat 
spinal cord reveal a ventral to dorsal sequence of neuronal production in the neural 
tube, whereby spinal motor neurons are the first to be generated followed closely by 
interneurons and finally dorsal horn neuronal populations (Altman & Bayer, 1985; 
Jessell, 2000).  
 
1.6  Controlling neuronal fate – the !HLH genes. 
 
A complex array of signalling processes orchestrate the assembly, birth and migration 
of neurons within the neural tube. The dorsoventral pattern of neurons in the cord is 
largely established by signals coming from Shh ventrally and BMP dorsally (Jessell, 
2000). How are ventral Shh signals interpreted by progenitor cells? These occur 
through the action of Class I and Class II homeodomain transcription factors, whose 
distinct boundaries of expression are defined by cross-repressive interactions between 
the two pairs of genes. Motor neurons arise from the pMN domain that expresses 
Nkx6.1 and Pax6, which repress the determination of other neuronal cell types in this 
domain. Nkx2.2, Irx3 and Dbx2 repress motor neuron differentiation in non-pMN 
domains (Lee et al, 2004; Muhr et al, 2001). This results in Olig2 expression at the 
pMN domain driving motor neuron differentiation and expression of neuronal 
transcription factors Isl1/2, MNR2, Hb9 and Lim3. MNR2 then self regulates its 
expression, directing the cell toward a motor neuron fate. Gain of function studies of 
class I and class II transcription factors revealed they act repressively through the 
Groucho family of co-repressors (Muhr et al, 2001) (Figure 1.5 A-C).  
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Figure 1.5 (A) Scheme of gene pathways regulating neurogenesis. Shh and RA initiate 
the expression of Nkx6.1, Nkx6.2 (Nkx6) and Pax6 in ventral spinal cord progenitors. 
The repressor activities of Nkx6 and Pax6 prevent the expression of inhibitors of MN 
formation, such as Dbx1, Dbx2 (Dbx) and Nkx2.2, and permit ligand-bound retinoid 
receptors to activate Olig2 expression (red). Within MN progenitors, Olig2 directs MN 
differentiation by repressing Irx3 and other unidentified target genes that regulate the 
expression of the MN-specific transcription factors, MNR2, Lim3, Isl1, Isl2 and Hb9, 
and the pan-neuronal transcription factors, Ngn2 and NeuroM/Math3. The repressor 
activity of Olig2 works in conjunction with the activator function of ligand bound 
retinoid receptors. (B) Transcription factor network controlling motor neuron 
differentiation. Olig2 promotes motor neuron development through repression of Irx3, 
Scl and unidentified targets (X). RA signaling lead to the expression of transcription 
factors downstream of Olig2, including MNR2, Lim3 and Ngn2. Ngn2 is negatively 
regulated by Hes that act downstream of the Notch signaling pathway. The activator 
properties of Sox1–3 appear to induce the expression of unknown inhibitors of Ngn2 
function (Y). Through blocking Ngn2 expression, Notch signaling, Hes genes and 
Sox1–3 maintain progenitors in an undifferentiated state. The release of Ngn2 leads to 
the up regulation of NeuroM and the exit of progenitors from the cell cycle. NeuroM 
then forms a transcriptional activator complex with Lim3 and Isl1/2, mediated by NLI, 
that activates Hb9. (C) Scheme of cellular expression profiles during neurogenesis. 
Progressive changes in progenitor cells during motor neuron development from (i) 
unpatterned progenitors to (ii) ventral progenitors, (iii) MN/Oligodendrocyte 
progenitors, (iv) committed MN progenitors and (v) differentiated MN state. A-C 
taken from Briscoe & Novitch, 2008. 
 
AB
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For motor neurons to arise, the combined expression of Nkx2.2, Nkx6.1 and Irx3 at the 
pMN domain is required (Briscoe et al, 2000). Nkx2.2 and Irx3 define the ventral and 
dorsal limits of motor neuron production while Nkx6.1 then induces Olig2 and MNR2 
expression (Novitch et al, 2001, Tanabe et al, 1998). Mnr2 was in fact sufficient to 
generate ectopic neurons in the neural tube without any effect or feedback onto the 
Class I and Class II transcription factors (Tanabe et al, 1998).  
 
Oligodendrocytes arise from older multipotent precursors that had already generated 
motor neurons from the pMN domain in the ventral spinal cord, through FGF 
signalling (Pringle et al, 2003). The two transcription factors Olig1 and Olig2 are 
expressed in this pMN domain. Olig1/2 loss of function reveals a failure of 
oligodendrocytes and motor neurons to develop, whilst over expression induced 
ectopic oligodendrocyte development. During motor neuron development, the 
proneural factor Neurog2 is expressed in the same domain as Olig2 and is involved in 
the production of motor neurons initially (Kessaris et al, 2001; Zhou et al, 2001). As 
development progresses, the progenitor cells switch off Neurog2 expression and 
instead express Nkx2.2. This represses motor neuron production whilst Olig1/2 
expression is maintained in these cells, and this Oligodendrocyte production ensues. A 
single progenitor cell therefore is able to produces phases of motor neurons and then 
glial cells. 
 
1.6.1 Generation of Progenitor pools  
 
Along the spinal cord, before axonogenesis, neurons acquire transcription factor-
specific columnar identities that strongly relate to their ultimate fate and function. 
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They can be grouped into subsets according to their expression profiles of transcription 
factors that determine their positional identity in the spinal cord (Jessell, 2000). 
 
Motor neuron generation in the ventral neural tube is dependent upon a graded Shh 
signal from the floor plate and notochord (Chiang et al, 1996), which specifies the 
identity of motor neuron progenitors along the ventricular zone of the spinal cord 
(Ericson et al, 1996). This in turn regulates the expression of homeodomain and !HLH 
transcription factors in the 2 major groups: Class I, repressed by Shh, and Class II, 
activated by Shh. These genes work in complementary pairs whereby Class I and Class 
II transcription factors cross-repress each other at the boundary of their expression, 
defining distinct expression profiles of these genes within these progenitor domains. 
This then sets up progenitor domains dorsoventrally with distinct boundaries along the 
ventricular zone (Jessell, 2000; Briscoe & Ericson, 2001) (Figure 1.4 A).  
 
Early studies on the specification of progenitor identity and neural cell fate in the 
ventral neural tube reveal that the combinatorial expression of Nkx6.1, Nkx2.2 and 
Irx3 is responsible for the identity of 3 neuronal subtypes here (Briscoe et al, 2000). In 
vitro studies reveal 5 classes of ventral neurons are generated in response to varying 
concentrations of Shh activity and therefore corresponds to their positional identities 
within the neural tube and Shh dose required for their specification (Ericson et al, 
1997). Downstream of the Shh signal various homedomain genes elicit the effects of 
the Shh dose in driving the differentiation of progenitor cells that are expressed within 
these progenitor cell domains, namely the Pax3/6/7, Nkx2.2 and Dbx1/2 genes 
regulating neuronal subtype identity (Briscoe et al, 2000). Progenitor cells expressing 
Nkx6.1 and Irx3 are regulated by a specific SHH dose and located within a distinct 
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domain in the ventral neural tube. Moreover, 5 class I homeodomain proteins are 
repressed by Shh, namely Pax7, Irx3, Pax6, and Dbx1/2 and two class II homeodomain 
proteins are induced by Shh namely Nkx6.1 and Nkx2.2. The initial pattern of Class II 
protein expression ultimately becomes independent of Shh signalling by HH10-15. At 
the ventral limits of these class I expression domains and dorsal limits of class 2 
expression domains sharp progenitor boundaries are defined. These cross repressive 
interactions are responsible for dividing the ventral tube into 5 distinct progenitor 
domains, V0, V1, V2, pMN and p3 in a dorsal to ventral progression (Briscoe et al 
2000) as well as 6 dorsal progenitor domains (Muller et al, 2002) (Figure 1.6 A –D).   
 
Misexpression of individual homeodomain proteins in a mosaic fashion by 
electroporation or retroviral transduction within the chick neural tube revealed an 
interesting effect on the progenitor boundaries. When considering the boundary at the 
pMN/p3 domain, delineated by Pax6 and Nkx2.2, misexpression of Pax6 ventral to its 
normal expression generate a cluster of ectopic Pax6 cells evident in the p3 domain, 
which lacked Nkx2.2 expression. The expression of Nkx2.2 in the p3 domain however 
was maintained by the other p3 domain cells that did not express ectopic Pax6, 
demonstrating a cell autonomous role for Pax6 here. The other homedomain proteins 
were not affected by the misexpression of Pax6. Misexpression of Nkx2.2 dorsal to the 
p3 domain, its region of expression, the progenitor cells expressing ectopic Nkx2.2 did 
not express Pax6. Pax6 expression was however maintained in cells neighbouring the 
ectopic Nkx2.2 cells indicating a further cell-autonomous, selective function of 
Nkx2.2, as other homedomain proteins remained unaffected by Nkx2.2 misexpression.  
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Figure 1.6 (A) Scheme of dorsal progenitor cell patterning. There are six progenitor 
cell subpopulations, p1–p6, in the medial spinal cord, with specific bHLH expression 
profiles. The six progenitor domains generate dorsal interneurons, dI1–dI6. These 
neurons are located laterally of the progenitors and are defined by their expression of 
homeodomain transcription factors. Taken from Zechner et al, 2007. (B) & (C) Scheme 
of mouse spinal progenitor patterning and specification. At E9 in the mouse (B), a 
gradient of Sonic hedgehog (red) ventrally and BMP/GDF7 (yellow) dorsally provide 
instructive positional signals to dividing progenitors in the ventricular zone. This leads 
to the restricted activation of patterning factors in discrete dorsventral domains, which 
are represented by Nkx6.1 (ventral), Pax6 (intermediate) and Pax3 and Pax7 (dorsal). 
At E11 in the mouse (C), eleven early classes of post mitotic neuron are present in the 
embryonic spinal cord. dI1-dI5 neurons that are derived from dorsal progenitors (grey) 
primarily contribute to sensory spinal pathways, while dI6, MN and V0-V3 neurons 
from ventral progenitors (yellow) are elements of the locomotor circuitry. Some of the 
post mitotic transcription factors that mark each of the eleven early generic populations 
are indicated. Taken from Goulding, 2007. (D)  Specification of neuronal subtype 
identity in the mouse/chick spinal cord. Right: neurons (circles) in the developing 
spinal cord can be uniquely identified by their transcription factor profiles. The 
different types of interneuron and motor neuron shown here derive from corresponding 
dorsoventral progenitor domains in the ventricular layer (Dp1 to Vp3), although their 
final location might alter due to cell migration. Left: neuronal identity is acquired 
when cells are still in the ventricular layer, in specific progenitor domains (vertical 
bars). Taken from del Corral & Storey, 2001.  
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Nkx2.9 expression transiently overlaps with that of Nkx2.2 in the p3 domain and 
misexpression of Nkx2.9 resulted in ectopic Nkx2.9 cells that lacked Pax6 activity. 
The repression of Pax6 was shown to be independent of Nkx2.2 in this instance 
suggesting the ventral boundary of the pMN domain may be influenced by Nkx2.9 as 
well.  
 
Observing the at the interactions at the p1/p2 boundary, between Dbx2 and Nkx6.1, 
misexpression of Dbx2 ventral to the p1 domain similarly showed the ectopic Dbx2 
positive cells lacking Nkx6.1 expression whilst neighbouring cells maintained this 
expression without affecting Pax6 or Pax7 expression. Misexpression of Nkx6.1 
resulted in the down regulation of Dbx2 in ectopic Nkx6.1 cells whilst Dbx2 
expression was maintained in neighbouring cells. This further suggested a selective, 
cell autonomous role for Dbx2 and Nkx6.1 in this domain. 
 
Looking at further progenitor relationships, the p0 domain gives rise to Evx1/2 
positive neurons, whilst the p1 domain gives rise to V1 En1 positive neurons. The p3 
domain gives rise to Sim1 positive V3 neurons and p2 domain gives rise to Chx10 
positive V2 neurons. The pMN domain exclusively gives rise to HB9 positive motor 
neurons (Saha et al, 1997). The division of V2 neurons and motor neuron progenitors 
initiates the onset of Lim3 expression, with later motor neuron progenitors expressing 
MNR2. Lim3 was shown to be expressed in the p2 and pMN domains whilst MNR2 
was expressed exclusively in the pMN domain (Reviewed in Price & Briscoe, 2004; 
Tanabe et al, 1998; Sharma et al, 1998; Briscoe et al, 2000).  
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When considering the three ventral most progenitor domains, misexpression of Nkx6.1 
in the absence of high level Irx3 expression (that begins after neural tube closure at 
p2/pMN domain) at early stages revealed an ectopic pattern of MNR2 and Lim3 
positive cells in dorsal positions to p2 domain in both progenitor cells and post mitotic 
neurons. Ectopic Islet1/2 and HB9 positive cells were also found on the lateral margins 
of the neural tube, possibly induced by the ectopic MNR2 expression driven by 
Nkx6.1. Furthermore, ectopic Chx10 V2 neurons were also observed in the p0 and p1 
domains. Thus Nkx6.1 in the absence of Irx3 was sufficient to generate motor neurons 
in ectopic locations. Where Nkx6.1 was misexpressed in regions with persistent Irx3 
activity, this resulted in ectopic Chx10 V2 neurons in the p0 and p1 domains as well as 
Lim3 positive cells within the dorsal most ventral progenitor domains.  
 
Ectopic expression of Nkx6.1 within the p0 and p1 domain also resulted in the ectopic 
expression of En1 V1 and Evx1/2 V0 neurons but not motor neuron markers. This 
suggests Irx3 counters the ability of Nkx6.1 to drive motor neuron fate, and that 
conversely Nkx6.1 and Irx3 together drive the generation of V2 neurons. 
Misexpression of Irx3 in regions ventral to the p2 domain resulted in Irx3 positive 
cells in ectopic locations that did not express MNR2, Islet1/2 or HB9, with V2 Chx10 
expressing neurons generated at more ventral positions often within the pMN domain. 
The Lim3 expression profile remained unaltered by Irx3 misexpression. Thus the 
domain at which Nkx6.1 is able to generate motor neurons is limited by Irx3 
expression dorsal to the p2/pMN progenitor boundary domain. 
 
Further misexpression of Nkx2.2 in more dorsal regions to the p3 domain resulted in a 
repression of MNR2, Lim3, Islet1/2 and HB9 in such cells ectopically expressing 
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Nkx2.2, ultimately allowing a sharpening of the p3/pMN domain. The misexpression 
of Nkx2.2 further resulted in the generation of V3 Sim1 positive neurons in the Nkx6.1 
domain and throughout the dorsal neural tube independently of Nkx6.1, suggesting an 
element of functional redundancy of Nkx2.2 and Nkx6.1 or they may have overlapping 
roles (Briscoe et al, 2000). 
 
1.6.2 Shh signal transduction and the Gli genes  
 
The zinc finger proteins of the Gli family, homologue of the Drosophila Cubitus 
Interruptus transcription factor (Ci) are thought to transcriptionally mediate the Shh 
signal in the neural tube and drive the dorsoventral patterning of this structure in 
vertebrates. Three Gli genes are implicated in this process namely Gli1, Gli2 and Gli3. 
Gli proteins are thought to integrate the various pattering signals during neurogenesis 
(Reviewed in Jacob & Briscoe, 2003). The Gli genes function as transcriptional 
activators in a graded manner and are expressed in the mouse in the ventral neural 
tube. Their expression is ultimately dependent upon Shh signals, with Gli2 taking a 
lead in the initial transduction of the Shh signal (Ruiz I Altaba, 1997; Dai et al, 1999; 
Wang et al, 2000; Bai et al, 2002). Individual Gli gene mutants show minor 
developmental defect yet ventral cell types fail to differentiate when all Gli signals are 
blocked. Gli signalling has also been implicated in the Wnt pathway and specifically 
GSK3 interaction (Mullor et al 2001) and also in BMP signalling whereby Smads 
associate physically with processed Gli proteins (Liu et al, 1998) whereby BMPs may 
regulate the post transcriptional control of Gli activity in concert with Shh derived 
signals. 
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Further studies revealed a gradient of Gli activity mediates the graded Shh signal 
(Stamataki et al, 2005). Gli2 and Gli3 but not Gli1 act dually as transcriptional 
repressors and activators, through proteolytic processing. Mouse knockout studies of 
Gli1 reveal normal patterns of spinal cord development whilst Gli2 knockout mice 
display abnormal ventral neural tube patterning. Gli3 loss of function mice reveal a 
dorsal expansion of the intermediate zone within the spinal cord. In mice with 
complete loss of all 3 genes, the ventral pattering of the spinal cord was abnormal with 
a loss of ventral cells and segregation defects throughout (Matise et al, 1998; Park et 
al, 2000; Persson et al, 2002; Bai et al, 2004).  
 
Stamataki and colleagues further generated activated Gli3 constructs that produce 
different levels of Gli activity to test if a Gli gradient of transcriptional activity was 
sufficient to mediate the graded Shh signal. Three dominant negative Gli3 variants 
Gli3Ahigh delivering stronger activation than the second, Gli3Amed by two to three 
fold, and similarly the third, Gli3Alow offering the lowest levels of activated by two or 
three fold where electroporated in ovo. The group found that Gli3Ahigh led to cells 
expressing floor plate and V3 neuronal markers in ectopic positions in a cell 
autonomous manner.  Furthermore not all the cells expressing Gli3Ahigh co expressed 
either Nkx2.2 or FoxA2, markers of the ventral most neural tube cells. Ectopic 
expression of Gli3Amed and Gli3Alow however was not sufficient to induce FoxA2 or 
Nkx2.2. Gli3Amed expression reduced levels of Pax6 and both Gli3Amed and 
Gli3Alow sometimes resulted in ectopic cells close to the roof plate that were FoxA2 
positive. Thus lower doses of Gli3 seem to have activator functions in this domain and 
that higher doses of Gli3 were sufficient to induce cells with ventral characteristics and 
markers in the intermediate zone of the neural tube.  
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The group further observed the action of the Gli3 constructs on the pMN and p2 
regions where ectopic expression of Gli3Ahigh in cells dorsal to p2 caused a cell 
autonomous ectopic expression of Olig2, MNR2/HB9, and Nkx6.1 whilst at the same 
time bringing about repression of Pax7 and Irx3. Within the pMN and p2 regions 
however this high dose of Gli3 results in down regulation of Olig2 and MNR2/HB9, 
with cells here acquiring a more ventral identity. With Gli3Amed, pMN and p2 
markers Olig2, Chx10 and Nkx6.1 were observed in the intermediate zone and Pax7 
repression amongst ectopic cells. The study suggested that lower doses of Gli3 were 
sufficient to induce V2 and MNs but not the ventral most cell fates. When the 
Gli3Alow construct was transfected, within the intermediate zone, low levels of 
ectopic Nkx6.1 expression was observed but not Olig2 or any motor neuron markers 
yet V2 neuronal markers were observed. However the low levels of Gli3 were 
sufficient to induce ectopic V1, V0 and dI6 fates with cells expressing Dbx2 and Cad7, 
while repressing Msx1 and Pax7 in these ectopic cells. This repression was sufficient 
to drive V1 and V0 neuronal fates in more dorsal positions and therefore the lower 
Gli3A does were sufficient to induce intermediate neural tube characteristics 
(Stamataki et al, 2005). 
 
Furthermore, to test whether ongoing Shh signalling was required for Gli3 action, 
coelectroporation of the higher dose constructs along with a Shh inhibitor. This on its 
own results in repression of ventral progenitor cell identities and ventral expansion of 
dorsal markers. Coelectroporation did not affect Gli3 activity and embryos displayed 
induction of FoxA2, Nkx2.2, Olig2 and Pax7 repression. This suggests that Gli3A 
effects are cell autonomous and not due to increased floor plate Shh or ectopic 
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induction of Shh, and further that an ongoing Shh signal in not required for Gli3 
activity, which is sufficient at the correct doses to drive the Shh dependent ventral 
patterning of the neural tube (Stamataki et al, 2005). 
 
1.6.3  Downstream of Shh action. 
 
Thus an initial external Shh signal is interpreted by the Gli genes that transduce the 
signal, converting the Shh gradient into an intracellular signal that can initiate a 
response in individual cells which then ultimately serve to regulate gene expression 
and control the identity of neurons during neurogenesis (Reviewed in Dessaud et al, 
2008). Once secreted, Shh itself undergoes post-translational modifications namely 
auto-catalytical cleavage and cholesterol modification at the C terminal, whilst being 
palmitoylated at the N terminus forming a molecule with a high molecular weight 
(Chen et al, 2004). The active Shh requires the transmembrane protein dispatched1 for 
its function whereby Disp1 loss of function eliminates the active high molecular 
weight Shh and severely disrupts ventral neural tube patterning. Further extracellular 
proteins modulate the Shh signal, whereby proteins bind extracellular Shh with the aim 
of restricting its diffusion or affecting its degradation.  
 
One such example are Heparan Sulphate Proteoglycans (HSPGs) that bind high 
molecular weight Shh at conserved sites (Rubin et al, 2002). Further, Shh binds to 
transmembrane proteins that transduce the Shh signal, ultimately affecting the 
differentiation of such cells in the ventral neural tube. For instance Shh action causes 
the transcriptional up regulation of Ptch1, a Shh receptor and Hhip1 that encodes an 
EGF-repeat membrane protein, whereby their expression then brings about inhibition 
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of Shh cell autonomously either through sequestration of the ligand or degradation of 
Shh and this helps modulate the Shh signal through a negative feedback loop and 
ligand dependent antagonism (Jeong & McMahon, 2005). 
 
Intracellulary, the transmembrane protein smoothened (Smo) is activated by 
extracellular Shh through a graded manner mimicking the Shh gradient and initiating a 
signalling cascade offering temporal adaption and positional regulation (Chen et al, 
2002; Dessaud et al, 2007; Chamberlain et al, 2008). Initially cells are highly sensitive 
to Shh, and low levels of Shh are able to induce the Gli genes however as development 
progresses, cells start to become desensitized to Shh and much higher levels of Shh are 
required to generate high levels of Gli expression whereby different amounts of Shh 
illicit an intracellular response at different time point where the duration of the signal 
is proportional to the Shh concentration. A negative feedback loop then comes into 
play by inhibitors such as Ptch1 that ultimately serve to desensitise cells to Shh. 
Furthermore these mechanisms then regulate the pattering of the ventral neural tube 
through the action on the !HLH and homebox genes. The intracellular mechanisms 
behind Shh signalling are the subject of much ongoing investigations. 
 
1.7       LIM homeodomain proteins 
 
Interneuronal and motor neuron populations are initially derived from progenitor cells 
expressing Nkx2.2 or Pax6, whereby Nkx2.2 has a primary role in interpreting a Shh 
signal and the determination of neuronal pattern, whilst Pax6 serves to provide indirect 
control of this pattern (Briscoe et al, 1999).  Motor neuron progenitors are located 
within the pMN domain that also gives rise to oligodendrocytes. Oligodendrocyte 
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development is also dependant upon a Shh signal. Following the production of somatic 
motor neurons in the ventral neuroepithelium, oligodendrocytes arise from progenitors 
within the ventral most Nkx2.2 expressing domain, and not within the Pax6 territory. 
Shh is sufficient for their induction but not required for their maintenance (Soula et al, 
2001). 
 
Olig2 is a proneural gene expressed in the pMN domain, a region of motor neuron and 
oligodendrocyte progenitors and is essential for their development, where it determines 
two different cell fates. Olig2 activates Ngn2 in the pMN domain, activating motor 
neuron production; consequently, Ngn2 down regulation initiates Nkx2.2 up regulation 
that then acts alongside Olig2 to produce oligodendrocytes (Marquardt and Pfaff, 
2001). More recently phosphorylation of Neurogenin2 was shown to regulate motor 
neuron development (Ma et al, 2008). 
 
The !HLH genes have traditionally acted through the notch signalling pathway, yet 
studies have implicated their interaction with the evolutionary conserved LIM-HD 
transcription factors and various other regulators in the specification of motor neuron 
subsets (Bertrand et al, 2002). LIM-HD transcription factors initiate their expression in 
early post-mitotic motor neurons, an event that is closely linked to cell cycle exit, and 
the commitment to a neuronal fate. Cell fate acquisition is synchronised with cell cycle 
exit, and the !HLH genes are involved in the specification of different neuronal and 
glial subgroups. 
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1.7.1 Motor neuron specification 
 
Motor neurons acquire their columnar identities once they have left the cell cycle. 5 
main columnar subgroups exist based on their expression of various transcription 
factors namely of the LIM-HD family (Fig 1.7). Two of these subgroups are located in 
the MMC at thoracic levels with its lateral branch projecting to somatic targets whilst a 
medial branch projects to axial muscles (Tsuchida et al, 1994). Another subgroup 
exists called the Column of Ternii at thoracic levels and contains preganglionic 
autonomic motor neurons, which project to sympathetic targets. Two other subgroups 
exist located within the lateral motor columns at limb levels with a medial subset 
projecting to ventrally derived somatic targets and a lateral subset whose neurons 
innervate dorsally derived limb muscles (Tosney et al, 1995).  
 
Dorsoventrally Shh acts to regulate Pax gene patterns in the ependymal layer to 
produce different classes of precursors. The ventral-most group of cells become motor 
neurons and express Islet1, which is required for the differentiation of all motor 
neurons initially. Early born motor neurons at the limb levels innervate ventral muscles 
and continue to express Islet1 but not Lim-1. In contrast, later born neurons migrate 
through these early cells settling laterally and innervating dorsal muscles, where these 
cells now turn off Islet-1 and switch on Lim-1 (Tsuchida et al, 1994). 
 
Islet1 & Islet2 are some of the first genes switched on in motor neurons after they 
leave the cell cycle (Pfaff et al, 1996). Cross-regulatory interactions between the 
!HLH genes establish the pMN domain where motor neurons arise, through the 
interaction of Nkx6.1, Nkx2.2 and Irx3 (Islet 1/2 are also expressed dorsally as well), 
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resulting in the expression of downstream genes namely Mnr2 and Lim3 (Tanabe et al, 
1998; Thaler et al, 1999; Sharma et al, 2000; Jessell, 2000) (Figure 1.5).   
 
Mnr2 is expressed by post mitotic motor neurons and helps to establish their identity, 
but in the chick its expression is initially restricted to the pMN domain (Tanabe et al, 
1998). Mnr2 and its related protein Hb9 (Saha et al, 1997), are expressed by motor 
neurons and belong to the Mnx class of homeobox transcription factors with a role in 
the determination of motor neuron fate.  
 
In Hb9/Mnr2 loss of function studies in mice, HB9 was found to be required for the 
consolidation of motor neuron identity and the correct emergence of motor neuron 
subtype identity along with the subsequent projection of motor axons. In this study the 
ectopic expression of Mnr2 in the chick lead to motor neuron differentiation and 
repression of V2 interneuronal character, whilst in the mouse, the generated motor 
neurons acquire characteristics of V2 interneurons once again (Arber et al, 1999).  
More recent studies have further implicated Notch1 signalling in V2 interneuronal and 
motor neuron generation, where Notch1 knockout mice exhibit lower numbers of 
motor neurons generated from the ventricular zone and higher numbers of V2 
interneurons to compensate (Yang et al, 2006). 
 
Mnr2 is initially normally expressed in the Medial Motor Column (MMC), Lateral 
Motor Column (LMC) and Column of Ternii (CT) neurons but only persists in the 
MMC. Mnr2 is required for the formation of CT neurons whereby Mnr2 & Hb9 act to 
suppress the generation of these neurons induced by Lim3. It acts as a transcriptional 
repressor during the acquisition of motor neuron fate (William et al, 2003). 
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Figure 1.7 (TOP) Organization of Hox proteins, motor columns and pools. MMC: 
median motor column; HMC: hypaxial motor column (formerly lateral MMC); PGC: 
preganglionic motor column; LMC: lateral motor column. Symp: sympathetic chain 
ganglion neurons. (B) 21 Hox proteins assign spinal MN identity. (C) Hox interactions 
specifying MN identity. Taken from Dasen et al, 2008. (BOTTOM) Columnar 
identities at different levels within the spinal cord. Taken from Tuschida et al, 1994. 
The diagram on the right represents the rostrocaudal location of motor columns in the 
chick neural tube, with schematic sections through the cord at different levels showing 
the columnar expression of transcription factors: [Blue – Isl1/2 & Lim3; Red – Isl1/2; 
Green – Isl2 & Lim1; Orange – Isl1] and the location of their peripheral targets to the 
right. LMC-Lateral Motor Column, m-medial branch, l-lateral branch; MMC-Medial 
Motor Column, m-medial branch, l-lateral branch; CT-Column of Ternii. 
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A study of the LIM-HD protein Hb9 has suggested a derepression model of gene 
regulation and cell fate specification in the neural tube, whereby ‘enhancer’ sequences 
can also target gene expression to a single neuronal subtype (Lee et al, 2004). This 
paper suggests 3 strategies that contribute to Hb9 regulation temporally and spatially in 
post-mitotic neurons. First, activator proteins in the neural tube interact with the Hb9 
promoter and stimulate its transcription. Second, the non-specific functions of these 
activators is constrained by repressor proteins such as Nkx2.2 in non motor neuronal 
cell sub-types and finally Hb9 expression is activated and maintained by an enhancer 
region within the Hb9 regulatory region which contains ‘cis’ elements for ‘positive’ 
factors such as Islet1, Ngn2, NeuroM & NeuroD. Synchronization of neurogenesis and 
motor neuron specification then occurs via !HLH and homeodomain transcription 
factors (Lee & Pfaff, 2003). Repressor proteins might also function in interneuronal 
populations such as those determined by Chx10, En1 and Evx1/2, which interact with 
the Gro/TLE class of co-repressors and this method of transcriptional depression can 
also operate within progenitor and post mitotic cells (Lee & Pfaff, 2003).  
 
 
Motor neurons have pool-specific identities during their initial outgrowth indicating 
that they must have cell surface differences, allowing their later axons to fasciculate 
with like axons. Furthermore these motor neurons recognize path finding guidance 
cues, enabling their axons to move around the neural tube (Landmesser, 2001). Motor 
neuron growth cones respond to guidance cues within targets and along the way, 
providing a differential detection and response both to inhibitory and attractive 
guidance cues, which are contact mediated or chemical as observed through fate 
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mapping studies using DiI labelling of progenitor cells (Tessier-lavigne & Goodman, 
1996; Erskine et al, 1998).  
 
1.7.2 Pool specific neuronal identities & columnar fates. 
 
The LIM-Homeodomain family of transcription factors play a pivotal role in the 
development of spinal cord tissues, and are predominantly expressed in interneurons 
and motor neurons along the length of the neural tube (Tsuchida et al, 1994). In this 
study the LIM homeobox genes Islet-1, Islet-2, Lim-1 and Lim-3 were cloned in the 
chick and found to define subclasses of motor neurons that subsequently segregated 
into columns within the neural tube. Previous studies in the Xenopus embryo have 
isolated variants of the Lim genes namely Xlim1 and Xlim3 (Taira et al, 1992; Taira et 
al, 1993). The purpose of the study was to identify the LIM genes that distinguish the 
different subclasses of neurons based on their dorsoventral and anteroposterior position 
within the neural tube. Combinatorial expression of the LIM genes was shown to 
define subclasses of neurons, which arrange neatly into columns yet this LIM-HD 
expression did not confer rostrocaudal identity or the delineation of individual motor 
pools. These genes were shown to be expressed post mitotically before these neurons 
arrange themselves into columns and further axonal pathways.  During neurogenesis 
for example, motor neurons express Islet-1 once they leave the cell cycle suggesting 
this LIM homeobox gene is involved in the differentiation of these neurons.  
 
Tsuchida and colleagues found that LIM homeobox genes are expressed by motor 
neurons prior to axonogenesis and columnar segregation, suggesting these genes may 
confer the topographical identities of motor neurons and their targets (Tsuchida et al, 
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1994). Antibodies raised against chick Islet-1 were found to label motor neurons that 
ultimately innervate somatic (skeletal) & visceral (sympathetic) motor neuron targets. 
The mRNA distribution of Islet-1 was found to be overlap with the 
immunohistological pattern. However from HH23 onwards not all Iselt-1 
immunoreactive cells expressed Islet-1 mRNA suggesting a related gene encoding a 
protein is also recognised by Islet-1 antibodies. The expression of Islet-2 was found to 
overlap with Islet-1 distribution within all somatic motor neurons in the ventral spinal 
cord suggesting the Islet-1 antibody also recognizes Islet-2. The group’s results 
showed that Iselt-2 expression was restricted to motor neurons whilst Islet-1 was also 
expressed dorsally by a subset of developing interneurons. Two further homeobox 
genes, Lim1 and Lim3 were later shown to be expressed by motor neurons as well, 
however expression of Lim-1 was also seen in interneuronal populations within the 
neural tube and Lim-3 expression also in a subset of cells dorsal to the motor neuron 
populations. Lim-2 and Lmx-1 expression was not seen in motor neurons but other 
distinct groups of neuronal cells.  
 
Based on these expression profiles, the chick spinal cord was divided into 5 columnar 
subsets. This pattern was apparent by HH35 with neurons migrate away from the 
ventricular zone laterally. These columns are the Median Motor Column (MMC) with 
a medial division MMCm projecting to axial muscles of the vertebrate column and a 
lateral division MMCl projecting to body wall muscles. The Lateral Motor Column 
(LMC) subdivides into a medial division LMCm with motor neurons contained here 
projecting to limb muscles of the ventral muscle mass and a lateral division LMCl 
projecting axons to limb muscles of the dorsal muscle mass. The fifth set, the column 
of ternii (CT) contains visceral motor neurons projecting to sympathetic targets.  
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The combinatorial expression of the LIM homeobox genes was shown to overlap with 
this columnar organisation of the spinal chord at various rostrocaudal levels by stage 
HH35. At this stage within the MMC extending rostrocaudally, where the lateral 
subdivision is restricted to thoracic levels, MMCm motor neurons co express Islet1, 
Islet2 and Lim3. MMCl motor neurons co express Islets 1 & 2 but not Lim3. Lim1 was 
not expressed by any MMC motor neurons. Within the LMC, restricted to the brachial 
and lumbar regions of the neural tube, Islet2 is expressed throughout, but not Lim3 at 
any level. Islet 1 expression was restricted to LMCm motor neurons. Lim 1 expression 
was restricted to LMCl neurons also co expressing Islet2. Within the column of ternii, 
extending to thoracic and rostral lumbar segments of the spinal cord, ventral neuronal 
populations express Islet1 but not Islet2, Lim1 or Lim3. Dorsal neuronal populations 
within the CT however did not express any of the Islet or Lim genes. Looking to 
understand what drives this columnar pattern by stage HH35, the onset of LIM 
homebox gene expression was investigated at earlier stages.  
 
Within the MMCm, Islet1, Iselt2 and Lim3 expression were first seen at HH14-15 with 
a sharp increase in cells expressing these LIM factors by HH 1718. Within the cervical 
spinal cord, by HH18 Islet-1 positive cells were observed that did not express Islet2 
and in particular these cells were located close to the ventricular zone. Furthermore, 
Lim3 cells were detected at the very lateral border of the neural tube. As neurons 
migrate laterally away from the ventricular zone, earlier born neurons will be located 
in more lateral locations, therefore the data suggested Islet1 is the first LIM homebox 
expressing gene to be switched on followed by Islet2 and then Lim3 (Tsuchida et al, 
1994).  
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Within the LMC, at lumbar levels where only MMCm neurons are present in the 
absence of MMCl and CT neurons, LMCm neurons were found to be born at HH18-19 
whilst LMCl neurons were generated at HH20-21 with earlier born neurons therefore 
taking up positions within the LMCm column. At HH17, cells of LMCm showed Islet1 
expression preceding that of Islet2, yet by HH18 both Islet1 and Islet2 were expressed 
in the LMCm, but not Lim1. In the LMCl at HH21 when only a few Lim1 positive 
cells are located in the ventral spinal cord, these cells co express Islet1. By HH23, 
numbers of Lim1 cells increased sharply, and now these cells began to co express 
Islet2 but not Islet1, suggesting the latter is switched off. Further mRNA in situ studies 
of these LIM genes revealed that LMCl neurons express Islet1 before Lim1 or Islet2, 
and that the transient Islet1 expression in these cells is followed by the lateral 
migration of cells and Lim1 & Islet 2 expression by HH24 and well before the 
formation of axonal trajectories by LMC neurons. Furthermore, neurons that co 
express Lim1 and Islet2 in the LMC migrate through the LMCm that were previously 
generated to reach their final positions within the LMCl. This also suggests that the 
LIM gene expression profile of these neurons is determined prior to lateral migration 
of cells and columnar organisation (Tsuchida et al, 1994). 
 
Spinal motor neuron development is also crucially dependent upon Retinoid signalling. 
LMC neurons express RALDH2, an enzyme capable of synthesising retinoic acid, 
converting inactive retinoid precursors to into retinoids that then carry out their effects 
in a non-cell-autonomous manner in order to bulk up motor neuron populations and 
bring about the LMCl expression profile. RALDH2 expression begins during the early 
phase of motor neuron development at brachial levels of the spinal cord specifically, 
that then distinguishes LMC neurons from other visceral or somatic neuronal 
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populations and leads to the differentiation of Islet2 positive, Lim1 positive LMCl 
neurons. Explant analysis at thoracic levels revealed that RA was sufficient to induce 
Islet2/Lim1 positive neurons phenotypes (Sockanathan & Jessell, 1998). 
 
When considering interneuronal cell populations that do not express RALDH2 
normally, brachial explants with or without RA resulted in many Chx10 positive V2 
cells yet none co expressed Lim1. However at HH14, dorsal neural tube explants 
grown alone contained D2 Islet1 positive neurons but Lim1 expression failed to be 
induced by Retinoic acid, therefore the ability of retinoid signalling to induce Lim1 is 
a selective feature amongst motor neurons. Ultimately motor neurons then lose the 
ability to respond to retinoid signalling once a LMCl phenotype is generated 
(Sockanathan & Jessell, 1998). 
 
1.7.3 Pax Genes  
 
Further studies in the early chick embryo reveal that Pax 2 is expressed by numerous 
interneuronal populations within the neural tube, suggesting this gene alone is not 
responsible for conferring regional identities of inter neuronal subsets. Pax2 is mainly 
expressed in dorsal subsets of post mitotic interneurons from Stage HH15-17 onwards 
with two distinct populations, a dorsal and ventral group with this expression 
extending from HH18 to HH24. From HH25 onwards, Pax2 expression was observed 
in the ventral and dorsal horns, displaying a similar pattern of expression in both the 
chick and the mouse. At HH20 all Pax2-positive cells were found to express Lim1/2. 
Some cells expressing only Lim1/2 and not Pax2 were observed dorsally, which may 
include commissural neurons, and in more intermediate zones. Pax2-positive cells did 
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not however co-express Islet1, demonstrating Pax2 is not expressed by motor neurons 
or dorsal interneurons (Burrill et al, 1997).  
 
Pax2 was shown to be expressed in new post mitotic neurons as they migrate into the 
mantle zone following neuronal differentiation and it is thought to function to 
determine cell fate. Within HH19 chick spinal cords, Pax2-positive cell domains were 
shown to overlap with Evx1 transcripts in a subset of ventral Pax2 cells, yet only half 
of the Evx1 cells expressed Pax2. However, nearly all En1 positive cells co expressed 
Pax2, highlighting a distinct subset of pax2 expressing cells that project ipsilaterally in 
the ventral neural tube. Furthermore the group found that En1 and Evx1 neurons did 
not overlap (Burrill et al, 1997). 
 
Pax7, an early pattering gene is expressed in the neuroepithelium, while Pax6 is 
expressed more widely in the dorsal basal plate and ventral alar plates, where it 
displays stronger levels of expression and weaker levels in the dorsal spinal cord 
region. Pax2 expression dorsally is found on the border of the dorsal expression 
domain of Pax6 and adjacent to Pax7 expression. The more ventrolateral Pax2 
expression is adjacent to the domain of Pax6 precursors whereby the dorsal boundary 
of Pax6 expression demarcates the boundary between the two populations of Pax2 
cells with En1-expressing cells evident adjacent to the ventral-most Pax6-positive 
precursor cells, suggesting Pax6-positive cells give rise to En1-positive neurons. Thus 
the combinatorial expression of PAX2, EN1 and EVX1 proteins may confer neuronal 
subtype identity in the neural tube in a similar manner to the combinatorial action of 
Lim homebox genes during motor neuron development, with Pax2 being required for 
interneuronal determination and En1 and Evx1 controlling terminal interneuronal post 
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mitotic function following on from the earlier actions of patterning genes such as Pax6 
(Burrill et al, 1997). 
 
Further studies highlighting the role of Shh in motor and interneuronal development 
reveal that an initial phase of Shh mediated repression of Pax3 and Pax7 leads to the 
formation of a subset of ventral progenitor cells in the neural tube. A later second 
phase of Shh activity then leads to the development of motor neurons and ventral 
interneurons (Ericson et al, 1996; Ericson et al 1997). Shh signalling was found to be 
necessary for the generation and induction of V1 and V2 subsets of ventral 
interneurons and also for motor neuron development in a dose dependent manner 
relative to the position of the cells within the spinal cord. Considering the downstream 
effects of Shh, the homebox genes Nkx2.2 and Pax6 (Goulding et al, 1993) were 
analysed with mutations in the Pax6 gene leading to defects in eye and forebrain 
development amongst Small Eye (Sey) mouse mutants. Thus Nkx2.2 and Pax6 were 
found to be involved in Shh orchestrated control of neuronal patterning and identity.  
 
Within the spinal cord, Pax6 expression in the ventral half shows a low ventral to high 
dorsal gradient of expression, however Nkx2.2 positive cells are restricted to just 
above the floor plate that do not express Pax6. Repression of Pax6 allows the 
generation of a second wave of ventral progenitor cell development that express 
Nkx2.2, driving the differentiation of progenitor cells and change in motor neuron fate. 
Ultimately the lack of Pax6 function amongst Sey mutants within more dorsal ventral 
progenitors of the spinal cord results in the loss of specific ventral interneuronal 
populations. However among these mutants, loss of Pax6 more dorsally in the ventral 
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spinal cord does not result in a ventral transformation of identity amongst progenitors 
causing the elimination of V1 interneurons altogether.  
 
The loss of Pax6 more ventrally however does cause a dorsal to ventral transformation 
of identity among progenitors, initially at spinal cord levels C1 to R7, albeit without 
changing motor neuron number but changing their identity from somatic neurons to 
visceral neurons. At cervical levels C4 to C3, progenitor cells are driven from motor 
neuron fate towards a ventral cell fate transforming the identity of these cells. Thus the 
consequences of Pax6 expression on motor neurons ultimately depends on their 
position along the rostrocaudal spinal cord (Ericson et al, 1996; Ericson et al 1997). 
 
Nkx2.2 is normally expressed above the floor plate and ventral to the Pax6 domain. 
Analysis of Nkx2.2 mutants reveals that the expression of Pax6 remained unaltered. 
Pax6 and Nkx2.2 were shown to have a reciprocal repressive relationship whereby 
ectopic expression of Nkx2.2 results in repression of Pax6, but with no effect on Pax7 
expression. Within Nkx2.2 mouse mutants the Pax6 expression domain remains 
unaltered and does not expand ventrally. However Nkx2.9 here was shown to be 
expressed transiently within the Nkx2.2 domain, suggesting a degree of functional 
redundancy between the Nkx family of genes (Briscoe et al, 1999; Briscoe & Ericson 
1999). 
 
1.8 Segmental identity of motor neurons and Hox genes. 
 
The rostrocaual, segmental identity of motor neurons is irreversibly specified by 
embryonic day 2 (E2) in the chick, where signals from the paraxial mesoderm cause 
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the limb regions of the spinal cord to become distinctly different.  The Hox genes play 
an important early role in the specification of the rostrocaudal patterning of neuronal 
populations within the neural tube. Motor neurons also rise along distinct dorsoventral 
domains along the spinal cord acquiring columnar characteristics. Such imposition of 
columnar fate was shown to be influenced by the Hoxc cluster of genes following 
transposition of the neural tube soon as it closes. Signals emanating from the paraxial 
mesoderm were shown to affect the fate of spinal motor neurons and their arrangement 
(Ensini et al, 1998) (Figure 1.7).  
 
Post mitotic motor neurons express a subset of Hox genes namely of the Hoxc cluster, 
and differential Hoxc expression with profiles of lumbar, thoracic and brachial MNs 
was shown to be induced in vitro through a dose dependent FGF stimulus (Liu et al, 
2001; Bel-Vialar et al, 2002). More specifically looking at LMC and CT neurons at 
brachial and thoracic levels respectively, that express Hoxc5/6/8/9, Dasen and 
colleagues found that brachial motor neurons expressed Hoxc6 whilst thoracic motor 
neurons expressed Hoxc9 with cells expressing both Hox genes located at the border 
of the thoracic and brachial regions. Hoxc5 and Hoxc8 expression followed a similar 
pattern with co expressing cells located at the mid brachial region. Thus rostral 
brachial LMC neurons co expressed Hoxc5 and Hoxc6 whilst caudal brachial LMC 
neurons co expressed Hoxc6 and Hoxc8.  
 
Within rostral thoracic levels, motor neurons initially expressed both Hoxc8 and 
Hoxc9 coincident with the temporal and spatial organisation of the columns. Ectopic 
expression of FGF8 in brachial and thoracic regions revealed down regulation of 
Hoxc6 expression and initiation of Hoxc9 expression at brachial regions suggesting 
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FGF over expression results in a brachial to thoracic transition of Hoxc profiles. 
Brachial expression of FGF8 reduced the Islet1/2 positive motor neuron pool by 30% 
(Stockanathan & Jessell, 1998; Dasen et al 2003).  
 
At brachial regions however following Fgf8 expression, motor neurons failed to 
express RALDH2 a marker of LMC neurons, with a loss of Islet2 and Lim1 
expression, suggesting increased FGF8 signalling here suppressed LMC differentiation 
similar to Hoxc6 suppression. Furthermore, raised levels of FGF8 signalling in 
brachial regions resulted in a shift from Hoxc6 to Hoxc9 expression and LMC to CT 
(thoracic) character respectively as a direct action of FGF8 cell-autonomously (Dasen 
et al, 2003).  
 
The group further examined if the switch in fate from LMC to CT neurons imposed by 
FGF8 could be mimicked by ectopic expression of Hoxc proteins. In the brachial 
region, Hoxc9 expression inhibited Hoxc6 in motor neurons cell-autonomously 
reducing the number of Islet1/2 positive and Lim1 positive LMCl neurons, 
furthermore these Hoxc9/Islet1/2 positive motor neurons also expressed BMP5 and 
were in dorsomedial positions similar to the arrangement of CT neurons.  
 
Thus Hoxc9 was found to mimic the action of FGF8 and repress Hoxc9 and LMC 
character whilst driving CT character (Dasen et al 2003). However, expression of 
Hoxc6 at rostral thoracic regions did not suppress Hoxc8 and further mis-expression of 
Hoxc8 at rostral brachial levels did not suppress Hoxc6 or RALDH2. Furthermore, 
misexpression of Hoxc8 at rostral brachial levels suppressed Hoxc5 action suggesting 
the expression domains of Hoxc5 and Hoxc8 arise as a result of a cross-repressive 
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relationship. Looking at the expression of Hoxc genes at HH15 in neural progenitors, 
demonstrated that brachial progenitors lacked Hoxc9 and Hoxc6 expression whilst 
thoracic progenitors lacked Hoxc6 but expressed Hoxc9. The influence of FGF8 
misexpression in progenitor cells at brachial levels showed that Hoxc9 was induced 
without Hoxc6, mimicking a thoracic shift in progenitor profiles.  
 
Furthermore to assess if motor neuron columnar identity could be changed through 
direct expression of Hoxc protein in post mitotic brachial motor neurons, the 
expression of Hoxc9 suppressed Hoxc6 and stopped the differentiation of LMCl 
neurons. Conversely, Hoxc6 was able to block CT differentiation at thoracic levels 
through repression of complimentary Hox pairs. Thus the Hoxc cluster in the neural 
tube appears to specify columnar identity through mutual pairs of cross-repressive 
interactions, thereby inducing column specific markers of differentiated motor 
neurons. Furthermore, the interaction of Hox5 and Hox8 during motor pool 
specification is asymmetric with activator roles here. Furthermore, the repressive, 
independent interaction of Hox4 and Hoxa7 during intersegmental motor pool 
diversification is required for correct patterning of this motor pool, but not an absolute 
requirement. The Hox genes are therefore essential in refining and determining the 
pattern of motor neurons in their distinct pools (Dasen et al, 2003; Dasen et al, 2005). 
 
1.9    Protein Tyrosine Phosphatases. 
 
Many of these transcriptional processes that define cell-cell adhesion events, cell 
proliferation and neurogenesis involve the phosphorylation and dephosphorylation of 
key amino acid residues within receptors and their effectors. Ultimately the product of 
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these processes is a well-organised, functionally-led pattern of transcription factor-
specific neuronal groups. Some of the signalling pathways and cellular behaviours 
seen during this early period of neural tube development are governed by key protein 
tyrosine phosphorylation events. Such phosphorylation results in conformational 
changes of target proteins, allowing interactions with other molecules. However, not 
all interactions are dependent upon a conformational change. Simply the presence of a 
phosphate is sufficient to trigger binding or “docking” to other effectors. These 
phosphorylation events must be co-regulated by receptor and non-receptor tyrosine 
kinases (PTKs), such as FGFR and src kinases, and the large, complementary family of 
Protein Tyrosine Phosphatases (PTPs). However, very little is known about the role of 
PTPs in spinal cord development. In the following section the literature on RPTPs will 
be introduced, as well as how these receptors might function within the early neural 
tube.  
 
The classical, tyrosine-specific PTP families fall into 2 categories: receptor-like PTP’s 
(RPTP’s), which are plasma membrane bound, and the cytoplasmic non-receptor 
PTP’s (Stoker, 2001; Tonks & Neel, 2001; Johnson & Van Vector, 2003; Alonso, 
2004; Stoker, 2005; Tonks, 2006; Hendriks et al, 2012). There are 21 mammalian 
RPTP’s, grouped into eight main subtypes based on their extra cellular domain 
structures (Figure 1.4).  
 
Their intracellular catalytic domains are highly conserved. They have been shown to 
be involved particularly in the regulation of neuronal development and axonal 
guidance (Ensslen-Craig & Brady-Kalnay, 2004; Alonso, 2004). These molecules 
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often have extracellular domains similar to cell adhesion molecules, implicating their 
role in axonogenesis and path finding.  
 
Differences in these extracellular domains suggest they have specific ligands and 
studies have led to the emergence of both heterophilic and homophilic ligands for 
these molecules. One such example is PTP$, which has been shown to bind the 
heparan sulphate proteoglycans agrin and collagen XVIII (Aricescu et al, 2002) and 
Nucleolin (Alete et al, 2006). 
 
1.9.1 Functional studies of RPTPs 
 
Loss of function data have demonstrated a role for RPTP’s in promoting axon target 
recognition in the motor nerve system and developing visual system, recognising 
guidance cues and later participating in synapse formation. This was first demonstrated 
in the Drosophila visual system.  
 
1.9.1.1    PTP action in motor axons 
 
Early studies of PTP function in Drosophila looked at the role of these molecules in 
axonogenesis and more specifically motor axon guidance. These studies arose as a 
result of the homology of RPTP’s extracellular domains to neuronal adhesion 
molecules such as N-CAM, implicating their potential role in cell surface signalling 
via tyrosine phospohorylation. 
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Figure 1.8 The RPTP family. The classical protein tyrosine phosphatases (PTPs) can 
be categorized as receptor-like (R) or non-transmembrane (NT) proteins. Use of 
alternative promoters (PTP#) or alternative splicing (PTPRO) leads to the production 
of transmembrane and cytoplasmic forms of some PTPs from a single gene. 8 RPTP 
subgroups exist. For RPTPs with two intracellular PTP domains, the membrane-
proximal D1 domain is catalytically active. In group R4, the D2 domain of PTP" also 
displays a low residual activity. For the remaining RPTPs, including PTP#, the D2 
domain maintains a PTP fold but lacks activity and is known as a pseudophosphatase 
domain. In each case, the PTPs have been designated by a name that is commonly used 
in the literature. Where this differs from the gene symbol, the latter is included in 
parentheses for clarification. In each case, the various subdivisions are based upon 
sequence similarity (After Tonks, 2006). 
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As several RPTPs are specifically expressed on axons, Desai and colleagues 
demonstrated their role in growth cone guidance and axonogenesis. They demonstrated 
that DPTP69D and DPTP99A were important for the correct guidance of certain motor 
axons (Desai et al 1996). Mutations in the DPTP69D and DPTP99A genes revealed 
that DPTP69D mutations resulted in an ectopically guided SNb nerve and in a limited 
number of cases the SNa nerve also displayed defects. DPTP99A single mutations did 
not reveal any abnormal phenotypes. Double mutations however in these two genes 
resulted in abnormal development of all SNb and SNa nerves, highlighting functional 
redundancy amongst the drosophila PTPs during development. Furthermore this and 
other studies in up to four drosophila RPTP’s have clearly demonstrated redundancy 
amongst these proteins (Desai et al, 1996; Krueger et al, 1996; Desai et al, 1997; Sun 
et al, 2001).  
 
The range of phenotypes observed amongst double mutants, namely the bypassing, 
stalling and detour of the SNb nerve, showed similarity with those of the adhesion 
molecule fascicilin II (drosophila homologue of N-CAM) over expression on motor 
axons, which also affects SNa nerves. Thus the group postulated that RPTPs could 
oppose fasciclin II-directed adhesion and therefore regulate repulsive ligands by 
decreasing tyrosine kinase signalling and allow growth cones to defasciculate from 
axonal bundles (Desai et al, 1996).  
 
In a further study Desai and colleagues observed drosophila motor axon patterns 
amongst DPTP69D, DPTP99A and DLAR mutants and showed a hierarchical control 
of RPTPs in the regulation of growth cone guidance along a single pathway, with these 
RPTPs acting both in competition and cooperatively (Desai et al 1997). Mutants of 
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DPTP69D, DPTP99A and DLAR (Krueger et al, 1996), show defects in the specific 
trajectory of the ISN, SNb and SNd motor axons whilst SN root branches namely SNa 
and SNc nerves remain normal. Furthermore the study revealed that in mutants, the 
bypass phenotype of SNb axons show their outgrowth is not stalled by loss of RPTP 
function. The combinatorial effect of RPTPs is also required for correct axonal 
trajectories of the ISN root motor axons either acting cooperatively at certain choice 
points or in opposition for instance at SNb choice points (Desai et al, 1997). 
 
In a screen of candidate signalling partners through dose dependent genetic 
interactions within growth cone choice points in drosophila RPTPs, Wills and co-
workers found that DLAR function during the guidance of ISNb axons has an 
antagonistic relation ship with Drosophila Abl, a tyrosine kinase (Wills et al, 1999). 
Loss of function Abl mutants suppress DLAR axon guidance phenotypes in double 
DLAR loss of function mutants, whilst Abl gain of function was found to mimic the 
DLAR mutant guidance defects in retinal axons described in the literature. In vitro 
studies revealed a directing binding of Abl to the DLAR cytoplasmic domain resulting 
in its phosphorylation, highlighting the role of DLAR in such axons to be dependent 
upon a tyrosine kinase domain to transduce the signal. The Abl substrate Enabled 
(Ena) also bound to the DLAR cytoplasmic domain in vitro, demonstrating DLAR, 
Abl and Ena may function as a ‘phosphorylation dependent’ switch to guide growth 
cones through signals at the cell surface that are transmitted to the actin cytoskeleton 
(Wills et al, 1999). 
 
The regulation of axon guidance across the midline of the drosophila embryo by 
RPTPs has shed light on further mediators of axon guidance cues. The group isolated a 
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fourth member of the DPTP family, DPTP10D and demonstrated that loss of function 
of this PTP did not show any abnormal phenotype. Double mutants however of 
DPTP10D and DPTP69D revealed defects in the guidance of the segmental (SN) nerve 
along with a re-routing of a subset of longitudinal axons across the midline. The 
guidance of axons at the midline is regulated by attractive cues from Netrins and 
repulsive cues from Slits, with Robo acting as a slit receptor, whilst the 
Commissureless protein down regulates Robo activity permitting axons to cross the 
midline. The group suggested that a midline repulsive signal required from Robo, was 
not being transduced by DPTP10D and DPTP69D. The group further conducted 
quadruple mutants of all 4 DPTPs and found that most longitudinal pathways of axons 
were converted to commisures suggesting that the tyrosine phosphorylation may 
regulate the response of growth cones to midline cues as positive regulators of Robo 
signalling (Sun et al 2000; Sun et al 2001). 
 
1.9.1.2     PTP function in the visual system. 
 
There have been further studies of RPTP function in Drosophila, this time in the visual 
system. Here photoreceptor axons showed a requirement for PTP69D during 
projection to the brain (Reviewed in Stoker, 2001). Photoreceptors in Drosophila occur 
as ommatidial clusters of eight neurons R1-R8, whereby pioneer R8 axons (and later 
R7 axons) terminates in the medulla, whilst R1-R6 axons fasciculate with R8 until 
they normally reach their terminus in the more proximal lamina. PTP69D was shown 
to be required for the retinal axons R1-R6 to terminate correctly in the lamina cell 
autonomously, where mutant retinal axons overshot the lamina and terminated in the 
medulla (Garrity et al, 1999). The group proposed that these retinal axons required 
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PTP69D to detect extracellular signals leading to growth cone motility via 
phosphorylation of specific substrates. This signal is translated to a ‘stop’ cue for the 
growth cone via dephosphorylation of a substrate, without which the R1-R6 axons 
terminate ectopically in the medulla of the optic lobe, remaining there in the adult 
suggesting the defect is permanent. Similarly in the drosophila visual system, RPTP 
DLAR mutants fail to synapse with their correct laminal targets (Garrity et al, 1999; 
Clandinin et al, 2001; Maurel-Zaffran et al, 2001).  
 
Further studies in the drosophila eye utilizing a mosaic model also demonstrated the 
role of DPTP69D in the guidance of photoreceptor axons. Moreover DPTP69D loss of 
function mutants showed mistrageting of R7 axons along with an overshooting of R1-
R6 axons beyond their normal targets. These defects were hypothesised to occur as a 
result of a loss of permissive signal within retinal axons in response to a defasiculation 
cue (reducing adhesion at choice points) as R1-R6 fasciculate with the R8 pioneer 
axon beyond the normal target (Newsome et al, 2000). 
 
Recent studies on LAR in the drosophila visual system have demonstrated that the 
correct targeting of R7 neurons requires 3 elements of the FNIII LAR domain as 
opposed to the Ig domains. Since the Ig domains bind known ligands Sdc and Dlp, 
these data may indicate the role of further unknown ligands for FNIII regions. In 
contrast to the neuromuscular junction development, R7 axon path finding does not 
require catalytic phosphatase domain activity. The group also tested a mutation in the 
wedge region of LAR, which prevents its intracellular dimerization and maintains 
phosphatase activity and therefore the ability to promote Neuromuscular junction 
formation. This mutation, however, displays defects in R7 axon path finding, even if 
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the catalytic site is further mutated, suggesting dual functions for this phosphatase 
domain, not restricted simply to its catalytic activity (Hofmeyer & Treisman, 2009). 
 
In vertebrates, RPTPs have various roles during neural development, as demonstrated 
by loss of function studies. PTP$ antibody perturbation (Ledig et al, 1999), or the 
expression of a catalytically inactive mutant form of the protein (Johnson et al, 2001), 
has resulted in defects of RGC outgrowth when cultured on retinal basement 
membranes. Experiments perturbing the interaction of PTP$ through the ectopic 
expression of a secreted form of the protein ectodomain (PTP$-VSV) in the chick 
produced axon guidance defects to tectal targets where additionally, the tectal 
basement membrane was shown to bind PTP$-VSV (Rashid-Doubell et al, 2002). 
These data indicate that PTP$ plays a role in retinal axon targeting.  Furthermore, 
Ephrin receptors are activated by the autophosphorylation of tyrosine residues upon 
the binding of their ligands, the ephrins where protein tyrosine phosphatase receptor 
type O (Ptpro) dephosphorylates EphA and EphB receptors as substrates at a 
phosphotyrosine residue required for the activation of the Eph receptor (Shintani et al, 
2006).  
 
1.9.3 Roles of PTPs in synaptogenesis. 
 
The LAR receptor family of tyrosine phosphatases has been widely studied in many 
invertebrate and vertebrate developmental systems (Reviewed in Chagnon et al, 2004). 
A study of DLAR in the drosophila larval neuromuscular junction showed that it was 
required for the correct formation of neuromuscular synaptic junctions along with its 
associated intracellular protein Dliprin-#. Yeast trap assays showed a binding of 
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Dliprin-alpha to DLAR, furthermore both loss of function mutants revealed similar 
neuromuscular phenotypes. Kaufmann suggests liprin-# may act downstream of 
DLAR, although liprin-# itself is not known to be phosphorylated. Instead it may 
recruit synaptic scaffold proteins as it is associated with them, or Liprin-a may serve to 
guide the DLAR receptors to their target sites (Kaufmann et al, 2002). These functions 
may be evolutionarily conserved in mammals since homologues of these proteins are 
found to be expressed in mammalian synapses (Kaufmann et al, 2002; Wyszynski et al 
2002). 
 
Roles for RPTPs have also been described during synaptogenesis through cell-cell 
signalling with key interactions with Cadherins and !-catenin which are both tyrosine 
phosphorylated, with LAR specifically implicated in synaptic adhesion and 
development (Dunah et al, 2005; Reviewed in Brigidi & Bamji, 2001). Further 
functions for PTPs have been described for the regulation of presynaptic vesicle 
clustering where the cadherin/p120-catenin complex binds to the cytoplasmic protein 
kinase Fer which results in the uptake of SHP2 that dephosphorylates !-catenin (Lee et 
al, 2008; Reviewed in Hendriks et al, 2012). 
 
Further interactions have been described between LAR and PTP$ and the adhesion 
molecule netrin-G ligand 3 (NGL-3) during presynaptic differentiation and the 
promotion of synaptic differentiation (Woo et al, 2009; Kwon et al, 2010).  
Furthermore, PTP$ on axons and its HSPG ligands bind differentially to Trk 
proteins, through complexes with TrkA and TrkC, but not TrkB where the 
transmembrane domain of PTP$ and TrkA were sufficient to drive the 
interaction of these two proteins. PTP$ as able to dephosphorylate Trk A, B and 
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C suppressing their phosphorylation in the presence of neurotrophins. The Trk 
proteins are receptor protein tyrosine kinases (RTKs) and are activated by 
neurotrophins that act as signaling centers for adaptor proteins and bring about 
transphosphorylation (Faux et al, 2007). More recently TrkC was shown to bind 
the ectodomain of PTP$ during synaptic differentiation and pre and 
postsynaptic functions in the cerebral cortex. This study found that PTP$ 
presynaptically triggers and TrkC post synoptically mediates clustering of 
postsynaptic molecules in dendrites, demonstrating a bidirectional function for 
these two proteins during synaptic organization (Takahashi et al, 2011). 
 
1.9.4 Interactions of RPTPs with cadherins and catenins 
 
As seen above, RPTPs can have significant influences over cadherin/catenin function. 
Experiments in Xenopous with PTP% and PTPµ, expressed along a dorsoventral 
gradient in the retina, show these molecules contribute to retinotectal development 
(Wang & Bixby, 1999; Sun et al 2000; Johnson & Holt, 2000). PTPµ has been shown 
to act selectively as both an inhibitory and permissive guidance cue within the visual 
system (Ensslen-Craig & Brady-Kalnay, 2005). Moreover, PTPµ has been shown to be 
required selectively for E-cadherin and N-cadherin dependent neurite outgrowth, with 
PKC function required for E-cadherin but not N-cadherin (Oblander et al, 2007; 
Oblander & Brady-Kalnay, 2010).  
 
Other phosphotyrosine signalling processes and adhesive cell-cell interactions have 
also been shown to involve cadherins and catenins and so likely involve regulation by 
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PTPs (Larsen et al 2003; Burridge et al 2006; Salle et al, 2006; McLachlan & Yap, 
2007). PTPs have been shown to play an important role in the regulation of cell-cell 
contacts at adherens and tight junctions whereby protein tyrosine inhibition can induce 
the release of cell-cell contacts (Chen et al 2007). Several further RPTPs have been 
implicated in the regulation of !-catenin and its dephosphorylation. For example LAR 
over expression resulted in an inhibition of cell migration. Furthermore, when PTP!/&, 
is bound to its ligand pleiotrophin this results in an increase in !-catenin tyrosine 
phosphorylation (Muller et al, 1999; Meng et al, 2000). Previous studies have also 
implicated PTP' interaction with !-catenin, with PTP' directly dephosphorylating !-
Catenin. PTPµ has been shown to affect Cadherin and bring about its 
dephosphorylation where its absence results in an increased state of Cadherin 
phosphorylation or its affinity for p120 (Fuchs et al, 1996; Cheng et al, 1997; Brady-
Kalnay et al, 1998; Zondag et al, 2000). PTPµ and cadherins also have a very precise 
trans interactions that creates a “spacer” complex at cell-cell interfaces (Coles et al, 
2011). 
 
In the chick embryo, PTP( has been shown to regulate the shape of the mid-hindbrain 
boundary (MHB) region (Badde & Schulte, 2008). Here this gene is expressed in a 
tight ring in the location of repressed Wnt1 activity. Furthermore RPTP( was shown to 
bind to !-Catenin and participate in the canonical Wnt pathway. Upon over expression 
of RPTP(, the activity of a !-Catenin responsive promoter was suppressed, resulting in 
reduced progenitor cell proliferation (Badde & Schulte, 2008). This indicates that 
RPTPs may be involved in the key regulatory processes that underlie cell proliferation 
and neurogenesis through the Wnt/!-Catenin pathway and multiple RPTPs may in fact 
share this role.  
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1.9.5   RPTP ligands and their functions 
 
The various isoforms of PTP$ have been implicated in neuronal development and its 
expression is localised on axonal growth cones (Stoker 1994; Stoker et al, 1995). 
Furthermore, its expression has been described amongst spinal motor neurons in the 
mouse (Schaapveld et al, 1998). PTP$ has also been shown to promote axon 
outgrowth and growth cone guidance and morphology (Ledig et al, 1999; Rashid-
Doubell et al, 2002). Extracellular heterotypic ligands for PTP$ have been described in 
the chick, where it has been shown to bind Heparan Sulphate Proteoglycans (HSPGs) 
in the retinotectal system, developing muscle and nucleolin (Haj et al, 1999; Aricesu et 
al 2002, Sajani-Perez, 2003, Alete et al, 2006). 
 
Nucleolin on developing skeletal muscle has been identified as a potential ligand and 
binding partner for PTP$.  It is also expressed in retinal basement membranes. 
Nucelolin was found to bind PTP$ ectodomains in vitro and shares a complimentary 
expression pattern in developing muscle with PTP$. Furthermore nucleolin is 
expressed on developing myotube surfaces and furthermore lectoferrin, a binding 
partner of nucleolin, blocks the binding of PTP$ ectodomains with muscle and retinal 
targets. This suggests nucleolin provides a target binding site for PTP$ on motor axons 
within muscles and the same may be true for the binding sites of PTP$ in retinal 
basement membranes, possibly through a surface receptor complex (Alete et al, 2006). 
 
This finding that associates PTP$ intimately with HSPGs within the extra cellular 
matrix has turned out to be an important one. A reduction in PTP$ expression has lead 
to faster regrowth of nerves (McLean et al, 2002), whereas in mice lacking functional 
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LAR, a structurally similar PTP family member to PTP$, have shown decreased nerve 
repair capacities (Van der Zee et al, 2003). The role of HSPGs here is proving to be of 
increasing interest. 
 
Heparan Sulphate Proteoglycans were shown to bind PTP$ with high affinity in the 
basal lamina. HSPGs are found in retinal basement membranes and glial end feet. Here 
the HSPGs Agrin and collagen XVIII were found to bind PTP$ through the heparan 
sulphate chains and first Ig-like domain of PTP$ in vitro (Aricescu et al, 2002). 
Furthermore site directed mutagenesis of the heparan binding site in the Ig domain 
blocked this binding affinity (Aricescu et al, 2002). Agrin, collagen XVIII and PTP$ 
have similar patterns of expression in the chick retinal system. All this demonstrates a 
heterotypic ligand for PTP$, bridging the link between axonal/growth cone PTP$ 
expression and signalling and extracellular matrix interactors.  
 
Of the ligands described for RPTPs (Reviewed in Mohebiany et al, 2012) members of 
the contactin family of IgCAMs, CNTN3, 4, 5 and 6 have been shown to bind PTPRG 
and PTPRZ in vitro. CNTN1 shows a high binding affinity to PTPRZ whilst PTPRG 
could potentially bind CNTN3 and CNTN4 in vivo as these genes are expressed in the 
same regions of the olfactory bulb in mice as PTPRG. Furthermore, PTPRG and 
PTPRZ are expressed in layer V of the cerebral cortex, and hippocampal pyramidal 
CA1 neurons. (Bouyain & Watkins, 2008).  PTPRG loss of function mice and CNTN6 
loss of function mice reveal similar phenotypes displaying impaired motor function 
and coordination. CNTN5 expression domain matches that of PTPRG within the 
cochlear nuclei post embryonic stages and nuclei of the vestibulocochlear nerve during 
 81 
embryonic stages indicating these genes may serve a common function in the domain 
in addition to their binding affinities in vitro (Bouyain & Watkins, 2008). 
 
Recent studies have indicated a proteoglycan specific molecular switch for the 
clustering of PTP$ during neurite extension. Here, this clustering results in a broadly 
uneven spread of phosphatase activity at the cell surface, with regions of depleted 
phosphatase activity enhancing the phosphorylated state for proteins, allowing neurite 
extension. Thus factors promoting PTP$ oligomerization may promote regeneration 
through proteoglycan binding. Both Heparan and Chondroitin sulphate proteoglycans 
are involved in cell signalling and it turns out that both serve as ligands for PTP$.  
Importantly, CSPGs are able to inhibit nerve regeneration via PTP$. PTP$ was found 
to act bimodally during sensory neuron extension. It inhibited axon elongation when 
contacting CSPGs, but promoted elongation when contacting HSPGs. Through 
detailed crystallography of these proteoglycans, Heparan Sulphate was shown to 
induce PTP$ ectodomain oligomerisation, this was inhibited by Chondroitin Sulphate. 
This demonstrates the proteoglycans can bring about opposing effects on neuronal 
outgrowth through competition during the control of oligomerization of PTP$ (Coles 
et al, 2011).  
 
Further studies have highlighted the formation of a complex between CNTN1 and 
soluble PTPRZ in culture that activates a signalling pathway crucial to the proliferation 
of oligodendrocyte precursor cells (OPCs) regulated by phosphacan that may serve as 
a promyelinating factor. This is supported by the impaired mylienating capacity of 
PTPRZ loss of function mice and PTPRZ up regulation in myelin sheath lesion repair 
in oligodendrocytes. Thus the modulation of OPC proliferation occurs through PTPRZ 
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binding via CNTN1 at the surface of these precursor cells as phosphacan actively 
inhibits proliferation of these cells (Lamprianou et al 2011). 
 
1.9.6 RPTPs and neural tube development 
 
RPTPs thus could participate in a wide array of developmental processes within the 
spinal cord beyond their roles in axon guidance, potentially including neurogenesis cell 
movement and later on synaptogenesis. In relation to this, RPTP proteins were indeed 
shown to be expressed strongly within the neural tube at early stages of development 
(Chilton & Stoker 2000). Within the early spinal cord and during neurogenesis, 
members of the RPTP family display a striking pattern of expression and it can be 
proposed that such receptors may have novel roles in the specification, differentiation 
or migration of neuronal precursors from their radial cell progenitors. (Chilton & 
Stoker, 2000; Gustafson & Mason, 2000; Ivanova et al, 2004) (Figure 1.9) (Figure 
1.10). 
 
The expression profiles of members of the RPTP family at E4 and E6 in the chick 
brachial spinal cord may suggest a role for these genes during early spinal cord 
development. PTP$ is a group IIa RPTP formerly known as CRYP# in the chick, and 
it has two main isoform, CRYP#1 and CRYP#2, products of alternative splicing of 
mRNA and differing by their number of fibronectin domains  (Figure 1.9) (Figure 
1.10). In the developing neural tube, the short isoform 1 is expressed in the ventricular 
zone with strongest expression with the LMC and MMC, whilst the long isoform 2 is 
expressed selectively within the ventricular and subventricular zones, with expression 
in a few scattered cells within the dorsal and ventral horns.  
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Figure 1.9 Expression of RPTPs in transverse sections of E6 chick brachial spinal 
cord. Immunocytochemical staining of (A) Islet1, (B) Lim1/2, and (C) Lim3 protein 
expression. DIG-labelled mRNA in situ hybridization to (D, H) RPTP" in the 
intermediate zone, above the floor plate (arrow, H) at thoracic levels (D) and in the 
dorsomedial LMC at brachial levels (H); (E) CRYP# (PTP$) in the ventricular zone, 
LMC and MMC (arrow); (F) RPTP# in the LMC and ventral midline; (G) CRYP2 in 
LMC; (I) CRYP#2 (PTP$) in the ventricular zone; (J) RPTP% in the dorsal neural tube 
and between the MMC and floor plate (arrow); (K) RPTP) in the lateral neural tube 
and floor plate (arrow); (L) RPTPµ in the vasculature. After Chilton & Stoker, 2000. 
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Figure 1.10 (TOP) Scheme of expression of RPTPs in transverse sections of E6 chick 
brachial spinal cord. Schematic DIG-labelled mRNA in situ hybridization to (A) 
PTP$ short isoform in the LMC and ventricular zone; (B) PTP# in the LMC and 
ventral midline; (C) PTPRJ in the LMC and faint expression in lateral regions; (D) 
PTP$ long isoform albeit a weaker expression to the short isoform in the ventricular 
zone and LMC; (E) RPTP% in the dorsal neural tube and between the MMC and floor 
plate; (F) PTPZ/ ! in the ventricular zone. Adapted from Chilton & Stoker, 2000. 
(BOTTOM) Scheme of PTP! expression in the chick neural tube from E2-E6. 
Schematic DIG-labelled mRNA in situ hybridization to RPTP" at (A) E2, in the dorsal 
region of the spinal cord laterally in brachial sections; (B) E4 in the intermediate zone 
and above the floor plate in brachial regions; (C) E6, in the intermediate zone, above 
the floor plate at thoracic levels; (D) E6, in the dorsomedial LMC at brachial levels 
and intermediate zone as well as expression above the floor plate. Adapted from 
Chilton & Stoker, 2000; Ivanova et al, 2003; Gustafson & Mason, 2000. 
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A group 3 RPTP, PTPRO, formerly know as CRYP2, displays an expression profile 
restricted ventrally within the LMC and absent from the Lim3-positive MMC (Chilton 
& Stoker, 2000). In this paper, further RPTP patterns are described where RPTP# 
expression is observed ventrally within the ventral midline, surrounding the floor plate 
and LMC where it may have further unknown developmental roles. 
 
PTP%, a member of group IIA RPTPs and LAR family member (Sommer et al, 1997), 
also reveals a striking expression pattern at E6 in the chick brachial spinal cord, with 
strong dorsal expression that overlaps with Lim1/2 cells. A population of ventromedial 
cells also express PTP% in between the MMC and floor plate.  This may suggest a role 
in the development of interneuronal populations rather than motor neurons. A group 
IIB member, PTP(, known as PTP) and PTPru (Alonso et al, 2004), displays a weak 
expression profile at the same ventral time point described for PTP% within the lateral 
neural tube with a slight, albeit very weak resemblance of PTP% expression, suggesting 
these genes may cooperate functionally within the more dorsal aspect of the neural 
tube. PTPµ is also a member of the group 2B family, however at E6 its expression is 
generally absent from the spinal cord and is only expressed in the capillaries of the 
spinal cord (Brady Kalnay et al, 1995; Stoker & Chilton, 2000).  
 
At thoracic levels at E4, PTP" expression is evident as a strong stripe dorsoventrally 
along the intermediate zone, overlapping the pattern of Lim1/2 interneurons within the 
dorsal and intermediate aspects of the neural tube. A line of expression above the later 
floor plate, the site of oligodendrocyte birth is also seen as an inverted smile by E6. At 
brachial levels, the expression patterns of PTP" at thoracic levels also extend to the 
dorsomedial LMC at stage E6, implicating a role for this gene during motor neuron 
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development (Chilton & Stoker, 2000; Gustafson & Mason, 2000) (Figure 1.5) 
(Figure1.6). The family of RPTPs is thus widely expressed, in a variety of 
developmentally regulated patterns in the early neural tube. This thesis focuses on two 
RPTPs with particularly interesting expression, PTPs and PTP". These will now be 
described in some further detail. 
 
1.9.7      PTP" 
 
The functions of RPTPs are still poorly understood during neural development, 
particularly in the development of the spinal cord. In situ data reveal striking patterns 
of expression in the spinal cord suggesting that they may play a role in the 
development of these tissues (Chilton & Stoker, 2000.) In particular PTP" displayed an 
interesting pattern of expression within the spinal cord, which correlates closely with 
the expression of proneural genes described earlier. This has led to the initiation of a 
study into the actions of this gene during spinal cord development.  
 
Chick PTP" was first isolated and described in 1996 (Xiong et al, 1996,) and displays 
approximately 88% sequence homology to its human counterpart. It contains a 
fibronectin type III repeat along with a carbonic anhydrase domain and is highly 
glycosylated. Intracellularly it has two tandem catalytic domains typical of the receptor 
like PTPs. The protein exists as both transmembrane and secreted isoforms (Shintani et 
al, 1997). PTP" expression in the chick is predominantly seen in the nervous system 
from gastrulation onwards, with low level expression in the primitive streak and the 
first formed somites. 
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Within the avian neural tube PTP" is first detected in the elevated neural folds of the 
presumptive forebrain and during neurogenesis of the spinal cord, it is initially 
expressed in the dorsal interneuron domain that consequently gives rise to neurons and 
interneurons at around E2. (Gustafson and Mason, 2000). 
 
PTP" expression then expands along the dorsoventral aspect of the spinal cord in two 
lateral stripes within the intermediate zone that partially overlaps with Lim1/2 
expression, and just above the floor plate in an inverted smile by HH24 (Gustafson and 
Mason, 2000; Chilton & Stoker, 2000). At brachial levels strong expression is also 
detected within the lateral motor columns. These data suggest that PTP" may have a 
significant role during early neuronal development in the chick neural tube.  
 
PTP" has been studied in experiments with Rat PC12 cells, where in cells transfected 
with PTP", NGF-induced neurite outgrowth was inhibited. This did not occur when 
these cells were transfected with the closely related RPTP PTP&, suggesting a specific 
inhibitory effect of this protein on neurite outgrowth (Shintani et al, 2001). Further cell 
culture studies have also shown PTP" to inhibit anchorage-dependent growth of breast 
cancer cells, suggesting that this phosphatase may have an important role during cell 
proliferation and regulation of tumorogenesis (Liu et al, 2004). Furthermore PTP" has 
been shown to regulate hematopoietic differentiation in culture (Sorio et al, 1997).  
 
In the mouse, PTP" has been shown to be expressed in the brain among cortical layers 
II and IV consisting of pyramidal neurons, suggesting this gene may play a role here in 
neuronal development maintenance of cortical function (Lamprianou et al, 2006). It is 
also expressed in sensory neurons. Genetic knock down of the gene however showed 
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that it was not apparently necessary for gross normal development, although these 
mice have subtle behavioural defects (Lamprianou et al, 2006). Further expression was 
observed in the sensory cells of the retina, ear and tongue suggesting there may be a 
level of functional redundancy amongst phosphatases when considering that the PTP" 
mutants appeared normal in such organs (Lamprianou et al, 2006). It is also worthy to 
note that in the mouse PTP" is expressed very weakly in the spinal cord, in contrast to 
the chick. 
 
1.9.8     PTP$ 
 
PTP$ has a dynamic expression pattern in the spinal cord with a strong expression 
pattern in two stripes intimately related to the ventricular layer and site of mitotic cells 
within the spinal cord, and in the lateral motor columns at E4 (Chilton & Stoker, 
2000.) A more diffuse expression is seen elsewhere in the cord. This expression 
persists in the ventricular layer to E6 in both the long and short isoforms studied and 
expression of a shorter isoform becomes restricted to the lateral motor column (Chilton 
& Stoker, 2000). These data suggest that PTP$ may be involved in early neurogenesis 
and axonogenesis. 
 
The knock out of PTP$ expression in the mouse has demonstrated a requirement for 
this gene in the proliferation and adhesiveness of various cell types (Elchebly et al, 
1999). Analysis of these mice highlighted defects in pituitary gland development, a 
reduced brain size and retarded growth patterns (Elchebly et al, 1999; Wallace et al, 
1999). Further studies have shown that PTP$ is required for normal cytoarchitectural 
development in the CNS and late onset expression of GAP-43 in the mouse (Meathrel 
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et al 2002). PTP$ knockout mice have also indicated a role for this molecule in axonal 
guidance and regeneration (Uetani et al, 2006; Shen et al, 2009; Fry et al, 2010). 
 
A study using dsRNAi in ovo to knock down the expression of PTP$, PTP% and 
PTPRO from HH18 in the lumbar spinal cord has shown defects in the dorsal anterior 
iliotibialis nerve in all three gene knockdown experiments despite apparently normal 
development of the limbs (Stepanek et al, 2005). Combined RNAi targeting of two or 
all three of these PTPs showed less severe phenotypes than the silencing of PTPRO 
alone implying a dose dependant function of PTPs during axonal outgrowth or an 
incomplete penetrance of the 3 genes studied (Stepanek et al, 2005). 
 
The roles of LAR, PTP$ and PTP% during motor neuron axon targeting were studied 
further amongst single and double mutants in mice. Although the single PTP% and 
PTP$ mutants were viable, the double PTP$/% knockout mice displayed severe muscle 
dysgenesis and a severe loss of motor neurons in the spinal cord. Within these 
embryos, spinal cord development is initially normal yet after the generation of motor 
neurons is when motor neuron death occurs possibly due to a lack of target contact. 
This study also showed functional redundancy of these two genes during motor neuron 
development (Uetani et al, 2006).   
 
Further studies have indicated that PTP$ -/- stem cells have altered functions and 
considering the ventricular expression profile of PTP$ it is probably involved at some 
level in neurogenesis (Kirkham et al, 2006). 
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In this study, PTP$ was implicated in neuroendocrine and neuronal development, 
whereby sub ventricular zone neural stem cell cultures of PTP$ knockout mice and 
sibling controls showed that neurospheres from the knockout mice developed 
heterogeneous characteristics showing similar morphological characteristics to the age 
matched siblings. However, although PTP$ expression decreases as development 
progresses, it remains high with the continued renewal and passage of the 
neurospheres. Progenitor cells and differentiated neurons, astrocytes and 
oligodendrocytes all expressed PTP$. No differences were observed in developing 
neurospheres or glia from PTP$ knockout mice, the neuronal migration patterns and 
neurites were affected in vitro. In particular, neurons migrated farther from the 
neurosphere centers and the neurite outgrowth exceeded the length of the neuronal 
processes from age matched sibling controls. The study implicated a specific role for 
PTP$ in the neuronal lineage through inhibitory influences on neurite outgrowth, and 
showed a role for PTPs in neuronal progenitor cell differentiation. (Kirkham et al, 
2006). 
 
1.10      RNA interference 
 
These studies on PTP$ and PTP" have together have raised questions into the role and 
function of these two genes in the chick, looking specifically at their potential roles in 
spinal cord growth and neurogenesis. In order to potentially perturb the function of 
these two genes in ovo, I adopted an experimental approach utilizing RNAi in this 
thesis and this will now be described. 
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RNA interference (RNAi) is a post-transcriptional method of gene silencing first 
discovered in C.elegans where double stranded RNA (dsRNA) resulted in sequence-
specific gene silencing (Fire et al, 1998). Sense and antisense RNA were able to direct 
interference and this system was developed as an approach to inhibit gene expression.  
The dsRNAs were shown to be a more potent silencing trigger following studies in 
plant pigmentation, where RNA viruses were used to generate dsRNA molecules 
(Bernstein et al, 2001). The dsRNA operate at the post-transcriptional level, resulting 
in the targeted loss of mRNA through its degradation, or translational blockage. 
However, additional mechanisms exist where the dsRNA can target promoter 
sequences resulting in transcriptional repression (Mette et al, 2000). 
 
Studies in Drosophila have shed light into the cellular mechanisms driving RNAi. 
Hairpin RNA precursors or dsRNA are processed cytoplasmically by a Dicer nuclease 
complex, an evolutionary conserved dimeric enzyme complex which cleaves these 
sequences into 21-25 nucleotide RNA sequences termed small interfering RNAs 
(siRNAs) (Zamore et al 2000). There are no intermediate cleavage products of dsRNA, 
and these SiRNAs are double stranded duplexes with 2 nucleotide 3’ overhangs and 5’ 
phosphate termini. The siRNAs are then recruited into an RNA-induced silencing 
complex (RISC) (Hammond et al 2000).  
 
The conserved Argonaute family of genes are important for the assembly of the 
silencing complex and contain PAZ domains also found in dicer proteins (Hammond et 
al, 2001). Upon activation of the RISC complex by ATP, the complex is remodelled 
into an effector nuclease complex causing the siRNA to unwind, guiding it to its target 
mRNA. Single stranded siRNAs are more effective at finding their targets. Silencing is 
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triggered through the nuclease complex targeting homologous mRNAs for degradation 
or by inhibiting mRNA translation. The effector complex may cause RNA 
amplification or drive chromatin remodelling in the nucleus (Figure 1.11). 
 
RNAi can be triggered by small amounts of dsRNA (Bernstein et al, 2001). This 
model suggests a mechanism for cell-autonomous amplification of the silencing signal 
but not on its transmission. SiRNAs must have perfect complementarity to their 
mRNA target except for the overhangs. However, naturally occurring siRNAs such as 
those involved in viral host defence mechanisms e.g. lin-4 and let-7, are termed micro 
RNAs (miRNA) and do not show perfect complementarily to their targets, driving 
translational inhibition rather than degradation of the target mRNA (Ambros et al 
2004; Silva et al, 2002). 
 
RNAi presents a powerful tool for analysing gene function. However siRNAs have 
transient effects and mammals may lack the mechanisms that amplify its signal as in 
C.elegans. Stabilisation can instead be made to occur through a hairpin loop of the 
inverted repeated sequence. Small hairpin RNAs (ShRNA) can be expressed in vivo 
from polIII promoters to induce stable expression, however non-specific off-target 
effects can occur as with the induction of the RNA-dependant protein kinase (PKR) 
pathway (Ohkawa et al, 2000; Sui et al, 2002; Brummelkemp et al, 2002).  
 
Off target RNAi effects can be avoided if sequences are ~21bp (El-Bashir et al, 2001.) 
Novel phenotypes can therefore only be accepted and corroborated if the generation of 
a cell phenotype occurs with at least 2 different siRNAs targeting different sites on the 
same mRNA molecule.  
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Figure 1.11 Model of RNAi. Adapted from Hannon, 2000. Nuclear Hairpin or extra 
cellular dsRNA precursors are cleaved by the dicer complex into siRNA duplexes. 
These are recruited into the RNA-induced silencing complex (RISC) which upon 
activation by ATP causes unwinding of the siRNA duplex which guides the single 
stranded RNA to its target for either: 1 nuclear chromatin remodelling; 2 RNA 
amplification; 3 Translational inhibition or 4 mRNA degradation. 
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This then largely rules out off-target effects. At the time our experiments were 
instigated, another common, negative control was usually obtained using an shRNA 
with no homology to any other gene in the genome.  
 
Gene silencing in chick embryos using a vector-based shRNA system was described in 
2003, allowing spatially and temporally restricted gene silencing via an shRNA using 
the pSilencer commercial vector in ovo (Katahira & Nakamura, 2003). The chick also 
serves as a good model due to ease of embryo accessibility and manipulation, allowing 
in ovo gene transfer by electroporation. Through combining RNAi with 
electroporation in ovo, a powerful model system was therefore established for 
screening gene function (Pekarik et al, 2003). This system has since successfully been 
used during neurogenesis to analyse the function of Transitin during stem cell division 
and localisation of Numb in mitotic neuroepithelial cells (Wakamastsu et al, 2007). 
 
A further study has demonstrated a functional knock-down of the neuropilin-1 receptor 
in ovo by siRNAs derived from hairpin structures driven by a mouse U6 promoter, 
whereby the embryos displayed nervous system defects associated with the functions 
of the Neuropilin receptor (Nrp-1) for semaphorins. The DRG defects presented, 
implicated Sema3A and its receptor on neurons, with misprojections of DRG axons 
and defects in the guidance of primary sensory afferents to their synaptic targets. 
 
This study demonstrated an effective use of shRNAs to effectively knock down the 
targeted gene and was published after the start of my research (Bron et al, 2004). Later 
studies have also demonstrated the use of RNAi to study the effect of serine/threonine 
phosphatases, where interference of the Protein Phosphatase-1 (PP1) gene, through 
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small interfering RNA molecules, was shown to enhance the phosphorylation state of 
Pax-6 both in culture and in vivo thereby showing the modulation of Pax-6 by PP1  
(Yan et al, 2007).  
 
RNAi has been used in the chick using dsRNA molecules directed against PTP%, 
PTP$, LAR and PTPRO in the developing nervous system (Stepanek et al, 2005).  
Furthermore, shRNA molecules directed against PTP( in the chick mid-hindbrain 
barrier have shown evidence for PTP( in the regulation of the Wnt-1 expression 
domain (Badde & Schulte, 2008). The RNAi technology has also moved to the mouse 
whereby Cre-LoxP systems and U6 promoters have been used to deliver RNAi through 
shRNA in a tissue specific manner (Shukla et al, 2007; Seibler et al 2007). 
 
Further applications of siRNA specifically in the chick are discussed in chapter 3. 
Based on the literature studied at the time our study was started (2003), RNAi in the 
chick was considered a good and novel method of potentially analysing gene function 
of the RPTP’s during neurogenesis within the neural tube.  
 
1.11    Experimental Aims. 
 
In the following study, the RNAi approach was taken to knock down PTP" and, in a 
more limited study PTP$, in the chick spinal cord prior to and during the onset of 
neurogenesis. To complement this, PTP" gain of function experiments were also 
conducted to test the effects of over expression of this gene within the neural tube.  
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Given the known functions of RPTPs during neural development and the expression 
patterns of PTP" and PTP$ in the developing spinal cord, we hypothesised that these 
two RPTPs could be integrally involved in regulating either early neural tube growth, 
neurogenesis, or early neuronal migration, or a combination of these. At the start of 
this project, no vertebrate RPTPs had been functionally tested for such roles in the 
neural tube. 
 
The aims of the experiment were therefore to determine through the use of RNAi, the 
potential functions of PTP" and PTP$ during the development of different neuronal 
populations within the spinal cord. In particular, we wanted to address if these RPTPs 
could be specifically involved in either the proliferation, survival, differentiation or 
migration of neuronal precursors and progenitors.  We wanted to determine the 
function of these two genes more specifically during early neurogenesis and motor 
neuron patterning and whether RPTPs may be involved in these early processes. 
 
The specific aims of the project were to: 
 
• Establish an shRNA system for use in ovo, in order to suppress the mRNA 
expression of RPTPs in the early neural tube. 
• Define the potential developmental function of PTP" in the early neural 
tube, using shRNA knockdown. 
• Define the potential developmental function of PTP" in the early neural 
tube, using cDNA over expression in ovo. 
• Establish similar findings with the PTP$ gene in the neural tube.
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Chapter 2:  Methods & Materials 
 
2.1  DNA preparation. 
 
This procedure was used to obtain sterile quantities of DNA plasmids for transfection 
in culture or microinjection in vivo. DNA extraction kits were used throughout that are 
described further below. 
 
2.1.1  Bacterial Cultures. 
 
Bacteria (Competent DH5# cells, Sigma) were transformed with the required DNA 
plasmid by heat shock at 42°C for 45 seconds and were then incubated overnight in 
200ml sterile Luria Broth (LB, Sigma) solution at 37°C whilst vigorously shaking. The 
bacterial cells were then centrifuged at 6000g for 20 minutes at 4°C, and the 
supernatent discarded. The pellet that remained was processed using the Qiagen 
HiSpeed Plasmid Maxi Prep Kit. 
 
2.1.2  DNA Extraction. 
 
The bacterial pellet was resuspended in 10ml chilled resuspension buffer (50mM Tris-
Cl pH 8.0, 10mM EDTA & 100µg/ml Rnase A.) The solution was then gently mixed 
with 10ml lysis buffer (200mM NaOH, 1% SDS w/v) at room temperature for no 
longer than 5 minutes to prevent shearing of the genomic DNA. To this 10ml of 
neutralisation buffer was added (3.0M potassium acetate pH 5.5) turning gently to 
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allow the buffers to mix completely and produce a white precipitate of genomic DNA, 
cell debris and protein. The plasmid DNA remains in solution. 
 
2.1.3  DNA Filtration 
 
The solution was incubated in a QIAfilter cartridge for 10 minutes at room temperature 
allowing the precipitate to float to the top of the cartridge. The solution was filtered 
through the cartridge using a plunger into a HiSpeed Maxi Tip previously equilibrated 
with equilibration buffer (750mM NaCl, 50mM MOPS (free acid) pH 7.0, 15% 
isopropanol v/v & 0.15% triton X-100 v/v). The filtrate was discarded as the plasmid 
DNA remains bound within the resin. Wash buffer (1.0M NaCl, 50mM MOPS pH 7.0 
& 15% isopropanol v/v) was added to the Maxi Tip, discarding the filtrate.  
 
2.1.4  DNA Elution. 
 
The Maxi Tip was attached to a clean falcon and the DNA bound within the resin of 
the Tip was eluted using elution buffer (1.25M NaCl, 50mM Tris-Cl pH 8.5 & 15% 
isopropanol v/v.) The eluate was precipitated using 0.7 volume of isopropanol at room 
temperature for 5 minutes. 
 
2.1.5 DNA Purification. 
 
The precipitate was then spun at 15,000g for 30 minutes to allow the DNA to form a 
pellet. The supernatent was discarded and the pellet was washed in clean 70% ethanol 
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and spun again for 15 minutes at 15,000g. The supernatent was discarded and the 
pellet was resuspended in sterile distilled water at the desired concentration.  
 
2.2  Micro preparation. 
  
This is a procedure for rapid screening of large numbers of bacterial colonies, for the 
presence of recombinant clones within larger sized super-coiled plasmids. 
 
2.2.1 Colony selection and pre-treatment. 
 
A colony was picked directly from a plate using a yellow tip, and expelled into a tube 
containing 6 %l protoplaster solution (30 mM Tris.Cl pH8, 5 mM Na2EDTA, 50 mM 
NaCl, 20% sucrose, 50 mg/ml RNase A & 50 mg/ml lysozyme.) This was vortexed for 
5-10 seconds while gently holding the top of yellow tip. The cells were resuspended in 
protoplaster, and left for 5-10 minutes, at room temperature.  
 
2.2.2  Agarose gel preparation. 
 
Agarose 0.7% running gel was prepared using 0.7% w/v SDS & agarose (Sigma), in 
1x TAE buffer (40mM Tris Acetate pH 8.0, 1mM ethylenediamine tetraacetic acid 
EDTA.)  Once the gel had set in the plastic running gel casts (BioRad) 3 ml of lysis 
solution (1x TAE buffer, 2% SDS, 5% sucrose & bromophenol blue) was loaded into 
each gel slot.  
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2.2.3  Agarose gel electrophoresis 
 
The bacterial solution was placed carefully "under" the lysis solution and a control and 
non recombinant plasmid lane was also loaded.  This was run in 1x TAE at 40 V for 
first 15min, then increasing the voltage to 100 V until the bromophenol had reached 
the end of the gel, at which point the gel was stained with Etidium Bromide and 
photographed under UV exposure. The supercoiled recombinant plasmids showed up 
larger in size from the control due to insert sequences. 
 
2.3 The generation of silencing constructs. 
 
The specific details of the vector and insert constructs are described and illustrated in 
Chapter 3. 
 
2.3.1 Designing and preparing the plasmids 
 
The PTP" silencing constructs were designed using Ambion algorithms 
(www.ambion.com) (Michael Hurley). Six pairs of complimentary hairpin RNA 
encoding PTP"-related cDNA oligonucleotides were annealed and ligated into the 
pSilencer 1.0 U6 vector (Ambion, USA). These were named Si1-6 and the sequence 
homologies to other off target genes were checked in Genbank, reducing the likelihood 
of off target effects and ensuring target specificity of the hairpins (M Hurley). This 
was repeated for PTP$ using the pSilencer 2.1 U6 vector (Ambion, USA) and the six 
new silencing constructs were named Sig1-6.  
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2.3.2  Annealing the PTP$ oligonucleotides. 
 
The six complimentary pairs of hairpin encoding oligonucleotide inserts designed 
against PTP$ were diluted in molecular grade water (Sigma) to a final stock 
concentration of 100µM. To anneal the oligonucleotide sense and antisense strands, 
50µl of annealing mix was prepared (2µl of sense DNA at 1µg/µl in TE (10 mM Tris, 
1 mM EDTA), 2µl of antisense DNA at 1µg/µl in TE, 46µl 1x DNA annealing 
solution, Ambion.) This mixture was heated to 90°C in a heat block for three minutes 
and left to cool to room temperature, where the mix was incubated for an hour. 
 
2.3.3  Ligation of templates. 
 
In order to link the annealed hairpin encoding nucleotides to the silencing vector, two 
ligation mixes were prepared, one with and one without the insert as a control. 5µl of 
the annealed template mix was diluted into 45µl of molecular grade water. The ligation 
mixes comprised of the following: 
 
 +  Insert - Insert 
Diluted annealed nucleotide mix (8ng/µl) 1µl - 
1x DNA Annealing solution (Ambion) - 1µl 
Nuclease free water (Sigma) 6µl 6µl 
10X T4 DNA Ligae Buffer (Roche) 1µl 1µl 
pSilencer 2.1-U6 Hygro Vector 1µl 1µl 
T4 DNA Ligase (5U/µl) 1µl 1µl 
Total 10µl 10µl 
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The ligation mixes were incubated at room temperature for 2 hours and then a stock 
was stored at -20°C and an aliquot set aside to proceed with the transformation. A 
negative control ligation without the insert was also set up that yielded no plasmids. 
 
2.3.4  Culturing the clones 
 
Following the ligation, 1µl of the ligation mix was transformed as previously described 
into competent DH5# bacterial cells and incubated in 1ml of LB solution without 
antibiotics at 37°C for one hour. 200µl of the cultures were plated onto pre-prepared 
agar plates (Sigma) with ampicillin antibiotics added as the silencing vector conferred 
amplicillin resistance and thus only bacteria that had taken up the silencing vector 
should form colonies on the agar plates.  
 
These were left to culture overnight and the following day individual colonies (five 
clones for each silencing construct) were selected, expanded and mini-preps of DNA 
(Qiagen) conducted as previously described for sequencing. These DNA were initially 
digested and ran on 0.7% agarose gels to give an indication of the correct size for the 
plasmid before sequencing to ensure every insert was of the correct sequence. 
 
2.3.5  Sequencing the constructs. 
 
The DNA was then sequenced, where ~100ng was primed against a region of the 
vector upstream of the insert in a thermocycler (95°C 20’’, 50°C 10’’, 60°C 1’; for 25 
cycles – Minicycler, MJ Research.) The reaction mix composed of (5µl DNA ~20ng, 
3µl  1x sequencing dye, 2µl oligonucleotide and 5µl water) for each clone selected. 
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The product was extracted using 2µl 7.5M ammonium acetate and 55µl absolute 
ethanol. This was centrifuged for 15 minutes at 13,000rpm at room temperature and 
consequently detected using dye on a capillary machine, MEGAbase (Amersham) to 
check the correct orientation of the insert and for point mutations. The sequences were 
found to be correct. 
 
2.4  Cell culture studies.  
 
2.4.1  Creating a working stock. 
 
Human Embryo Kidney 293T cells were cultured in 16.7g/L Dulbecco’s Modified 
Eagle’s Medium (DMEM) (Sigma, UK), 100U/ml penicillin/streptomycin & 10% 
foetal bovine serum (FBS) (Sigma, UK.) A working stock of cells was expanded from 
a starter culture, split into 10cm plates and incubated at 37°C, 5% CO2 under sterile 
conditions.  
 
2.4.2  Expanding the cells. 
 
Once the cultures had reached 80% confluency, the medium bathing the cells was 
aspirated and cells washed with phosphate buffered saline (PBS). The PBS was then 
aspirated and 0.05% trypsin added for one to five minute to detach cells from the plate.  
 
The cells were collected using the prepared DMEM at 37°C through pipetting and 
centrifuged at 1,000 rpm for one minute. The culture medium was aspirated and the 
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pellet of cells resuspended in fresh DMEM as previously prepared at 5% confluency 
and incubated again at 37°C, 5% CO2. 
 
2.4.3  Cell Transfections. 
 
Once a confluency of 30% was reached (approximately 2 million cells per 10cm plate) 
the cultures were subsequently co-transfected with various silencing constructs and a 
PTP" expression construct (The full length PTP" cDNA was kindly provided by Lu 
Hai-Wang and was subcloned (A Stoker) in frame with the 3xFLAG tag into 
p3xFLAG-CMV14 (Sigma).) 10µg of total DNA (4µg PTP" plasmid, 4µg silencing 
vector, 1µg GFP plasmid, 1µg luciferase reporter plasmid) was used per 10cm culture 
dish at 30% confluency (Concentrations - 2µl of 2µg/µl PTP", 2µl of 2µg/µl Silencing 
vector, 0.5µl of 2µg/µl GFP and 1µl of 1µg/µl luciferase construct). The total DNA 
was diluted in distilled water and 10% 2.5M CaCl2 and added drop by drop into an 
equal volume of 2X HEPES buffered saline (pH7.05) (1ml total per 10cm plate) in a 
falcon whilst gently bubbling air into the buffer. The transfection mix was added to the 
cells drop wise and left in culture for 48 hours.  
 
2.4.4  Protein Extraction. 
 
Following 48 hours in culture the cells were lysed in 0.25% (v/v) TritonX-100, 150nM 
NaCl, 100mM NaCl, 50mM Tris-Cl pH 7.6 buffer with 1:100 v/v protease inhibitors 
(Complete, Roche) and centrifuged at 4,000rpm to remove cell debris. The supernatent 
containing soluble cellular proteins was collected.  
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2.4.5  Luciferase Assays. 
 
A GFP Plasmid, pCA!IRES-GFP (Jon Gilthorpe) at a concentration of 2µg/µl and a 
Renilla Luciferase reporter construct, vector pRL-SV40-renilla (Promega, UK) 
encoding the firefly luciferase protein was also transfected (1µg/µl) to check for 
relative transfection efficiency amongst experiments in addition to the silencing and 
PTP" plasmids described above. The shRNA was not tagged directly with GFP or 
other reporter constructs as these vectors were not commercially available at the time.  
The short hairpin encoding vectors that were available were driven by mouse U6 
promotors rather than chick. 20µl aliquots of lysates were tested using the Renilla 
Luciferase assay system (E2810 Promega, USA).  
 
The growth medium from cultured cells transfected as above were rinsed with PBS 
and 1ml 1X Renilla luciferase Assay Lysis Buffer (150mM HEPES pH8.0, 0.25% 
Triton X-100, 1mg/ml porcine gelatin, 10% glycerol and 0.05% antifoam 289) added 
to the cells. These lysates were then scraped from the culture dish to create a 
homogenous lysate. The lysate was then transferred to an eppendorph. The Renilla 
Luciferase assay substrate was then prepared at 1µl of 100X assay substrate to 100µl 
Assay buffer (0.5M Nacl, 0.1M potassium phosphate, 1.0mM Na2EDTA, and 1mg/ml 
porcine gelatin pH7.6). For each sample, 100µl of Renilla luciferase assay reagent was 
added to the luminometer tube resting in the luminometer, and 20µl of cell lysate 
solution added. 
 
The lysate mix and detection reagent consequently measured for luminescence rapidly 
within the first few seconds in a manual luminometer (Berthold Technologies 
Luminometer LUMAT LB 9507 – Bad Wildbad, Germany) The luminescence was 
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measured and recorded. In this reaction, light is produced through the formation of 
oxyluciferin. Firefly luciferase, a monomeric 61kDa protein, catalyzes luciferin 
oxidation and a flash of light is generated that decays rapidly after the enzyme and 
substrates are combined. This flash of light is subsequently detected by the 
luminometer.  
 
2.5  Protein detection. 
 
In order to detect the cellular proteins in our sample we used the Western blotting 
technique. 
2.5.1  Cell Lysis 
 
The transfected cells were lysed in 500µl lysis buffer (0.5% NP4O, 25mM Tris pH 7.2, 
150mM NaCl, 5mM MgCl2, 5% Glycerol) and 1:100 v/v protease inhibitor (Complete, 
Roche.) The lysate was then kept on ice to prevent protein degradation whilst 
syringing up and down three times to ensure the cells were fully lysed. 
 
2.5.2  Protein Reduction. 
 
The lysates were centrifuged at 13,000 rpm at 4°C for 10 minutes and washed in wash 
buffer (50mM Tris pH 7.4, 150mM NaCl, 0.5% Tween20) and pulsed at full speed for 
30 seconds. The cleared lysates were reduced using an equal volume of 2X loading 
buffer (0.1M Tris-HCl pH6.8, 2.5% Sodium Dodecyl Sulfate (SDS - Sigma), 10% 
glycerol, 10% b-Mercaptoethanol 14.2M (Sigma), 0.025% Bromophenoyl Blue BPB) 
at 100°C for 5 minutes then left to cool to room temperature. 
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2.5.3  SDS-PAGE Electrophoresis. 
 
In order to separate the proteins according to their size, SDS gel electrophoresis was 
used whereby the binding of the protein products to SDS results in fractional 
separation by size as a current is passed through the gel.  
 
The reduced samples were consequently loaded onto an SDS PAGE electrophoresis 
running gel prepared at 6% (30% Acrylamide, 1.5M Tris pH 8.8, 10% SDS, 10% 
ammonium persulphate (APS), 0.08%v/v NNN’N’-Tetramethylethylenediamine 
(TEMED - Sigma).)  A stacking gel was prepared at 5.1% (30% Acrylamide, 1M Tris 
pH 6.8, 10% SDS, 10% APS and 0.08v/v TEMED.) The gel was allowed to 
polymerize and samples then loaded into the wells within the loading buffer. This was 
run at 40mA, <180V for an hour in an electrophoresis cell (BioRad, USA) filled with 
running buffer (25mM Tris, 0.2M Glycine, 0.1% SDS).  
 
2.5.4  Gel Transfer 
 
The gel was then transferred onto a polyvinyliderediflouride (PVDF) membrane 
(Sigma Immobilon-P) soaked in methanol and sandwiched in between 6 pieces of 
3MM filer paper soaked in blot buffer (25mM Tris, 0.2M Glycine, 20% methanol) 
using a semi-dry transfer apparatus (Biorad) running at 400mA, <18V for 30 minutes. 
 
2.5.5  Immunoblotting. 
 
The membrane was then blocked in 10% milk/TBST (50mM Tris pH 7.4, 150mM 
NaCl, 0.2% Tween20) overnight at 4°C in preparation for immunoblotting. The 
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primary antibody was diluted in 10% Milk/TBST and incubated with the membrane at 
RT for 1 hour, then the membrane was washed with TBST for 5 minutes 5 times. The 
secondary HRP-conjugated antibody was also incubated in 10% Milk/TBST at RT for 
an hour and then washed in TBST for 5 mins 5 times.  
 
2.5.6  Protein Detection. 
 
Antibodies were detected through the use of chemical luminescence on the PVDF 
membrane, using the oxidation of lumenol by HRP with the ECL plus detection kit 
(Lumigen PS-3). Filters were exposed to Kodak light sensitive X-Ray film then 
developed in an x-ray developer machine. 
 
2.6  In ovo electropration 
 
2.6.1  Microinjection 
 
Silencing constructs were co-injected in ovo at final concentrations of  2µg/µl in PBS 
with 2µg/µl GFP in PBS (pCA!IRES-GFP, Jon Gilthorpe) in order to visulise the 
targeted region of electroporation. The total electroporation mix consisted of 2µl of 
2µg/µl silencing vector, 0.5µl of 2µg/µl GFP and 0.2µl of 2% fast green.  
Microinjection needles made of 1mm glass capillary tubing were pulled using a KOPF 
needle puller Model 720 (David Kopf Instruments, USA) and were backfilled with 
DNA mix & 2% fast green dye (Sigma) and loaded onto micromanipulators 
(Narishige, Japan) attached to a cell microinjector (Microdata Instruments Inc 
PM1000).  
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2.6.2  Electroporation. 
 
5mm Gold-plated electrodes (BTX Inc model 508) were placed 3mm apart and 
connected to a Square Wave Porator (BTX, Inc model ECM 830). DNA was injected 
into the neural tube at a pressure of 5 psi under a Ziess stereoscope (Steni SV11) The 
targeted region was then electroporated at 20V, for 5 pulses lasting 50ms, with 950ms 
intervals between pulses (parameters as outlined after Canatella et al, 2001). The 
embryos were then reared and GFP visualised using a Leica MZ stereomicroscope and 
Leica DC500 digital camera running Leica IM1000 software.) 
 
2.6.3  Embryo Dissection and Storage. 
 
Embryos were staged according to Hamburger & Hamilton, 1951, dissected out of 
their amniotic sacs and fixed in 4% PFA overnight at 4°C. 4g of paraformaldehyde 
was added to 80ml distilled water and heated to 70°C. Two drops of 1M NaOH was 
added to this while swirling until the solution went clear, and allowed to cool to room 
temperature. 10ml of 10x PBS was added and this was topped up to 100ml with 
distilled water.  This 4% PFA was then stored at -20°C. 
 
2.6.4  Cryoprotection and frozen sections. 
 
The embryos were cryoprotected in 30% sucrose in PBS for another night at 4°C then 
snap frozen in OCT (Bright Inc) and stored at -80°C. 12µm cryosections were 
collected on superfrost plus slides (VWR) and stored at –20°C for further analysis. 
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2.7 Cell Death and Proliferation. 
 
 
The purpose of the following treatments were to determine if interfering with PTP 
expression lead to reduced proliferation through the detection of BrdU introduced into 
the developing embryo, or increased cell death through the detection of cleaved 
Caspase 3 enzyme expressed in apoptotic cells. For both treatments embryonic 
sections were pre-treated to facilitate access of the probe to its intracellular target. 
 
 
2.7.1  Apoptosis 
 
Apoptosis is a programmed form of cell death, triggered through a cascade of 
proteolytic enzymes expression called Caspases. This results in the cleavage of protein 
substrates, causing the cell to disassemble. Caspase 3 acts as a key effector in the 
apoptotic pathway, present in numerous cell lineages and is responsible for the 
cleavage of various molecules such as actin. If cells were undergoing apoptosis during 
our silencing experiments then Caspase 3 detection would highlight the temporal and 
spatial pattern of cell death within the spinal cord. 
 
 2.7.1.1  Pre-treatment for Caspase 3 detection. 
 
Cryosections were placed in freshly prepared 1x Declere (Cell Marque Corp, USA) for 
40 minutes whilst steaming. The slides were then placed in fresh Declere that had been 
pre-heated in the steamer for 10 minutes to allow it to warm up and left at room 
temperature to cool slowly. 
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2.7.1.2  Peroxidase Quenching. 
 
Once at room temperature, the slides were washed three times in Tris Buffered Saline 
(TBST) (100mM Tris pH7.5, 150mM NaCl, 0.1% Tween) for five minutes each wash. 
The endogenous peroxidase activity was then quenched with 3% H2O2 for ten minutes. 
This was followed by 3 subsequent washes in TBST for 5 minutes each. 
 
2.7.1.3  Primary Antibody Application 
 
The slides were blocked in blocking solution (0.15% Glycine, 2mg/ml BSA (Fraction 
V – Sigma), 5% Goat Serum and 0.1% TritonX) for 30 minutes at room temperature. 
The Caspase 3 primary antibody (see table for concentrations) was diluted in blocking 
solution and placed on the slides overnight at 4°C.  
 
2.7.1.4  Secondary Antibody Application 
 
The slides were then washed in TBST three times for five minutes each wash. The 
slides were then incubated at room temperature with a biotinylated secondary antibody 
to increase the signals detected within the cells, diluted in blocking solution for an 
hour at room temperature. Following incubation, 3 subsequent washes in TBST for 5 
minutes each were carried out to remove residual secondary antibody. 
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2.7.1.5  Enhancing the Caspase signal. 
 
To increase the Caspase 3 signal within the cells, the sides were incubated in freshly 
prepared ABC (Vector Labs) solution for half an hour. The ABC kit provides an 
immunoperoxidase procedure for antigens through a biotinylated enzyme and Avidin. 
Avidin has a very high affinity for biotin, where the binding of avidin to biotin through 
cross linking forms a stable and irreversible complex, allowing some biotin sites to 
remain free for binding. Three further washes in TBST were carried out to remove 
excess ABC reagent.  
 
2.7.1.6  Detection 
 
The HRP enzymes within the complex were detected visually as a brown precipitate 
using diaminobenzidine DAB+ reagent kit (DAKO, USA). The Caspase 3 antibody 
and its biotinylated complex reacts with horseradish peroxidase-conjugated 
streptavidin molecules and chromogen leading to the visible precipitate developing at 
the site of the antigen. The DAB+ solution was made in 5ml of PBS using 4 drops of 
the DAB+ reagent and 2 drops of hydrogen peroxide provided with the kit. This was 
applied directly to the sections at room temperature for 2 minutes. Three further 
washes in TBST were carried out to remove excess DAB+ reagent.  
 
2.7.2  Proliferation. 
 
The spatiotemporal pattern of dividing cells can be analysed using specific markers. 
Proliferating cells can be detected using Bromodeoxyuridine (BrdU) which is a 
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synthetic analogue of thymidine that uses nucleotide substitution to replace thymidine 
with uridine in the DNA structure of dividing cells. It is incorporated in newly 
synthesized DNA of dividing cells during the S phase of the cell cycle. Once the BrdU 
is incorporated into cells it can then be detected through antibodies specific to BrdU 
and usually antibody binding will require both acid and heat treatment to expose the 
BrdU antigens.  
 
2.7.2.1  BrdU incorporation. 
 
Embryos were treated with 100 µl BrdU (Sigma, UK) 10mg/ml 2 hours prior to 
harvesting by dropping this directly on top of the embryo. The embryos were 
processed according to the protocol for Immunohistochemistry.  
 
2.7.2.2  Pre-treatment 
 
Cryosections were boiled within a slide box covered in cling film in the microwave, 
bathed in citric acid buffer (0.01M pH6.0) on medium heat for 4 times lasting 2 
minutes, allowing 2 minute intervals between heating. The slides were allowed to cool 
to room temperature, then rinsed in PBS. The slides were then passed through 0.1M 
HCl for 30 minutes at RT. This was replaced with 2M HCl for 30 minutes at 37°C and 
finally in 0.1M sodium borate pH 8.5 for 10 minutes at RT followed by a rinse in PBS.  
 
2.7.2.3 Peroxidase quenching. 
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The endogenous peroxidase was quenched with 2% H2O2 for 15 minutes followed by 
2 subsequent washes in PBS for 5 minutes each. The slides were then blocked in 10% 
Normal Goat Serum (NGS) (Vector Labs) in PBS for an hour at room temperature.  
 
2.7.2.4  Antibody Application. 
 
The slides were then incubated in anti-BrdU (DSHB) diluted in blocking solution for 
an hour at room temperature, followed by 3 washes in PBS for 5 minutes each. The 
slides were then incubated with secondary antibody diluted in blocking solution in a 
humid chamber for an hour at RT followed by 3 washes in PBS for 5 minutes each.  
 
2.7.2.5  Detection  
 
DAB+ solution was then used to visualise the location of the antibody through biotin 
complexes as previously described. The slides were then rinsed in PBS and mounted in 
Floursave (Calbiochem) a glycerol free, ready to apply aqueous mounting medium that 
helps to preserve fluorescent markers within the tissue of the GFP electroporated 
embryos. 
 
2.8   Immunohistochemistry 
 
Slides were washed in PBS, then 1% H2O2/PBS for 20 minutes in order to quench the 
endogenous peroxidase. The sections were then blocked in 4% BSA (Fraction V, 
Sigma) in PBS for another 20 minutes at room temperature.  
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The primary antibody was added to fresh blocking solution and 200µl added to each 
slide which was incubated in a humid chamber for an hour at RT (see table for 
concentration of antibodies used). The slides were washed in PBST (0.2% Tween20) 
for 5 minutes three times.  
 
The secondary HRP, biotinylated or fluorescent conjugated antibody was then applied 
and incubated for an hour at RT. The slides were washed in PBS and fluorescence 
observed with a conjugated secondary antibodies and Cy3 fluorescent tag (Amersham) 
or they were consequently detected using DAB (Vector Labs, USA). 
 
Primary antibodies 
 
Antibody Donor species Notes Concentration  
Neurofilament Mouse DSHB 3A10 1:100 
!-Tubulin Mouse Babco 1:100 
Islet1/2 Mouse DSHB 39.4D5 1:100 
Lim1/2 Mouse DSHB 4F2 1:100 
Nkx2.2 Mouse DSHB 74.5A5 1:20 
Mnr2/Hb9 Mouse DSHB 81.5C10 1:400 
Engrailed1 Mouse DSHB 4G11 1:200 
Lim3 Mouse  DSHB 67.4E12 1:5 
Evx1 Mouse DSHB 99.1.3A2 1:20 
Hoxc9 Mouse DSHB 5B5-2 1:20 
Olig2 Guinea pig S. Guthrie 1:400 
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P-Histone 3 Rabbit Upstate 1:500 
Caspase-3 Rabbit Upstate 04-439 1:1000 
BrdU Mouse DSHB 1:100 
RPTP" polyclonal Rabbit (AB69) A. Stoker (aa99-118) 1:5000 (Western) 
RPTP$ polyclonal Rabbit A. Stoker 1:1000 (Western) 
Anti-Flag M2  Mouse Sigma 1:10,000 
(Western) 
 
 
• Polyclonal anti-avian PTP" serum AB69 was generated locally using chick PTP" 
peptide  YQELDGFDNESSNKTWMK aa99-188, by M Hurley & A Stoker. 
 
Secondary antibodies 
 
Antibody Donor species Conjugation Concentration 
Anti mouse Rabbit TRITC 1:50 (DAKO) 
Anti mouse Rabbit FITC 1:50 (DAKO) 
Anti guinea pig Rabbit HRP 1:100 (Abcam) 
Anti rabbit Goat HRP 1:100 (DAKO) 
Anti mouse Rabbit HRP 1:100 (DAKO) 
Anti rabbit Goat Biotinylated 1:250 (DAKO) 
Anti mouse Rabbit Biotinylated 1:100 (DAKO) 
Cy3 Mouse Streptavidin (3°) 1:400 (Amersham) 
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2.9   Histological staining 
 
Slides were washed in PBS and stained with 1% Haematoxylin (Ehrlich’s - Sigma) for 
5 minutes then rinsed with running tap water. The slides were then quickly dipped in 
acid alcohol (1% HCl in 70% ethanol) and rinsed again under running tap water and 
counterstained with 1% Eosin (Raymond Lamb) for 2 minutes, and then rinsed under 
running tap water, dried and mounted in Floursave as previously described. 
 
2.10  Non-radioactive in situ hybridisation with digoxygenin (DIG) labelled 
probes. 
 
Embryos were processed for cryosectioning, as previously described, only using DEPC 
treated reagents to prevent RNA degradation. The slides were stored in black slide 
boxes with silica gel to remove moisture. The treatment took place over three days. 
RNA probes were produced against cellular targets namely PTP mRNA, giving an 
indication of the gene expression profile throughout the spinal cord at different 
embryonic ages. 
 
2.10.1  DNA Linearisation. 
 
1µg of DNA was linearised with appropriate restriction enzymes at 37°C for 2 hours in 
a total of 40µl volume (34µl DNA & dH2O, 4µl specific buffer, 2µl enzyme) which 
was then purified using a PCR purification column (Qiagen). High salt binding buffer 
was added to the linearised mix and this was centrifuged at full speed for one minute in 
the spin column. This resulted in the DNA binding to the silica gel membrane within 
the spin column and impurities being washed away. The DNA was then eluted off in 
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50µl molecular grade water (Sigma) through centrifugation at full speed for a minute, 
collecting the eluate in a sterile eppendorf. The sizes of the digested DNA were then 
checked on 0.7% agarose gel as previously described.  
 
2.10.2  Probe Synthesis 
 
The probe synthesis mix was made up to a total volume of 20µl & incubated at 37°C 
for 2 hours. 47µl of ddH20 was added and this was purified by centrifuging the probe 
mixture using an RNA purification column (Qiagen) and collecting the eluate 
containing the desired RNA probe. To this eluate, 33µl of formamide was added taking 
the total volume to 100µl of probe which was stored at -20°C. The following plasmids  
were used to prepare the RNA probes: Chick NeuroM, pBSK-NeuroM (M Gullivet 
1997); Chick PTP$, pCRYPmyc1 (A Stoker 1994); Chick PTP" 3xFlagGamma-
CMV14 (Ledig et al 1999), full length PTP" cDNA provided by Lu Wang. 
 
Probe synthesis was initiated using: 
 
13µl        linear DNA template in H2O 0.25µ total 
2µl          5x transcription buffer 
2µl          DIG RNA labelling mix (Roche) 
1µl          RNA inhibitor (Roche) 
2µl          RNA polymerase (T3, T7, Sp6 Roche) 
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2.10.3  Hybridization. 
 
2-5µl of probe per 1ml of hybridisation buffer (1x salts (10x stock: 2M NaCl, 50mM 
EDTA, 100mM Tris-HCL pH7.5, 50mM NaH2PO4.2H2O, 50mM Na2PO4), 50% 
formamide, 0.1mg/ml yeast tRNA, 10% dextran sulphate, 1x Denharts solution) was 
denatured for 5 minutes at RT and allowed to stand for 5 minutes on the bench. 150µl 
of this dilution was added to each slide and a coverslip placed on top. This was 
hybridised in a humid chamber with tissues soaked in 2x SSC/Formamide at 70°C 
overnight. 
 
2.10.4  Antibody Treatment. 
 
The following day post hybridisation, the slides were washed in wash buffer (1x SSC, 
50% Formamide, 0.1% Tween20) at 65°C for 30 minutes three times. 3 consequent 
washes in TBST were carried out for 30 mins each at room temperature. The slides 
were dried and blocked (TBST, 2% nucleic acid blocking reagent – Roche, 10% heat 
inactivated sheep serum) for 1 hour at RT. Anti-Digoxygenin AP-conjugated antibody 
(Roche) was diluted 1:1500 in blocking solution and the slides were incubated with 
this in a humid chamber overnight at 4°C. 
 
2.10.5  Signal Detection. 
 
Following overnight incubation, the slides were washed 3 times in TBST for 10 
minutes each, then washed in pre-staining buffer (100mM Tris pH9, 100mM NaCl, 
5mM MgCl2) for 10 mins twice. Staining buffer was prepared using and equal volume 
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of prestaining buffer with 10% (w/v) polyvinyl alcohol and 18µl/ml of combined 
NBT/BCIP (Roche). The slides were then incubated at 37°C in the dark until a 
satisfactory signal was achieved. They were then rinsed in distilled water and mounted 
in Floursave. 
 
2.11 Quantification of cell numbers from spinal cord sections. 
 
 
Quantification of cell numbers in different regions of the neural tube stained with 
respective neuronal specific antibodies, as well as apoptosis markers and proliferation 
markers, Caspase 3, pH3 and BrdU respectively were carried out on spinal cord 
sections. The embryos analysed for PTP" and PTP$ loss of function and PTP" over 
expression as well as control sets were stained against Islet1/2, Lim1/2, MNR2, Lim3, 
Caspase3, p-Histone3 and BrdU antibodies.  
 
The counts were carried out ‘blind’ using the Openlab software, where the region of 
cells to be counted was outlined, marked and compared against its control side within 
the same embryo. Three serial sections per embryo analysed were counted to ensure 
accurate results. The mean ratio between the control and electroporated sides of the 
neural tube of stained cells was determined for each embryo in the silenced group and 
control group. The average ratios of cells amongst experimental sets were then 
determined as an average of the individual embryo counts and tabulated. 
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Chapter 3:  Testing shRNA knockdown of PTPs in culture. 
 
3.1  RNA Interference in the chick. 
 
Since its discovery in 1998 (Fire et al, 1998) RNAi has allowed researchers to test the 
post-transcriptional effects of genes spatially and temporally in vivo, without the need 
to create a genetic knock-out organism. A number of studies had previously validated 
the chick as a model system for RNAi technology (Mette et al, 2000; Katahira & 
Nakamura, 2003; Bourikas & Stoeckli, 2003). These studies demonstrated the 
effective silencing of target genes during embryonic development. 
 
RNA interference has many advantages over conventional methods of gene analysis 
and is becoming a powerful tool in deciphering genetic interactions during 
development. Moreover, studies have demonstrated the use of short hairpin RNA 
plasmids in the chick neural tube (Chesnutt & Niswander, 2004). The use of small-
interfering RNA and short-hairpin RNA molecules to deliver silencing of the genes 
involved in proliferation, both in human and murine cell types, has also been 
investigated (Berns et al, 2004; Gupta et al, 2004).  
 
During and after this project, several more studies have further validated shRNA use in 
the chick. These studies have utilized the vector-based approach using avian 
retroviruses or U6 promoters, to drive shRNAs during commissural axon development, 
neural tube development and in the developing eye (Bourikas et al, 2005; Bron et al, 
2004; Harpavat & Cepko, 2006).  
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Together, these results have set precedent and validated the use of short-hairpin/small-
interfering RNA molecules using U6 promoters in the chick nervous system directed 
against Protein Tyrosine Phosphatases. 
 
3.2 Designing the RNAi constructs 
 
Using the chick as a model organism allowed the screening of the effects of multiple 
double stranded RNA molecules over a short space of time, with sequences 
specifically targeting the mRNA of members of the RPTP family without the need to 
create knock out organisms. Initially, the hairpin-encoding constructs were designed 
and assembled and their efficacy tested in culture.  
 
3.2.1  Designing the target sequences. 
 
Six target sequences were selected at different locations on the chick PTP$ cDNA 
(Figure 3.1A), using the online manufacturers algorithm for creating the silencing 
vectors (www.ambion.com) (Ambion, USA). Once the target sequences were 
determined the sense and anti-sense oligonucleotides encoding the short-hairpin 
molecules were designed (Figure 3.1B). These were then obtained directly from 
Operon UK. 
 
The activity of six RNAi encoding vectors against PTP", previously constructed using 
the p-silencer1.0 U6 vector (Ambion) by M Hurley, were also used (Figure 3.2A). The 
target sequences of the PTP" cDNA were also designed using the Ambion algorithm 
(Figure 3.2B & 3.2C).  
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Figure 3.1 (A) Table of the 6 anti-sense cDNA target sequences for PTP$, Sig 1-6 and 
the location of the various target sequences along the length of the cDNA. The 
corresponding GC content for each target sequence is also listed. (B) The full sense 
and anti-sense pairs of hairpin sequences constructed for the six PTP$ cDNA targets. 
Key: White- Target sequence, Yellow – Hairpin loop sequence, Green – AA/TT target 
sequence overhangs, Blue - 5’ GATCC terminus, Red- RNA pol III terminator 
sequence on antisense strand and Pink- its complimentary sense strand RNA pol III 
terminator sequence.  
 
 
AB
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Figure 3.2 (A) The pSilencer 1.0-U6 plasmid used to drive shRNAi molecules against 
PTP". Reproduced from Ambion. (B) Example of hairpin oligonucleotides and 
orientation for the pSilencer 1.0-U6 plasmid. Reproduced from Ambion. (C) PTP" 
cDNA target sequences after M Hurley. 
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3.2.2  The optimum parameters. 
 
The hairpin-encoding complimentary DNA oligonucleotodies were designed according 
to the guidelines from Ambion, ensuring the loop sequences and orientation were in 
the correct alignment. Amongst these parameters were a low GC content and an 
avoidance of long AAAA repeats within targets. The sequences would ultimately span 
targets including regions encoding the intra-cellular and extra-cellular domains of the 
receptor. These would all be expected to result in degradation of the mRNA transcript.  
 
3.2.3  Building the PTP$ silencing vectors. 
 
The six complimentary sequences against PTP$ were annealed and ligated into the 
pSilencer-2.1 plasmid (Ambion) (Figure 3.3A & 3.3B). A negative control pSilencer-
2.1 U6 Hygro plasmid containing an RNA sequence of no homology to any specific 
gene was supplied by Ambion. The sequence had been checked against the emerging 
chick genome database, with no homologies found.  
 
This negative control vector controls for the non-specific effects of a hairpin in our 
system. Numerous studies have indicated this requirement to provided another level of 
evidence against off-target effects and non-specific activation of the RNAi machinery 
and specificity of target gene silencing (Ohkawa et al, 2000; Sui et al, 2002; 
Brummelkemp et al 2002; El-Bashir et al, 2001). 
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Figure 3.3 (A) The pSilencer 2.0-U6 hygro plasmid used to drive shRNAi expression 
against PTP$. Reproduced from Ambion. (B) Schematic representation of an example 
target sequence, annealed hairpin DNA insert and the resulting hairpin siRNA 
structure and orientation. Star denotes a GC overhang. Reproduced from Ambion. 
AB
 133 
3.3  In vitro assays. 
 
The silencing vectors used to knock down the RPTP genes in the following 
experiments were all based on short-hairpin (sh) RNA molecules. To validate the 
shRNA expression vectors and find the most effective ones for use in ovo, the 
silencing vectors were tested for knock-down efficiency in a cell culture system using 
HEK 293T cells. In the following paragraphs, the results of the biochemical analysis of 
knocking down PTP$ and PTP" using shRNAi in vitro are discussed further.  
 
3.3.1  PTP" 
 
When considering levels of plasmid expression in the culture system, it is worthy to 
note that although the co-transfected PTP$ (Figure 3.6D) and PTP" (Figure 3.6B) 
plasmids were amplifiable in HEK 293T cells, the silencing plasmids were not. A 
number of the vectors demonstrated an efficient and reproducible reduction of protein 
levels (Figure 3.4A & 3.4B), when compared against a negative control silencing 
plasmid co-transfected with PTP". The level of target gene expression was detected 
using an anti-PTP"69 antibody (M Hurley & A Stoker, unpublished data). 
 
3.3.2  Setting the control experiments. 
 
All the silencing cultures were co-transfected with a firefly luciferase construct in 
order to normalise the intensity of protein expression on western blots, against the 
transfection efficiency within experimental groups (Appendix I).  
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The level of expression of the luciferase reporter in culture allowed its detection 
through measuring the degree of luminescence from a small sample of cell lysate, 
using the Renilla Luciferase Assay (Promega). Once the transfection efficiency was 
determined, the values were then used to normalise results within each sample group 
against the density of the protein bands obtained, in order to give an accurate 
indication of the level of silencing.  
 
Control transfections using only a proportional amount GFP (Figure 3.6A), were 
established as a negative control against the non-specific binding of the PTP"69 
antibody in non PTP" transfected cultures (Figure 3.4A & 3.4B). Equal volumes of the 
cell lysates per experimental group were processed further for western blotting, the 
results of which are described below.  
 
3.3.3  Quantifying the level of mRNA knock down. 
 
Amongst independent experimental sets Si1, Si3 and Si6 consistently demonstrated 
very effective PTP" protein knock down by approximately 90 % (Figure 3.4C). These 
data then allowed us to select these three vectors and test their effects within the chick 
spinal cord. The results also gave an indication of silencing plasmids that did not 
reduce the levels of PTP" expression so effectively, which could then be used as 
controls in our in vivo experiments where they would be predicted to be less effective 
than Si1, Si3 and Si6.  
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Figure 3.4 (A) Level of PTP" protein expression on western blots detected by anti 
PTP"69 (A Stoker, Unpublished.) In order to determine this, the protein gels were 
scanned on a BIORAD scanner, and values of expression intensity normalised against 
the luciferase readings for each sample. Equal amounts of protein from the lysates 
were added to each lane as determined by Coomassie Brilliant Blue R-250 staining of 
gels ran once they had been developed. These consistently showed proportional 
amounts of protein within the 20µl aliquots of lysate used (data not shown). The 
expression intensities on film were compared to the PTP" control at 100%. Strong 
PTP" expression is evident in the PTP" labelled lane containing the negative control 
silencing vector and chick PTP". The sample containing no PTP" DNA (con) shows no 
antibody binding as expected. A strong level of knock down of PTP" is seen from Si1, 
Si3 and Si6 when compared to the PTP" lane. The level of knock down achieved from 
Si2, Si4 and Si5 is not as pronounced. (B) The previous set of experiments were 
repeated with similar results with Si2 remaining the least efficient PTP" silencing 
vector. (C) Table of quantified PTP" knock-down by the silencing vector, normalised 
against the luciferase assay results and taking the expression of the PTP" control lane 
as 100%. (Each vector was tested the following number of times: n=4; Si1 n=2; Si2 
n=2; Si3 n=4; Si4 n=4; Si5 n=3; Si6 n=3) (Each colour marker, Green, Blue, Red, 
Yellow indicates an experimental set analysed per western blot for instance amongst 
the yellow sample set, expression intensities for PTP", Si1, Si2, Si3, Si4, Si5 and Si6 
were recorded) (Raw data in appendix). 
A150  _
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3.3.4  PTP$ 
 
The RNAi vectors constructed against PTP$ were tested in cell culture for their 
efficiency in reducing the level of PTP$ protein in HEK 293T cells. PTP$ was 
detected using an anti-PTP$ antibody (Stoker et al, 1995). The results show that 
amongst independent experimental sets, when compared to the expression of PTP$ 
(Figure 3.7D), that were treated with the negative control RNAi hairpin, Sig1, Sig5 
and Sig6, proved particularly effective at reducing the expression of its target protein 
(Figure 3.5A & 3.5B). The results indicated that using Sig1, Sig5 and Sig6, could 
significantly knock down the level of PTP$ protein expression in the culture system. 
 
3.3.5  PTP" over-expression vectors. 
 
Once the most suitable vectors for silencing were determined, the converse experiment 
for PTP" was designed. An over-expression vector for PTP" was used to demonstrate 
that the PTP" protein could be significantly over-expressed in culture. This would then 
serve as a useful indicator of PTP" gain of function during development, and may 
prove useful for any future studies attempting to rescue the effects of silencing.  
 
An over-expression construct was generated using chick PTP" cDNA (previously 
generated by M Hurley and A Stoker) driven by a !-actin promoter in the IRES-GFP 
vector (Figure 3.7C). This was transfected in HEK 293T cells to test the levels of its 
expression along with the previous PTP" CMV25 and PTP" CMV14 expression 
plasmids generated by M Hurley.  
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Figure 3.5 (A) Level of PTP$ protein expression on western blots detected by anti 
PTP$ (Stoker et al, 1995). Equal amounts of protein from the lysates were added to 
each lane as determined by Coomassie Brilliant Blue R-250 staining of gels ran once 
they had been developed. These consistently showed proportional amounts of protein 
within the 20µl aliquots of lysate used (data not shown). Strong PTP$ expression is 
evident in the PTP$ labelled lane containing the negative control silencing vector and 
chick PTP$. A strong level of knock down of PTP$ is seen from Sig1, Sig5 and Sig6 
when compared to the PTP$ lane. The level of knock down achieved from Sig2 is not 
as pronounced. (B) The previous set of experiments were repeated with similar results 
with Sig2 remaining the least efficient PTP$ silencing vector and Sig5 the most 
efficient (n=4 for each Sig vector). 
 
 
Figure 3.6 Level of PTP" protein expression on western blots detected by anti PTP"69 
(A Stoker Unpublished). Equal amounts of protein from the lysates were determined 
by Coomassie Brilliant Blue R-250 staining of gels. These showed proportional 
amounts of protein within the 20µl aliquots of lysate used per sample set (data not 
shown). Strong PTP" expression is evident in the IRES-PTP" labelled lane containing 
the new IRES vector when compared to the previous PTP"14 CMV expression vector, 
and less efficient expression is observed from the PTP"25 expression vector (M 
Hurley). As expected the control GFP labelled lane containing only IRES-GFP does 
not show a signal when treated with anti-PTP"69 antibody (n=3). 
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The PTP" protein was detected on a western blot using anti-PTP"69 antibody. This 
was tested alongside the original PTP"14 and PTP"25 plasmid (Figure 3.7B), to 
compare their relative levels of expression for the same total amount of transfected 
vector. A high level of gene expression of IRES-PTP" was detected when compared to 
the PTP"14 expression vector and least efficient PTP"25 vector (Figure 3.6). This was 
most likely the result of the !-actin promoter, which was more efficient at gene 
expression than the previous CMV promoter, which is generally considered to be an 
unreliable promoter in ovo. This then allowed us to proceed with the gain-of-function 
studies in vivo. 
 
3.3.6  Conclusions of in vitro assays. 
 
The results of the cell culture experiments using shRNAi directed against PTP" and 
PTP$ suggest that Si1, Si3 and Si6 are the most efficient silencing vectors for 
knocking down PTP" and that Sig1, Sig5 and Sig6 provide the greatest levels of knock 
down directed against PTP$. Furthermore a set of controls were established to test the 
integrity of the RNAi process, that all returned negative results providing confidence 
that the silencing effects were target specific. Furthermore an IRES over expression 
vector for PTP" proved successful at lifting the levels of PTP" protein in culture when 
compared to a similar quantity of a PTP" encoding vector utilising the CMV promoter. 
These results together provided a good foundation upon which to test the efficacy of 
the silencing vectors in vivo, providing loss-of-function, and the PTP" expression 
vector providing gain-of-function. 
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Figure 3.7 RPTP Expression vectors used in the cell culture studies (A) 
pCABetaIRESGFP vector expressing GFP (Gift of John Gilthorpe). (B) 
3xflagGamma-CMV14 vector (Sigma, UK) expressing PTP" (M Hurley). (C) 
cPTPGam-IRESGFPgrip vector over-expressing PTP" (A Stoker). (D) p3xFLAG-
CMV25-PTPs-Myc vector expressing PTP$ (A Stoker). 
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Chapter 4:  Defining the PTP"  and neuronal expression domains. 
 
4.1  Introduction 
 
Neurons within the spinal cord arrange in pool-specific identities during their initial 
outgrowth, indicating that they must have cell surface differences which allows them 
to fasciculate with like axons and recognize path-finding guidance cues during 
axonogenesis (Tessier-Lavigne & Goodman, 1996). The LIM-Homeodomain family of 
transcription factors plays an important role in the development of motor neurons with 
pool-specific identities (Tsuchida et al, 1994). Members of this family set up various 
neuronal subtypes within the spinal cord and refine the initial patterns that are already 
established.  
 
Cell movements within the spinal cord are subsequently critical to determining the 
final location of these neuronal subtypes. It is during the refinement of initial patterns 
and during axonogenesis that neurons acquire transcription factor specific columnar 
identities, that strongly relate to their fate and function. The cells located within these 
neuronal pools project their axons towards the limbs and axial components of the 
body.  
 
In the following paragraphs, I will describe in more detail how such transcription 
factors interact and demonstrate expression profiles of those members of the LIM-HD 
family implicated in motor neuron development, and why PTP" could, based on its 
expression profile, play an important role in the generation and migration of spinal 
neurons. 
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4.2  Axonogenesis 
 
The progression of axonogenesis follows the birth of the first spinal motor and 
interneurons, and tracing the axonal architecture of the spinal cord highlights the route 
axons of differentiated neurons take towards their targets. 3A10, a neurofilament 
marker was used for this purpose at HH stages 18, 20, 22 and 26 in order to gauge the 
degree of axon outgrowth.  
 
This is also as a general indicator of axonal circuitry, and therefore correct path finding 
of differentiated neuronal projections. At HH18, interneuronal populations have 
extended their axons dorsoventrally, and the first sensory and motor neurons have 
exited the ventral nerve roots (Figure 4.1, Panel A).  
 
From HH stages 20 and 22 the decussation of commissural axons is visible along the 
ventral-most aspect of the spinal cord as well as extensive dorsal and ventral root 
innervations (Figure 4.2, Panel A and Figure 4.3, Panel A). At stage 26, the prominent 
dorsal root entry zones and extensive dorsal root ganglion neurons are highlighted 
(Figure 4.4, Panel A).  
 
Within the spinal cord, interneurons can be observed associated with axons that run 
anteroposteriorly along the embryo and within the outer perimeter of the ventral horns 
within the white matter, ventral to the commissural plate. 3A10 thus serves as a good 
indicator of correct axonal trajectories from pool specific interneurons and motor 
neurons of the spinal cord at all dorsoventral and mediolateral levels. 
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Figure 4.1 Expression of neuronal markers in transverse sections of wild type HH18 
chick brachial spinal cord sections. Immunocytochemical staining of (A) 3A10, (B) 
Islet1 & Islet2 expression in ventral motor neurons, (C) Lim 1 & Lim2, arrows denote 
Lim1/2 positive dorsal interneurons, (D) Lim 3 expression in ventral motor neurons, 
and (E) Mnr2 protein expression in motor neurons. Dig-labelled mRNA in situ 
hybridization to (F) PTP" in dorsal spinal cord, arrows denote dorsal interneurons and 
(G) NeuroM expression predominantly in the ventral spinal cord. Scale bar is 0.5mm. 
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4.3  Lim-HD expression profiles of differentiating neurons. 
 
4.3.1  Islet1/2 
 
Islet 1 is a LIM HD transcription factor expressed by all motor neurons by stage HH 
18. Islet 1 determines the mediolateral position of motor neurons providing an 
indication of the time that has elapsed from their birth, whereby they exit the cell cycle 
and initiate the expression profile of differentiated neurons (Karlsson et al 1990, 
Ericson et al 1992). At stage 18 the expression of Islet 1 in the motor neurons fated to 
form part of the medial branch of the LMC is evident. At this stage, cells occupy both 
medial and lateral positions distal to the ventricular zone (Figure 4.1, Panel B).  
 
At HH20, Islet-1 positive cells occupy the ventral spinal cord within groups fated to 
form the LMC, as newly differentiated migratory motor neurons. The early born 
neurons prior to HH18, predominantly populate the medial branch of the LMC and 
later born neurons occupy the lateral branch of the LMC (Tsuchida et al, 1994). It is 
worthy to note that at this stage, these LMC cells express a combination of Islet 1 and 
Islet 2 but not Lim1/2 (Figure 4.2, Panel B). 
 
By stage HH22, Islet 1 is expressed in the medial zone proximal to the ventricular zone 
(Tsuchida et al, 1994). As the cells within the motor column start to express Islet 2, 
Islet 1 expression is maintained in the medial branch of the LMC. The motor columns 
are now anatomically clearly evident, and a few Islet 1 positive dorsal interneurons are 
visible (Figure 4.3, Panel B). Towards HH26, this dorsal expansion is more evident, 
whereby Islet 1 and Islet 2 occupy dorsal, intermediate and ventral locations along the 
outer edges of the spinal cord (Figure 4.4, Panel B). 
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Figure 4.2 Expression of neuronal markers in transverse sections of wild type HH20 
chick brachial spinal cord sections. Immunocytochemical staining of (A) 3A10, (B) 
Islet1/2 clearly highlighting the ventral column motor neurons, (C) Lim 1/2 positive 
interneurons dorsally, arrows (D) Lim 3 in the outer lateral segments of the motor 
columns, and (E) Mnr2 protein expression in the motor pools. Dig-labelled mRNA in 
situ hybridization to (F) PTP" across the dorsoventral aspect of the spinal cord, arrows 
denote regions of strong expression ventrally and dorsally and (G) NeuroM expressing 
strongly in the ventral spinal cord and weakly in dorsal mantle zone. Scale bar is 
0.5mm. 
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Although the antibody used highlights both Islet 1 and Islet 2 positive cells 
indistinguishably, it is worthy to note that as the neurons migrate laterally within the 
lateral motor column they begin to express Lim 1 and Islet 2. The transient period of 
expression of Islet 1 ends once cells occupy this more lateral columnar location. The 
cells within the medial branch of the LMC maintain the expression of Islet 1 as well as 
Islet 2 (Tsuchida et al, 1994). 
 
4.3.2  Lim 1/2 
 
Lim 1 and Lim 2 are two further members of the LIM HD family, expressed in motor 
neurons and interneurons (Tsuchida et al 1994). Their expression begins by HH18 in 
the first-born interneurons, where a few cells are evident in the dorsal and intermediate 
margins of the spinal cord (Figure 4.1, Panel C).  
 
By HH 20 and HH 22 this expression domain progressively extends ventrally towards 
the intermediate zone yet persists along the lateral edges of the mantle zone, with 
interneurons located dorsally and medially along the dorsovental length of the spinal 
cord (Figure 4.2, Panel E; Figure 4.3, Panel E). These Lim 1/2 positive cells also co-
express Pax 2, but not Pax 6 or Pax 7 (Burrill et al, 1997; Tsuchida et al 1994). Toward 
HH 26, Lim 1/2 expression continues to extend ventrally as new cells arise to occupy 
ventral motor neuron populations of the lateral branch of the LMC (Figure 4.4, Panel 
C). These Lim 1/2 LMCl positive motor neurons also express Islet 2 at this 
developmental stage (Tsuchida et al, 1994). It is worthy to note that in this ventral 
location a Lim 1/2 expression profile is initiated only once cells have cycled through 
Islet 1 and then Islet 2 expression.  
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Figure 4.3 Expression of neuronal markers in transverse sections of wild type HH22 
chick brachial spinal cord sections. Immunocytochemical staining of (A) 3A10, (B) 
Islet1/2 clearly marking the ventral motor pools, (C) Lim 1/2 in the mantle zone, 
arrows, (D) Lim 3 in a few cells in the ventral motor pools, arrows and (E) Mnr2 
ventrally within post mitotic neurons protein expression. Dig-labelled mRNA in situ 
hybridization to (F) PTP" across the dorsoventral aspect of the spinal cord, and 
diffusely in the ventricular zone, arrows and (G) NeuroM in the ventral spinal cord and 
dorsal mantle zone. Scale bar is 0.5mm 
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4.3.3  Lim3 
 
A further member of the cysteine-histidine rich Lim HD family, Lim-3 is transiently 
expressed by ventrally located neurons in the spinal cord in the most lateral positions. 
This suggests that these cells are acquiring their terminally differentiated identities 
following cycling of Islet 1/2 states albeit at a lower frequency than the Islet 1/2 cells 
(Tsuchida et al 1994). Lim 3 expressing neurons arise at HH 18 from the pMN domain 
predominantly, where Lim3 is expressed in the cells on the extreme lateral edges of the 
spinal cord (Figure 4.1, Panel D). It is expressed by motor neurons laterally and 
reaches a peak in expression at HH 20 (Figure 4.2, Panel D). However, at this early 
stage and within the brachial region, Lim 3 positive motor neurons  also express other 
markers as these cells transit through their Lim-3 differentiation state. The number of 
cells expressing Lim-3 decreases in number by HH 22 (Figure 4.3, Panel D), and is 
absent by HH 26 altogether (data not shown). Its expression returns to the MMC later 
during development at brachial levels (Tsuchida et al, 1994). 
 
4.4  Mnx-HD and Nkx-HD transcription factor profiles of nascent motor neurons. 
 
The Mnx group of HD transcription factors are expressed by post mitotic motor 
neurons, their functions are evolutionary conserved and well documented. Two 
members of this family, Mnr2 and Hb9 have been implicated in the generation of 
motor neurons (Tanabe et al, 1998; Arber et al, 1999). 
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Figure 4.4 Expression of neuronal markers in transverse sections of wild type HH26 
chick brachial spinal cord sections. Immunocytochemical staining of (A) 3A10, arrow 
shows ventral commisure (B) Islet1/2 clearly marking the ventrally located lateral 
motor pools, (C) Lim 1/2 in the ventral motor pools, medially and dorsally in distinct 
segments, arrow shows lateral aspect of LMC (D) Mnr2 protein expression ventrally 
within the lateral and medial motor columns, (E) Nkx2.2 in a thin stripe just above the 
floor plate. Dig-labelled mRNA in situ hybridization to (F) PTP" in the dorsoventral 
aspect of the spinal cord, and diffusely in the ventricular zone and motor columns 
shown by the arrows, with stronger expression in the dorsal most region of the spinal 
cord and a strong level of expression medially and (G) NeuroM in the ventral spinal 
cord, just outside of the ventricular zone and dorsal mantle zone. Scale bar is 0.5mm 
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All motor neurons express Mnr2 initially, and all Mnr2 expressing cells arise from the 
pMN domain. In motor neuron progenitors, Mnr2 has functions in the initial 
specification of motor neuron identity and a later wave of expression regulates motor 
neuron columnar identities, where it plays a role as a transcriptional repressor directing 
motor neuron identity whilst inhibiting interneuronal identities (William et at 2003). 
 
At HH18, Mnr2 expression is restricted to the ventral spinal cord as its cells arise from 
the pMN domain (Figure 4.1, Panel E.) The antibody used in these experiments detects 
both Mnr2 and Hb9, however we shall refer to the results in the context of Mnr2. From 
HH20 to HH22, the expression of Mnr2 lies sandwiched between the outer pial edge 
and inner ventricular layer in the ventral spinal cord at the level of the pMN domain. 
Interestingly the expression of Lim3 lies outside of the Mnr2 expression domain 
(Figure 4.2, Panel E; Figure 4.3, Panel E). This expression persists through to HH 26, 
where at axial levels it is also expressed in the Column of Ternii neurons (Figure 4.4, 
Panel D).  
 
Mnr2 has been shown to act as a transcriptional repressor during the acquisition of 
motor neuron fate (William et al, 2003). Hb9 expression is activated and maintained 
by an enhancer region within the Hb9 regulatory region that contains ‘cis’ elements for 
‘positive’ factors such as Islet1, Ngn2, NeuroM & NeuroD. Hb9 therefore maintains 
its own expression via a positive feedback loop. Synchronization of neurogenesis and 
motor neuron specification then occurs via !HLH and homeodomain transcription 
factors (Lee & Pfaff, 2003).  
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Nkx2.2 is expressed by the ventral most progenitor domain dorsolateral to the floor 
plate, giving rise to the ventral most V3 neurons where it is required for their 
generation and maintenance (Briscoe et al 1999). These cells repress their potential for 
somatic motor neuron generation, whilst they are required for the development of 
oligodendrocytes that arise from progenitors within the Nkx2.2 expressing domain. 
Nkx2.2 thus marks the ventral most cells, and is a useful marker as its expression 
coincides, in part with that of PTP" at HH26 (Figure 4.4, Panel E). 
 
4.5  The expression of PTP"  in the chick spinal cord 
 
PTP" is a member of the RPTP type V group. These molecules have extra-cellular 
domains similar to cell adhesion molecules implicating their role in axonogenesis and 
path-finding. Differences in these extracelluar domains suggest they have specific 
ligands and studies have led to the emergence of both heterophilic and homophilic 
ligands for these molecules. The onset of PTP" expression begins at around HH18, 
where this gene displays an interesting pattern of expression within the spinal cord, 
whose onset of expression overlaps with neurogenesis.  
 
Chick PTP" was first described in 1996 (Xiong et al, 1996). The protein exists as both 
transmembrane and secreted isoforms (Shintani el al, 1997). PTP" expression in the 
chick is predominantly seen in the nervous system from gastrulation onwards with low 
level expression in the primitive streak and the first formed somites.  
 
Within the neural tube PTP" is first clearly detected at HH18, where it is initially 
expressed in the dorsal interneuron domain (Gustafson & Mason, 2000) (Figure 4.5, 
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Panel B). Traces of PTP" expression can however be observed as early as HH16 within 
the spinal cord (Figure 4.5, Panel A). By HH20, PTP" is expressed in the medio-
ventricular region. This expression domain expands ventrally from HH20 to HH23 
within the intermediate zone (stronger expression) and is seen in the cells just above 
the floor plate and within the lateral motor columns (weaker expression) (Figure 4.5, 
Panels C, D, E & F respectively). PTP" is also expressed at lower levels in the 
ventricular progenitors of motor neurons and interneurons by HH20, at least three 
quarters of the way up the spinal cord (Figure 4.6, Panel C). Dbx1 and Dbx 2 
homeobox genes define the fate of V0 and V1 interneurons from progenitors, whereby 
Dbx1 loss of function mutants fail to produce V0 interneurons (Pierani et al, 2001). 
Dbx1/2 however was not used as a marker as the onset of its expression within 
interneuronal populations was much earlier than that of PTP" expression. Furthermore 
we had initially set about identifying motor neuron markers of the motor pools and 
dorsal interneurons (the populations of cells that were used in our cell counts). This 
however would prove useful in future studies in determining the effect of PTP" 
expression on V0 and V1 interneurons and their development. 
 
Looking closely at the expression of PTP" within individual cells (presumed to be 
bipolar in morphology or daughters of bipolar cells retaining trailing processes) at high 
magnification, intense regions of staining are seen within the cytoplasm of the cell 
outside of the nucleus yet intimately associated with it. As the PTP" mRNA is being 
detected within these sections, this is presumed to be the often enlarged Rough 
Endoplasmic Reticulum amassed with ribosomes and thus a hub for the translational 
machinery of cells with bipolar morphology (Moreels et al, 2005). 
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Figure 4.5 Expression of PTP" and NeuroM in transverse sections of wild type chick 
brachial spinal cord sections from HH16-23. DIG-labelled mRNA in situ hybridization 
to (A) PTP" which is expression absent at HH16 at brachial level, shown by the 
arrows(B) PTP" at HH18 and the onset of expression in dorsal regions, arrows, (C) 
PTP" at HH20 showing an expression domain diffusely across the dorsoventral aspect 
and ventricular zone, arrows, (D) PTP" at HH21 with expression persisting 
dorsoventrally however with higher expression levels in the dorsal mantle layer and as 
a stripe just above the floor plate, (E) PTP" expression persists through HH22 with 
weaker expression in the ventricular zone, arrows and (F) PTP" expression intensifies 
by HH23 in similar regions to HH21 and HH22. Dig-labelled mRNA in situ 
hybridization to NeuroM (G) HH16 where expression is predominantly in the ventral 
region, (H) HH18 where this expression extends dorsally, (I) HH20 expression is 
evident in two lateral stripes dorsoventrally with stronger expression ventrally, (J) 
HH21 expression persists ventrally with some dorsal neuronal staining in a 
complimentary pattern to PTP" expression, (K) HH22, (L) HH23. Scale bar is 0.5mm. 
 

 161 
Figure 4.6 Expression of PTP" in transverse sections of wild type chick brachial spinal 
cord sections from in two different embryos. DIG-labelled mRNA in situ hybridization 
to (A) PTP" at HH22 showing clear mRNA expression amongst post mitotic cells and 
evident ventricular staining, arrows (B) PTP" at HH20 showing c mRNA expression 
amongst post mitotic cells in the mantle zone (C) PTP" expression in the ventricular 
progenitors and pMN domain, arrows. Scale bar is 0.5mm. 
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At higher magnifications, bipolar cells clearly express PTP" mRNA at HH22 and 
HH20 (Figure 4.6, Panels A & B respectively – inserts show area of enlargement). 
Further into development and at HH26, PTP" expression is evident along the 
dorsoventral aspect of the spinal cord in two lateral stripes within the intermediate 
zone that partially overlaps with Lim1/2 expression, and just above the floor plate in 
an inverted smile. A prominent area of expression is seen in the dorsolateral regions of 
spinal cord and a ball of strong expression is observed the equator of the spinal cord 
distal to the luminal surface.  
 
Diffuse gene expression is seen elsewhere when compared to a clean background 
outside of the spinal cord. These observations were then analysed in context of the 
previously described motor neuron markers and of the neurogenic marker NeuroM . 
 
4.6  Signalling neurogenesis. 
 
NeuroM is a !HLH transcription factor whose transient expression is restricted to the 
cells lining the ventricular zone following proliferation. Its role has been implicated in 
defining the transition between undifferentiated, premigratory and differentiated 
migratory neural precursors (Roztocil et al, 1997). NeuroM expression is located at the 
interface of the proliferative and non-proliferative zones of the neural tube. Its 
expression is initially seen in the first post-mitotic primary interneuronal cells. This 
expression gradually forms a bilateral stripe between the ventricular zone and the 
subpial zone. This pattern becomes more apparent with the highest expression in the 
ventral neural tube (Roztocil et al, 1997). This gene is therefore a good marker of 
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nascent neurons embarking on their migration and highlights a key stage in every 
neuron’s life. 
 
The expression of NeuroM begins at around HH16, coinciding with the generation of 
the first primary interneurons and motor neurons, essentially the first post mitotic cells 
in the spinal cord (Figure 4.5, Panel G). Towards HH 18, NeuroM is expressed along 
the pial surface and in the ventricular zone level to the pMN domain (Figure 4.5, Panel 
H). 
 
 
NeuroM forms direct molecular complexes with Islet 1/2 in motor neurons and is 
involved in their differentiation (Lee & Pfaff, 2003). From HH 20, NeuroM appears 
adjacent to the ventricular zone in the intermediate zone along the entire dorsoventral 
aspect of the spinal cord. (Figure 4.5, Panel I).  
 
From HH21 to HH23, NeuroM expression becomes prominent within the ventricular 
layer at the level of the pMN domain and a dampening of expression is evident within 
the dorsal spinal cord although still present (Figure 4.5, Panels J, K & L respectively). 
The expression of NeuroM is reduced to two prominent stripes within the ventricular 
zone of the ventral spinal cord from HH 26 (Figure 4.7, Panels A & D).  
 
Moreover, a similar dorsal expression domain is seen to that of PTP", however when 
the expression of NeuroM and PTP" were overlapped using serial sections, a 
complementary expression pattern was observed at HH 26 in all dorsoventral regions 
except for a slight overlap within the dorsal and intermediate zones of the spinal cord. 
This is shown amongst two individual examples (Figure 4.7, Panels C & F, arrows). 
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Figure 4.7 Expression of PTP" and NeuroM in transverse sections of wild type chick 
brachial spinal cord sections from HH26 in two different embryos. DIG-labelled 
mRNA in situ hybridization to (A) NeuroM, (B) PTP", (C) Overlap of in situ staining 
on different serial sections of PTP" (Red) and NeuroM (Green) demonstrating a 
complementary pattern of expression and a slight overlap medially, arrows (D) 
NeuroM, (E) PTP" (F) Overlap of PTP" in situ staining on different serial sections 
(Red) and NeuroM (Green) demonstrating a complementary pattern of expression and 
a slight overlap medially. Arrowhead shows more medial expression of NeuroM and 
arrow indicates NeuroM expression in absence of PTP" expression. Scale bar is 
0.5mm. 
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In several places, the strongest PTP" expression is lateral to NeuroM, however weak 
expression of PTP" overlaps with NeuroM elsewhere. The complimentary patterns of 
PTP" and NeuroM are also evident at HH20 and HH22 (Figure 4.8, Panels E & J 
respectively). 
 
4.7   PTP"  in the context of cellular differentiation. 
 
The expression profile of PTP" within the spinal cord during neurogenesis reveals an 
interesting pattern when compared with different neuronal markers at HH 20 and HH 
22. The expression analysis data highlights potential interactors and non-interactors of 
PTP" based purely on their corresponding regions of expression with respect to PTP" 
gene expression from adjacent overlapped serial sections of the same embryo. These 
findings are briefly discussed here with the aim of providing directions for the study of 
PTP" gene function with the spinal cord tissue. 
 
PTP" expression at HH20 is present but relatively faint within the ventral spinal cord 
around the pMN domain proximal to the ventricular lumen (Figure 4.8, Panel A). By 
HH22 expression of PTP" is almost absent from this region (Figure 4.8, Panel F). This 
deficit in PTP" expression seems to be filled by an early wave of the bHLH gene, Olig-
2 expression (Figure 4.8, Panels B & G). 
 
Olig2 is implicated in the generation of motor neurons within the spinal cord at this 
early stage of development, and is expressed during neurogenesis (Takebayashi et al, 
2000). This observation may suggest that Olig2 suppresses the expression of PTP" to 
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an extent within this domain, or that the two genes have for the most part divergent 
functions from each other, however this is purely speculation. 
 
Analysis of Islet1/2 expression and PTP" show a ventral region of overlap within the 
lateral branch of the LMC at brachial levels, that is not present in the distal most cells 
of the LMC, whereby PTP" expression is sandwiched within the Islet1/2 positive 
LMC. Dorsal Islet1/2 cell populations show regions of partial overlap with PTP" when 
comparing serial sections of the same embryo at HH 20 and HH 22 (Figure 4.8, Panels 
C & H respectively). The few cells dorsally positive for Islet1/2 may or may not be 
expressing PTP" as in Figure 4.8 different serial sections were used to achieve 
overlaps.  
 
This may suggest an interaction of PTP" with either Islet1 or Islet2 expressing cells 
and their arrangement during LMC development and dorsal interneuronal 
specification. Once again this is a prediction based upon the expression domains of 
these factors. 
 
Further analysis of the LIM HD genes Lim1/2 and PTP" from HH 20 to HH 22 within 
the dorsal spinal cord reveals a striking pattern of overlapping expression. Most of the 
dorsal PTP" expression is seen within the domain of Lim1/2 expressing differentiated 
neurons. A small population of the ventral most Lim1/2 expressing cells are for the 
most part outside of the region of strong PTP" expression both at HH 20 and HH 22 
(Figure 4.8, Panels D & I respectively).  
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Figure 4.8 Expression of PTP" and various neuronal markers in transverse sections of 
wild type chick brachial spinal cord sections at HH20 and HH22. DIG-labelled mRNA 
in situ hybridization to (A) PTP" at HH20 showing an expression domain diffusely 
across the dorsoventral aspect, in situ hybridization to PTP" and overlap of PTP" in 
situ and immunohistochemical staining on different serial sections (B-E) at HH20 of 
(B) Olig 2 at HH20 within the motor neuron progenitor domain, (C) Islet 1/2 at HH20 
showing complimentary expression dorsally, arrows, and slight overlap ventrally 
within the motor pools, (D) Lim 1/2 at HH20 showing strong overlap of expression 
medially ventrally and dorsally with PTP" mRNA, arrows, and (E) NeuroM and PTP" 
mRNA at HH20 showing complimentary expression patterns. DIG-labelled mRNA in 
situ hybridization to (F) PTP" at HH22 showing an expression domain dorsoventrally 
along the mantle layer with strong expression medially, in situ hybridization to PTP" 
and overlap of PTP" in situ and immunohistochemical staining on different serial 
sections (G-J) at HH22 (G) Olig 2 at HH22 within the motor neuron progenitor 
domain, (H) Islet 1/2 at HH22 showing slight expression dorsally and stronger overlap 
ventrally within the motor pools with PTP", (I) Lim 1/2 at HH22 showing strong 
overlap of expression medially, dorsally, and ventrally with PTP" mRNA, arrows, and 
(J) NeuroM and PTP" mRNA at HH22 showing complimentary expression patterns 
with NeuroM mRNA being expressed closer to the ventricular zone ventrally. Scale 
bar is 0.5mm. 
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This observation suggests that at these stages and in fact at earlier time points, the 
expression of PTP" coincides with the expression of Lim1/2 in differentiating neurons 
both temporally and spatially. This highlights the potential interaction of the Lim1/2 
genes with PTP".  
 
Together these results suggest that the markers studied can effectively be used to 
delineate cell populations during neuronal development within the chick spinal cord, 
and that the expression of PTP" within certain neuronal cell domains suggest this may 
be an area where PTP" may be functionally active amongst these post mitotic cells 
types.  Moreover, the expression of PTP" within the regions of Islet1/2, Lim3 and 
Mnr2 expression may also suggest a role for PTP" in the positioning, development or 
maintenance of these cell populations. 
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Chapter 5: PTP"  Loss-Of-Function. 
 
5.1  Introduction. 
 
Biochemical studies on PTP" reveal that Si1, Si3 and Si6 were the most effective at 
knocking down levels of PTP" expression in HEK 293T cells. Experiments were then 
conducted in ovo to determine the effect of silencing PTP" in the spinal cord, initially 
using the aforementioned silencing constructs based on their knock-down ability in 
cell culture. The aim of these of experiments was to determine to what extent 
perturbing the level of PTP" expression would affect the generation of patterns and 
survival of neurons, as defined through the expression patterns of the neural markers in 
Chapter 4.  
 
5.1.1  Silencing RPTP’s  in ovo. 
 
During the initial stages of this study, there had been little further use of shRNAi, 
although it had been successfully used in many other cell and tissue systems (Bron et 
al, 2004; Sui et al, 2002). As my study progressed and soon afterwards, there have 
been several uses of RNAi and miRNA in ovo, all of which have proven that, if 
carefully controlled, this is a reliable technology for gene knockdown (Das et al, 2006; 
Harpvant & Cepko, 2006). shRNA does therefore provide a powerful tool to study the 
functions of RPTP’s transiently and spatially in the chick neural tube, without any 
obvious off target effects and therefore delivering specific effects relative to the genes 
perturbed. 
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5.1.2  Taking a closer look at PTP". 
 
The functions of RPTPs are still poorly understood during neural development, 
particularly, in the development of the spinal cord. In situ data reveal striking patterns 
of expression in the spinal cord suggesting that they may play a role in the 
development of these tissues (Chilton & Stoker, 2000).  
 
Developmental roles for PTP" have been previously described. In experiments where 
Rat PC12 cells were transfected with PTP", NGF-induced neurite outgrowth was 
inhibited as PTP" is also expressed in peripheral tissues. This did not occur when these 
cells were transfected with PTP&, suggesting a specific inhibitory effect of this gene on 
neurite outgrowth (Shintani et al, 2001). Furthermore in vitro studies have also shown 
PTP" to inhibit anchorage-dependent growth of breast cancer cells suggesting that this 
phosphatase may have an important role during proliferation and regulation of 
tumorogenesis (Liu et al, 2004). 
 
In the murine brain, PTP" is normally expressed in pyramidal neurons of cortical 
layers II and IV and sensory neurons, suggesting this gene may play a role in neuronal 
development, or maintenance. PTP" loss of function mice showed that the gene was 
not necessary for normal development, however expression of this gene varies 
amongst model organisms and these genes may exhibit a certain level of functional 
redundancy over conserved cellular functions (Lamprianou et al, 2006). Further 
expression of PTP" is evident in the sensory cells of the retina, ear and tongue yet the 
mutants appeared normal despite gene expression in such organs, suggesting 
functional redundancy where other phosphatases may rescue PTP" function 
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(Lamprianou et al, 2006). It is also worthy to note that in the mouse PTP" is expressed 
very weakly in the spinal cord, in contrast to the chick. 
 
 PTP" expression in the chick nervous system is seen from gastrulation onwards with a 
low level of expression in the primitive streak and somites. In the neural tube PTP" is 
first observed in the neural folds of the presumptive forebrain. During neurogenesis, 
this expression remains robust within the dorsal interneuron domain that gives rise to 
interneurons (Gustafson and Mason, 2000; Chilton & Stoker, 2000). By E5, PTP" 
expression expands along the dorsoventral aspect of the spinal cord in two lateral 
stripes within the intermediate zone, and just above the floor plate in an inverted smile 
(Gustafson and Mason, 2000). At brachial levels strong expression is also detected 
within the lateral motor columns. The expression profile of PTP" is described in detail 
in Chapter 4.5. 
 
5.1.3  Experimental Aims. 
 
The effect of silencing PTP" using siRNA in the chick spinal cord was observed, and 
in particular the effect this would have on the generation of different neuronal 
populations and their migration. Furthermore, the proliferation of such cells from 
radial glial progenitors at the ventricular lumen were studied, focussing on two distinct 
stages of the cell cycle. The final aim of the experiments was to determine whether 
reducing levels of PTP" would initiate a programme of apoptosis in cells whose 
survival was perhaps dependent upon sustained levels of PTP" expression. If so, was 
there a particular spatial pattern that dying cells would follow, reflecting neuronal 
progenitor populations and their associated differentiated domains? 
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5.2  Establishing the RNAi system in ovo. 
 
5.2.1  Electroporation efficiency. 
 
To establish RNAi as a reliable approach for analysing gene function, a set of control 
experiments were designed to test uptake of the plasmids injected within the targeted 
region. This was to determine whether the embryos developed normally following 
microinjection and electroporation in ovo at HH10 (Figure 5.1, Panels A-C). These 
embryos were co-injected with a negative control siRNA vector containing a random 
sequence with no homology to any gene, together with GFP, to visually determine the 
efficiency and spatial specificity of the electroporation.   
 
The embryos were injected at HH10 with DNA directly into the neural tube and the 
presumptive brachial region was targeted for electroporation. Strong GFP expression 
was achieved within the brachial region and along the length of the spinal cord 
indicating that the vector was efficiently expressed from a few hours after 
electroporation (Figure 5.1, Panel D). GFP expression could be sustained until both E5 
and E7, the two time points that were initially studied. Control groups appeared to be 
viable with no gross non-specific abnormalities (Figure 5.1, Panels E & F).  
 
5.2.2  Embryo Viability and Controls. 
 
Of the eggs injected and electroporated, approximately 50% survived to the time 
points at which they were harvested, whilst also displaying strong GFP expression, to 
help visualize the targeted region (Figure 5.1, Panel E –Asterix).  
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Figure 5.1 Microinjection & Electroporation at HH10 (A) Microinjection of the 
plasmid into the chick neural tube at HH10, along with fast green dye. The spinal 
lumen contains the injected solution along its length (B) Aligning the electrodes either 
side of the neural tube around the presumptive brachial region, (C) Electroporation of 
the vector, and uptake in the neural tube, where bubbles forming on the electrodes 
confirming the flow of current, arrow. Embryo viability and vector expression (D) 
Active GFP expression along the length of the neural tube at HH 16, (E) GFP 
expression persists until E5 within the brachial region denoted by the asterix and (F) A 
viable electroporated embryo in bright field at E5. 
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Brachial sections from treated embryos were assessed on the degree of vector uptake 
and hence GFP expression. The embryos obtained at E5 and E7 were further analysed 
both histologically and immunohistochemically for any defects (Table 5.1). 
 
To ensure that the RNAi hairpins were not inducing off-target effects, a set of control 
embryos treated with a random hairpin encoding pSilencer vector were analysed in 
more detail at E5 and E7 through expression of 3A10, Nkx2.2 and Iselt1/2 (Figure 
5.2). Overall, it was confirmed that introducing a scrambled silencing vector encoding 
hairpin with no homology to any known sequence in vivo does not trigger any off 
target effects.  
 
5.3 PTP"  silencing induces a range of ectopic phenotypes at E5 & E7. 
 
5.3.1  Classification of phenotypes. 
 
To begin examining the role of PTP" in spinal cord development, we went about 
silencing this gene in ovo, through the use of 6 different silencing constructs, of which 
three were shown to significantly knock down target protein levels (Figure 5.12 M; 
Figure 5.14 M; Figure 5.16M). Spinal cord sections were analysed for their overall 
histology and structure, visually through specific neuronal markers.  
 
A total of five PTP" silencing vectors were studied from HH18 to E7 and a total of 197 
embryos were analysed at the different developmental stages and classified according 
to their phenotypes. Only embryos with strong electroporation spanning the entire DV 
axis of the neural tube were used for analysis as visualised by GFP (Table 5.1). 
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Figure 5.2 Expression of neuronal markers in transverse sections of E5 (A-D) & E7  
(E-G) chick brachial spinal cord in control embryo shRNA treated embryos, showing 
normal patterns of Immunocytochemical staining to (A) 3A10, (B) Islet 1/2 , (C) 
Nkx2.2, (D) Lim1/2. (E) 3A10. (F) Islet1/2, (G) Nkx2.2. Scale bar is 0.5mm. 
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Table 5.1 Table of embryos electroporated with the negative control silencing vector, 
GFP and Si1-6 at E5 and E7. These are pooled according to normal, truncated and 
heterotopic phenotypes.  
 
 
 
 
 
Experiment/Stage Normal Phenotype Truncated Phenotype Heterotopia Phenotype Total 
     
p-Silencer  
negative control                                  
    
E5 21 0 0 21 
     
GFP     
E5 38 0 0 38 
E7 4 0 0 4 
     
Si1                                     
E5 7 4 0 11 
     
Si3     
E5 30 23 3 56 
E7 3 1 2 6 
     
Si4                                     
E5 10 0 0 10 
     
Si5     
E5 12 0 0 12 
     
Si6     
E5 12 8 0 20 
E7 4 2 0 6 
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Initial analysis using the silencing vectors provided a set of phenotypes classified as 
either normal, mild (truncated) or invasive (heterotopic). The mild phenotype 
represented an obvious truncation in the ventral area of the spinal cord while the severe 
invasive heterotopia phenotype presented with an ectopic displacement of neuronal 
cells into the ventricular lumen of the spinal cord (Figure 5.3). 
 
5.3.2  Silencing PTP" and resulting gross phenotypes in ovo. 
 
By E5, Si3 injected embryos showed a mild phenotype in nearly half the samples, with 
a slight shift of the spinal cord territory dorsally as shown by the neurofilament marker 
3A10, along with the expression domains of Islet1/2 and Nkx2.2 (Figure 5.4 – Panels 
G, B & I respectively). A similar observation was made with Si6 at E5 as shown by 
Islet1/2 and Nkx2.2 immunoreactivity (Figure 5.4, Panels E & J). A more severe 
phenotype was demonstrated by Islet1/2 that included a mild disruption in the dorsal 
groups of Islet1/2 cells, a more profound shift dorsally of the spinal cord territory, a 
ventral truncation and an ectopic ventricular localisation of neurons, whose cells were 
also Islet1/2 positive (Figure 5.4, Panels C & D).  
 
 
At both E7 and E5, histological staining highlighted a disruption in the ependymal cell 
layer amongst ectopic embryos (Figure 5.5, Panels B & G respectively). The 
ependymal layer appeared to be missing in extreme cases, replaced by neuronal 
precursors. At E5, the example shows that what should be a smooth inner luminal 
ependymal cell lining, was uneven and ruffled on the electroporated side, with an 
absence of the ependymal cell layer structure in the region of the ingrowth (Figure 5.5, 
Panel G, arrows).  
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Figure 5.3 Schematic representation of the two main phenotypes observed amongst 
PTP" silenced embryos showing the normal, truncated and heterotopic examples. 
 
Figure 5.4 Expression of neuronal markers in transverse sections of E5 chick brachial 
spinal cord. Immunocytochemical staining of (A) Islet 1/2 in a control embryo, (B) 
Islet 1/2 in an Si3 treated embryo. Arrow indicates region of truncation; (C) Islet 1/2 
Si3 treated embryo showing a heterotopic phenotype indicated by the lower 
arrowhead. Upper arrowhead shows the region of mild cell loss dorsally, (D) Copy of 
plate C showing the boundary of the neural tube, highlighted in pink. The arrow 
indicates the degree of truncation on the electroporated side in green, when compared 
to the right hand side of the neural tube. (E) Islet 1/2 Si6 treated embryo showing cell 
loss on the treated side in green. (F) 3A10 in a control embryo, (G) 3A10 in a Si3 
treated embryo, (H) Nkx2.2 in a control embryo, (I) Nkx2.2 in a Si3 treated embryo is 
expressed above the floor plate and shows a disrupted expression pattern, (J) Nkx2.2 in 
a Si6 treated embryo displaying a truncated phenotype and disruption of the Nkx2.2 
domain. Scale bar is 0.5mm. 
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At E7, H&E staining showed that the normal ependymal tissue appears to be missing. 
The cells within the lumen instead stained positive for the neuronal marker 3A10, and 
there was a general distortion in the neurofilament pattern elsewhere in the ventral 
spinal cord. (Figure 5.5, Panel C). These cells were also positive for Islet1/2 and 
Nkx2.2 (Figure 5.5, Panels D & E respectively). These enlargements are shown within 
the spinal cord at lower magnifications in Figure 5.4, Panels D, E and F. The ectopic 
effect on Nkx2.2 cells maybe as a consequence of breakdown of the ependymal layer 
and not a direct consequence of PTP" targeting. These results led to further studies to 
determine what has lead to the truncation of the spinal cord, and a number of different 
markers were used. 
 
At E5, the luminal invasion of cells occurred in a region of strong eGFP expression 
(Figure 5.5, Panel F), and numerous cells here were shown to be Islet1/2 positive 
(Figure 5.5, Panel H). However, when the same embryo, a few sections higher in the 
region of the ingrowth was stained with Lim1/2, cells within and surrounding the 
luminal region failed to stain with Lim1/2 (Figure 5.5, Panel I). Interestingly, ectopic 
luminal Nkx2.2 positive cells were again observed (Figure 5.5, Panel J).  
 
5.3.3  Explaining the phenotypes. 
 
When Lim 1/2 positive neurons were studied, a more significant reduction in these  
cells compared to Islet 1/2 expressing cells were observed at E5, consistently seen 
using 3 different vectors Si1, Si3 and Si6 (Figure 5.7, Panels A – E). Two other 
vectors studied, Si4 and Si5 did not yield any abnormal phenotypes, supporting the 
knock down results in vitro (22 embryos studied – data not shown).  
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Figure 5.5 Expression of histological & neuronal markers in transverse sections of E7 
(A-E) and E5 (F-J) chick brachial spinal cord in a Si3 treated embryo. (A) H&E 
staining, boxed region is magnified in panels B-J. (B) H&E, arrow indicates 
heterotopic phenotype and loss of ependymal layer, (C) 3A10, arrow indicates ectopic 
presence of neurofilament in the lumen, dashed line represents the luminal boundary; 
(D) Islet 1/2,  arrow showing ectopic location of cells in the lumen; (E) Nkx2.2, arrow 
indicates presence of these cells within the lumen; (F) Strong GFP expression in 
ectopic region,  arrow; (G) H&E staining, arrows indicate abnormal structure of the 
ependymal layer; (H) Islet 1/2, arrowhead indicated the ectopic location of cells within 
the lumen, (I) Lim 1/2 arrowhead indicated complete absence of Lim 1/2 cells within 
the ectopic luminal cells and within the ventral spinal cord; (J) Nkx2.2, ectopic cells 
stain positive within the lumen. All embryos shown were electroporated on the right 
hand side of the neural tube as denoted by the green E in sections A & F. Scale bar is 
0.5mm. 
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Figure 5.6  (A-C) Expression of neuronal markers in transverse sections of E7 control 
chick brachial spinal cord. Immunocytochemical staining of (A) 3A10 in a control 
embryo, (B) & (C) Isl 1/2 in a control embryo. (D-F) Whole transverse sections of E7 
Si3 treated chick brachial spinal cord. Immunocytochemical staining of (D) 3A10, 
arrows showing abnormal neurofilament staining; (E) Islet 1/2  positive cells 
abnormally located in the lumen of the spinal cord as shown by the arrow; (F) Islet 1/2,  
further example of the heterotopic phenotype. Embryos were electroporated on the 
right hand side of the neural tube, denoted by the green “e” in section D. Scale bar is 
1mm. 
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Figure 5.7  Expression of neuronal markers in transverse sections of E5 chick brachial 
spinal cord. Immunocytochemical staining of (A) Lim 1/2, in a control embryo 
showing the dorsal, intermediate and ventral regions of expression, (B) Lim 1/2, in an 
Si1 treated embryo. Arrowhead indicates region of truncation; (C) Lim 1/2, Si3 treated 
embryo, arrowhead showing a complete absence of the motor pool in the ventral 
region; (D) Lim 1/2, Si6 treated embryo arrowhead shows a loss of the motor pool; (E) 
Lim 1/2, Si6 treated embryo with a small loss of dorsal and intermediate Lim1/2 
positive (top arrowhead) cells and the ventral motor pool is absent as indicated by the 
bottom arrowhead on the treated side, green. Scale bar is 0.5mm. 
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The loss and mislocation of certain cell types led to the use of different neuronal 
markers to indicate which other cell populations could also be affected by PTP" 
silencing. Mnr2 is a motor neuron marker within the ventral neural tube and is 
expressed in the cells of the LMC and Column of Terni (CT). Its expression was also 
slightly affected in embryos treated Si1, Si3 & Si6 at E5, with a slight shift in the 
expression domain, in cases with Si3 & Si6 (Figure 5.8, Panels A - D).  
 
A further more dorsal phenotype was observed at E5 in only one case, however it is 
perhaps worth mentioning. In one embryo treated with Si3, a reduction in the number 
of Lim1/2, Islet1/2 positive cells were observed, and mislocated neurons expressing 
those markers outside of the periphery of the spinal cord (Figure 5.9, Panels E & F 
respectively). 3A10 staining also reveals the ectopic projection of axons dorsally 
towards the ventricular lumen of the neural tube within the same embryo (Figure 5.9, 
Panel D – boxed region), and a potentially fused dorsal root ganglia to the spinal cord 
(Figure 5.9, Panel C - arrow).  
 
Together these data suggest that loss of PTP" causes a mislocation of ventral spinal 
cord cells, amongst which are Islet1/2 and Nkx2.2 positive cells in ectopic locations. 
These cells are presumed to be motor neurons. Of these cells, the Islet1/2 cells also 
seem to project their axons radially in a somewhat disorganised pattern, suggesting 
PTP" silencing may also induce migrational defects amongst certain spinal cord cell 
types. The indication that the luminal cells were Lim1/2 negative suggested that PTP" 
silencing may be causing a mislocation of selected groups of neurons for example Islet 
1/2 positive, Lim 1/2 negative. 
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Figure 5.8  Expression of  Mnr2 in transverse sections of E5 chick brachial spinal cord. 
Immunocytochemical staining of Mnr2 to (A) Control embryo showing the lateral 
motor column LMC and Column of Ternii CT, (B) Si1 treated embryo showing little 
effect; (C) Si3 treated embryo, showing a disruption of the normal Mnr2 expression 
patter, arrows, (D) Si6 treated embryo showing little effect. The embryos are 
electroporated on the right hand side of the neural tube as denoted by the green “E” in 
panel A. Scale bar is 0.5mm. 
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Figure 5.9  Expression of neuronal markers in transverse sections of E5 chick brachial 
spinal cord. (A) GFP in a control embryo, (B) 3A10 in a control embryo, (C) GFP in 
Si3 treated embryo, arrow indicates dorsal fusion of the DRG to the neural tube; (D) 
3A10 in Si3 treated embryo arrow showing misguidance of axons in boxed region 
dorsally, this region studied in panels E-F in the same embryo; (E) Lim1/2 in ectopic 
locations outside of the neural tube, arrow; (F) Islet1/2 in similar ectopic locations, 
arrow; (G) DAPI staining showing location of apoptotic nuclei within that region. 
Scale bar is 0.5mm. 
 
 
 
 
 
__
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5.4  Quantitative analysis of  neuronal pools. 
 
5.4.1  Effects on Islet1/2 positive neuronal populations. 
 
Of the embryos where a spatial disruption of the Islet1/2 cell pattern was observed, 
initial observations indicated a possible loss of these cells from the LMC that would 
explain the shift or perhaps loss of the spinal cord tissue from the ventral region. Cell 
counts of Islet positive cells from the ventral most Islet1/2 positive cell populations 
were conducted.  
 
The counts were carried out ‘blind’ using the Openlab software (Figure 5.10), where 
the region of cells to be counted was outlined, marked and compared against its control 
side within the same embryo. The mean ratio between the control and electroporated 
sides of the neural tube of Islet1/2 cells was determined for each embryo in the 
silenced group and control group. Interestingly, the results showed no overall change 
in the ratio of these cells between the 2 sides of the neural tube compared to the control 
groups (Figure 5.11, Chart A). However, as stated in previous sections, there were 
defective patterns of Islet 1/2 cells in some embryos.  
 
5.4.2  Effects on Lim 1/2 positive neuronal populations. 
 
The motor horns contain many distinct types of motor neurons, some expressing Islet 
1/2, others expressing factors such as Lim 1/2 (Tsuchida et al 1994). Further analysis 
examined whether motor neurons expressing Lim 1/2, a LMCl marker, were altered 
spatially or numerically amongst PTP" silenced embryos.  
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Figure 5.10 Screenshot of the Openlab software and method of counting cells. 
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At E5, the broad expression domain of Lim1/2 could be was split into 3 main areas, a 
dorsal, intermediate and ventral cell (motor horn) grouping, as previously described. 
Embryos treated with Si3 showed a consistent loss of Lim1/2 cells predominantly from 
the ventral LMC populations. Furthermore, a significant loss of cells was observed 
amongst the dorsal group of Lim1/2 cells (Figure 5.11, Chart B). 
 
These results were corroborated with cell counts of the ventral most and dorsal most 
Lim1/2 positive cell populations, and carried out in a similar way to the Islet1/2 cell 
counts. The results indicated PTP" loss-of-function causes a significant loss of Lim1/2 
cells, over 50% reduction of Lim1/2 cells in the motor horns when compared to the 
control groups (Figure 5.11, Chart C). 
 
5.4.3  Summary 
 
In summary, PTP" loss-of-function starting from HH10 induces a loss of Lim1/2 cells 
by E5.  Embryos treated with Si1, Si3 and Si6 clearly demonstrate the loss of Lim1/2 
cells. This raises many questions as to what is exactly happening with these cell types. 
Are we seeing a death of cells or do they in fact fail to proliferate?  
 
Apparent mislocation defects are presented, and so what role does PTP" play in the 
specification and positioning of the various cell types within the neural tube? In order 
to understand at what point the cellular defects were being initiated, further analysis on 
PTP" silenced embryos was carried out at earlier time points.  
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Figure 5.11 Chart A- Ratio of Islet 1/2 cells between control (Blue) (n=6) and Si3 
(n=19) treated (Red) groups at E5. No real difference in the number of Islet positive 
cells can be observed between treated and control groups. Chart B- Ratio of Lim 1/2 
cells in the dorsal third of the spinal cord between control (Blue) (n=6) and Si3 (Red) 
(n=12) treated groups at E5.  A significant reduction is evident in the number of Lim 
1/2 positive cells between treated and control groups (P < 0.01; Student T Test). Chart 
C - Ratio of Lim 1/2 cells in the ventral third of the spinal cord between control (Blue)  
(n=6) and Si3 (Red) (n=14) treated groups at E5.  A larger reduction is evident in the 
number of Lim 1/2 positive cells between treated and control groups ventrally (P < 
0001; Student T Test) (Error Bars show SD). 
 
 
 
 
  A 
 
 B 
 
 C 
 
Key (A-C): Blue Bars denote ratio of cells between treated and non-treated sides of 
the spinal cord among control shRNA samples. Red Bars denote ratio of cells 
between treated and non-treated sides of the spinal cord among Si3 shRNA samples. 
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5.5 Studying PTP loss-of-function at earlier embryonic time points. 
 
5.5.1  HH18 
 
The onset of PTP" expression within the dorsal marginal zone of committed neurons in 
the spinal cord coincides temporally with the birth of the first motor and interneurons, 
and onset of neurogenic activity generally throughout the cord at around HH14-15 
(Landmesser, 2001, Briscoe & Novitch, 2008; Bertrand et al, 2002). The earliest time 
point studied in detail was HH18, when PTP" is still only expressed in interneurons 
(Table 5.2).  
 
Within samples treated with Si3, a small number of cells expressing Islet1/2, Lim1/2, 
Lim3 and Mnr2 appeared to show no significant change in number when compared 
against Wild Type embryos (Figure 5.12, Panels A-N). This was confirmed with cells 
counts of Islet1/2, Lim1/2, Lim3 and Mnr2 positive neurons (Figure 5.13).  
 
5.5.2  HH20 
 
Two later stages of development, HH20 and HH22 were studied to ascertain what was 
happening to the neuronal profiles within the spinal cord following PTP" silencing. 
These time points were chosen, as at those stages PTP" expression was prevalent 
throughout the spinal cord. At HH20, a shortening of the spinal cord on the targeted 
side become apparent, consistent with a loss of Islet1/2, Lim1/2, Lim3 and Mnr2 fated 
cells and slight reduction in PTP" expression (Figure 5.14 A-N).  
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Table 5.2 Table of embryos at HH18, HH20 and HH20 between control and PTP" loss 
of function experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Experiment/Stage Normal Phenotype Truncated Phenotype Heterotopia Phenotype Total 
     
p-Silencer  
negative control                                  
    
HH18 8 0 0 8 
HH20 7 0 0 7 
HH22 8 0 0 8 
     
Si1                                     
HH22 4 3 0 7 
     
Si3     
HH18 9 2 1 12 
HH20 12 13 2 27 
HH22 13 10 1 24 
     
Si6     
HH22 5 5 0 10 
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Figure 5.12 Immunocytochemical and DIG-labelled mRNA in situ hybridisation in 
transverse sections of HH18 chick brachial spinal cord in a WT control (A-G) and a 
Si3 treated embryo (H-N) to (A) 3A10 (B) Islet 1/2, (C) Lim 1/2; (D) Lim3; (E) Mnr2; 
(F) In situ of PTP"; (G) In situ of NeuroM; (H) 3A10, the Si3 treated side is shown in 
green by its GFP fluorescence (I) Islet 1/2, (J) Lim 1/2; (K) Lim3; (L) Mnr2; (M) In 
situ of PTP"; and (N) In situ of NeuroM. Scale bar is 0.5mm. 
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Figure 5.13 Chart of LIM-HD positive cell numbers. Ratio of neurons compared 
between treated (Red) and non treated (Blue) sides of the spinal cord between shRNA 
control and PTP" silenced embryos at HH18. All four markers studied, Islet 1/2 (n=7), 
Lim 1/2 (n=7), Lim 3 (n=6) and Mnr 2 (n=6) showed no significant reduction in their 
cell numbers in PTP" silenced groups (P < 0.01; Student T Test) (Error Bars show 
SD). 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Key: Blue Bars denote ratio of cells between treated and non-treated sides of the 
spinal cord among control shRNA samples. Red Bars denote ratio of cells between 
treated and non-treated sides of the spinal cord among Si3 shRNA samples. 
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This effect extends along the entire dorsoventral aspect of the spinal cord. Cell counts 
reveal an average reduction in Islet1/2 cell number by 43% when comparing ratios 
between embryos. The number of Lim1/2 cells were reduced by 39%, and Lim3 cells 
demonstrated a reduction of 48%. Mnr2 cells reduced in number by the least 
percentage, on average a reduction of 31% (Figure 5.15). 
 
5.5.3  HH22 
 
Two developmental stages later at HH 22, ectopically located Islet1/2 and Mnr2 cells 
were observed very close to or at the site of the ventricular lumen (Figure 5.16, Panels 
I & L respectively – arrows). This observation further supports the invasive 
phenotypes observed at E5 suggesting that silencing PTP" triggers their occurrence at 
earlier embryonic stages.  
 
A truncated spinal cord develops with lower levels of PTP" expression (Figure 5.16 A-
N). Cell counts reveal an average reduction in Islet1/2 cells by 32% when comparing 
ratios between embryos. The number of Lim1/2 cells is reduced by 48%, and the Lim3 
positive cells by 46%.  
 
Mnr2 cells did not show any significant reduction in cell number on average at this 
developmental stage (Figure 5.17). There seemed to be a recovery of the Islet1/2 and 
Mnr2 patterns at this point when compared to cell counts at HH20. The expression 
profiles of Lim1/2/3 together displayed a greater reduction jointly than at HH20. It is 
worthy to note that at earlier stages to HH22, Lim 3 and Islet 1 cells are all motor 
neuron precursors whilst Lim 1/2 cells are predominantly interneurons at this stage. 
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Figure 5.14 Immunocytochemical and DIG-labelled mRNA in situ hybridisation in 
transverse sections of HH20 chick brachial spinal cord in a WT control (A-G) and a 
Si3 treated embryo bearing a truncated phenotype (H-N) to (A) 3A10 (B) Islet 1/2, (C) 
Lim 1/2; (D) Lim3; (E) Mnr2; (F) In situ of PTP"; (G) In situ of NeuroM; (H) 3A10, 
the Si3 treated side is shown in green by its GFP fluorescence (I) Islet 1/2, (J) Lim 1/2; 
(K) Lim3; (L) Mnr2; (M) In situ of PTP"; and (N) In situ of NeuroM. Scale bar is 
0.5mm. 
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Figure 5.15 Chart of LIM-HD positive cell numbers. Ratio of neurons compared 
between treated (Red bars) and non treated (Blue bars) sides of the spinal cord between 
shRNA control and PTP" silenced embryos at HH20. All four markers studied, Islet 
1/2 (n=13)(P<0.0001; Student T Test), Lim 1/2 (n=11)(P<0.001; Student T test), Lim 3 
(n=12)(P<0.0001; Student T Test) and Mnr 2 (n=9)(P<0.01: Student T test) showed a 
significantly larger reduction in their cell numbers in PTP" silenced groups (Error Bars 
show SD). 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Key: Blue Bars denote ratio of cells between treated and non-treated sides of the 
spinal cord among control shRNA samples. Red Bars denote ratio of cells between 
treated and non-treated sides of the spinal cord among Si3 shRNA samples. 
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Figure 5.16 Immunocytochemical and DIG-labelled mRNA in situ hybridisation in 
transverse sections of HH22 chick brachial spinal cord in a WT control (A-G) and a 
Si3 treated embryo (H-N) to (A) 3A10 (B) Islet 1/2, arrow indicates ectopically located 
cell close to the ventricular zone, (C) Lim 1/2; (D) Lim3; (E) Mnr2; (F) In situ of 
PTP"; (G) In situ of NeuroM; (H) 3A10, the Si3 treated side is shown in green by its 
GFP fluorescence (I) Islet 1/2, (J) Lim 1/2; (K) Lim3; (L) Mnr2, arrow indicates 
ectopic luminal cell; (M) In situ of PTP" showing a significant reduction in its 
expression compared to the control side and expression seen in panel F; and (N) In situ 
of NeuroM. Scale bar is 0.5mm. 
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Figure 5.17 Chart of LIM-HD positive cell numbers. Ratio of motor neurons compared 
between treated (Red bars) and non-treated (Blue bars) sides of the spinal cord 
between shRNA control and PTP" silenced embryos at HH22. Three out of four 
markers studied, Islet 1/2 (n=10)(P<0.0001; Student T Test), Lim 1/2 (n=10)(P<10
-7
; 
Student T test), and Lim 3 (n=10)(P<0.001; Student T test) showed a significantly 
larger reduction in their cell numbers in PTP" silenced groups. There was no 
significant change in the number of Mnr2  (n=10) cells at this stage amongst 
experimental sets (Error Bars show SD). 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Key: Blue Bars denote ratio of cells between treated and non-treated sides of the 
spinal cord among control shRNA samples. Red Bars denote ratio of cells between 
treated and non-treated sides of the spinal cord among Si3 shRNA samples. 
 
 
 
 
 
 
 
 
 220 
5.6  PTP" silencing induces a reduction in the proliferative capacity of LIM-HD 
expressing progenitors. 
 
The results described above show a reduction in the number of cells at HH20 and 
HH22. In order to determine the cause of this reduction, the proliferative activity of 
progenitor cells within silenced embryos was taken into account. The number of radial 
glia undergoing Mitosis were studied through the activity of phosphorylated Histone 3 
within those treated at HH20 & HH22 (Figure 5.18, Panels D - F) (Figure 5.19, Panels 
F – J).  
 
Cells were observed at different locations along the dorsoventral range of the 
ventricular layer and their distribution and number were gauged comparing the treated 
and control side of the spinal cord at HH 20. The number of cells during mitosis was 
reduced in number by the greatest percentages along the top third of the spinal cord 
and bottom third (Figure 5.20). The total numbers of mitotic cells were reduced by 
30% when comparing ratios of cells between 10 independent embryos (Fig 5.21). 
There was no clear evidence of any significant bias in the location of reduced mitoses.  
 
5.7  PTP" silencing induces apoptosis at HH20 and HH22. 
 
The previous studies on the proliferative capacity of silenced embryos reveal a 
reduction in the number of M-phase cells. However PTP" silencing may also be 
inducing cell death. I set about this study by determining the apoptotic activity at 
stages HH20 and HH20 using an antibody against activated Caspase-3. 
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Figure 5.18 Immunocytochemical cell death and proliferation markers in transverse 
sections of HH20 chick brachial spinal cord shRNA control (A & D), and two Si3 
treated embryos (B-C) & (E-F) to (A) Caspase3  (B) Caspase3, arrow indicates 
location of dying cells close to the ventricular lumen, (C) Caspase3, arrow indicates a 
trail of apoptotic cell debris in the ventricular zone; (D) pHistone3; (E) pHistone3; (F) 
pHistone3, arrow showing a reduced number of mitotic cells. Scale bar is 0.5mm. 
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Figure 5.19 Immunocytochemical cell death and proliferation markers in transverse 
sections of HH22 chick brachial spinal cord shRNA control (A & F), and Si3 treated 
embryos (B-E) & (G-J) in serial sections of the same embryo to (A) Caspase3  (B-E) 
Caspase3, arrows indicates location of dying cells close to the ventricular lumen in 
strings at different locations dorsoventrally in four samples; (F) pHistone3; (G-J) 
pHistone3, arrows indicate a reduced number of mitotic cells at different dorsoventral 
locations. Scale bar is 0.5mm. 
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Figure 5.20 Chart of proliferating cell numbers. Ratio of cells undergoing proliferation 
between treated and non treated sides of the spinal cord between control (Blue bar) and 
PTP" silenced (Red bar) embryos at HH20 (n=10)(P<0.001; Student T test) (Error 
Bars show SD).  
 
Figure 5.21 Schematic representation of proliferating cells in PTP" silenced embryos 
at HH20 (n= 10). Red spots indicate location of individual proliferating cells along the 
ventricular zone. Blue spots indicate pattern of proliferating cells on the control side of 
the neural tube in silenced embryos. The ventricular zone was split into six zones 
(boxed) and the percentage loss of proliferating cells on the electroporated side 
compared to the control side was recorded.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Blue Bars denote ratio of cells between treated and non treated sides of 
the spinal cord among control shRNA samples. Red Bars denote ratio of cells 
between treated and non treated sides of the spinal cord among Si3 shRNA samples.
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This revealed an interesting pattern with cells in treated tissue undergoing apoptosis 
either individually or as clusters along radial spoke-like units at different dorsoventral 
levels of the spinal cord, but predominantly within or neighbouring the ventricular 
zone (Figure 5.18 Panels A – C - Arrows) (Figure 5.19, Panels A – E – Arrows). 
Although a few caspase cells were stained at any one time, we were confident this was 
a genuine signal. Control embryos showed no staining other than the odd cell and the 
antibody used gave a very clean and clear signal with no background staining. 
Furthermore the resultant staining was indicative of apoptotic structures. 
 
This suggested that the integrity of clonally related progenitor neurons was 
compromised leading to an apoptotic programme. The general distribution of Caspase 
3 positive cells was recorded amongst 6 control embryos (Figure 5.23 - A) and 14 
PTP" silenced embryos at HH20 (Figure 5.23). This showed a distinct pattern of 
apoptotic cells arising predominantly from the p1 domain and the dorsal D3 domain 
(Muller at al 2002). These patterns of clustering were not observed on the control side 
or with the negative control shRNA treatments. Compared to these control embryos, 
with less than one apoptotic cell evident per section, loss-of-function embryos showed 
on average 5 apoptotic cells per section at HH22 on the treated side (Figure 5.23, Panel 
B).  
 
The rate of apoptosis at stage HH22 appeared reduced from the previous stage studied, 
with a halving of the rate recorded on average within the treated side of silenced 
embryos (Figure 5.23.) When the cumulative distribution amongst 6 control embryos 
and 14 silenced embryos at HH22 was compared, this consistently showed apoptotic 
activity arising from the pMN domain and dorsal D3 domain (Figure 5.23, Panel B). 
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Caspase3 positive cell counts at stage HH20 reveal 5 apoptotic cells on the silenced 
side of the spinal cord compared with 2.25 cells on average observed at stage HH22 
(Figure 5.23, Panel A). Amongst control embryos less than one caspase 3 positive cells 
were observed on either the control or treated samples. It is worthy to note that the 
control shRNA vector did not induce Caspase3 activity itself. 
 
5.8  Summary 
 
Altogether these data indicate that silencing PTP" leads to the mislocation of cells 
starting from HH20 onwards during the progression of development within the chick 
and a reduction of LIM-HD transcription factor expressing cells up to HH22. The 
development of the ependymal layer of cells on the treated side of the embryo is also 
disrupted suggesting that there is a defect in progenitor cell maintenance.  
 
A sustained loss of Lim1/2 expressing cells is maintained until E5, the latest time point 
studied. The loss of cells may arise through a reduction of the proliferative capacity of 
radial glial cells or a triggering of the apoptotic programme, which occurs at a higher 
rate at HH20 than HH22. These results will be discussed in more detail in the 
concluding chapter. 
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Figure 5.22 A - Chart of Caspase 3 positive cell numbers. Number of cells undergoing 
apoptosis between treated (Green bars) and non treated (Yellow bars) sides of the 
spinal cord between control and PTP" silenced embryos at HH20. Three different 
serial sections per embryo were analysed, the mean cells per embryo recorded on 
respective spinal cord halves. The average of the data from all the embryos in the 
experimental set were then tabulated. The control embryos showed no significant 
change in the number of dying cells, however this was significantly increased in PTP" 
silenced groups, observing around 5 cells on average on the treated half of the neural 
tube (n=18)(P<10
-5
; Student T test). B -Chart of cell numbers undergoing apoptosis. 
Ratio of cells undergoing apoptosis between treated (Green bars) and non treated 
(Yellow bars) sides of the spinal cord between control and PTP" silenced embryos at 
HH22.  At least two dying cells are observed per section in PTP" silenced embryos 
(n=11)(P<0.01; Student T Test) (Error Bars show SD).  
 
 
 
 
 
 
 
 
 
 
 
 
        A 
 
 
 
 
 B 
 
 
 
 
Key (A & B): Green Bars denote the average number of cells on the treated sides of the 
spinal cord among control shRNA  & Si3 sample groups. Orange Bars denote the average 
number of cells on the non-treated sides of the spinal cord among control shRNA  & Si3 
sample groups. 
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Figure 5.23 A- Schematic representation of apoptotic cells in control embryos at HH20 (n= 
6). Red spots indicate location of individual cells. B - Schematic representation of 
apoptotic cells in PTP" silenced embryos at HH20 (n= 18). Red spots indicate location of 
individual randomly located apoptotic cells. Green line represent approximate loss of tissue 
following loss of function treatment. C - Schematic representation of apoptotic cells in 
control embryos at HH22 (n= 6). Red spots indicate location of individual cells. D - 
Schematic representation of apoptotic cells in PTP" silenced embryos at HH22 (n= 11). 
Red spots indicate location of individual apoptotic cells. A distinct pattern of cell death 
develops at various dorsoventral locations. Green line represent approximate loss of tissue 
following loss of function treatment. Note that panels B and D represent the cumulative 
results from all experimental sets of embryos observed rather than data from one embryo. 
A B
C D
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Chapter 6:  PTP"  gain-of-function. 
 
6.1 Introduction 
 
The aim of the experiments in this chapter was to determine the effect of PTP" gain-of-
function on the generation of differentiated neurons and progression of the cell cycle, 
by studying the number of proliferation cells at S and M Phases of the cell cycle. This 
gain-of-function test would serve to complement the studies presented in Chapter 5, 
where the results showed missing and ectopically located cells within the spinal cord. 
This set of experiments would indicate if the gain-of-function of PTP" did have an 
impact on the expression profiles of the LIM-HD genes and cell cycle markers. 
 
6.2  PTP" over expression causes a broad reduction in the number of Lim-HD 
expressing neurons along the entire DV aspect of the spinal cord. 
 
In order to gain more insight into which populations of neurons were affected by PTP" 
over expression, the expression profiles of motor neuron markers, states of 
proliferative activity and cell death at stages HH 20 and 22 were studied. The total 
number of embryos studied for each developmental stage is shown in Table 6.1. 
 
A set of control embryos were treated with IRES-GFP plasmid at HH20, and of the 
neuronal markers observed, all displayed a normal pattern of development (Figure 6.1, 
Panels A-D).  
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Table 6.1 Table of  IRES-GFP and PTP"-IRES-GFP treated embryos at HH18, HH20 
and HH22. These are pooled according to normal, truncated and heterotopic 
phenotypes. 
 Experiment/Stage Normal Phenotype Truncated Phenotype Displacement Phenotype Total 
     
IRES-PTP!-GFP                                      
HH18 1 10 0 11 
HH20 1 12 0 13 
HH22 3 19 1 23 
     
IRES-GFP     
HH18 5 0 0 5 
HH20 6 1 0 7 
HH22 6 0 0 6 
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Figure 6.1 Immunocytochemical and DIG-labelled mRNA in situ hybridisation in 
transverse sections of HH22 chick brachial spinal cord in a control IRES-GFP treated 
embryo to (A) Islet 1/2, (B) Lim 1/2, (C) Lim 3; (D) Mnr2. Scale bar is 0.5mm. 
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At HH 20, of the 4 neuronal markers observed, Islet1/2, Lim1/2, Lim3 and Mnr2, all 
demonstrated a reduction in the total number of cells marked, along with a significant 
shortening and narrowing of the spinal cord in many cases (Fig 6.2, Panels A-D). No 
significant differences in Caspase-3 cells were observed between samples, with only 
one or two isolated cells appearing within each section (Fig 6.2, Panel E, arrows.) 
 
There appeared to be a slight reduction in the number of mitotic cells in tissues treated 
with IRES-PTP", shown by phosphorylated Histone3 activity at the ventricular lumen, 
although only the HH22 samples were quantified (Fig 6.2, Panel F & Panel G) (Figure 
6.3). 
 
6.3  The reduction in LIM-HD cell expression persists to HH 22 
 
At HH 22, the effect of IRES-PTP" gain of function on differentiating neurons 
expressing LIM-HD identities was similar to that at HH20, with a reduction of 
differentiated cells (Fig 6.3, Panels A-D).  
 
6.3.1  LIM-HD cell counts 
 
Cell counts at HH 22 reveal a reduction in the total number of Islet1/2 cells amongst 
PTP"-IRES-GFP and IRES-GFP treated embryos representing a ratio of 0.61 (relative 
to 0.92) when comparing treated and non-treated sides of the embryos amongst PTP"-
IRES-GFP sets relative to IRES-GFP sets (Fig 6.4 Chart A).  
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Figure 6.2 Immunocytochemical and DIG-labelled mRNA in situ hybridisation in 
transverse serial sections of HH20 chick brachial spinal cord in a PTP"-IRES-GFP 
treated embryo to (A) Islet 1/2 labelling, showing a reduction of the motor pool cells.  
(B) Lim 1/2 labelling, showing a clear loss of all ventral and most intermediate cell 
populations. (C) Lim 3 labelling, showing a significant reduction in the number of 
cells and absence of the ventral most Lim 3 population. (D) Mnr2 labelling, showing a 
sustained loss of cells. (E) Caspase3 labelling, arrows indicate the location of the dying 
cells. (F) pHistone3 labelling. (G) In situ to PTP" showing a reduction in spinal cord 
tissue ventrally and in intermediate levels, and a modest increase in PTP" signal in the 
electroprated side of the spinal cord. (H) Schematic outline of the spinal cord to 
highlight the reduction in spinal cord area. “e” denotes electroporated side of the 
neural tube. Scale bar is 0.5mm. 
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Figure 6.3 Immunocytochemical and DIG-labelled mRNA in situ hybridisation in 
transverse sections of HH22 chick brachial spinal cord in a PTP"-IRES-GFP treated 
embryo (in serial sections). (A) Islet 1/2 labelling, showing a reduction of  motor pool 
cells.  (B) Lim 1/2 labelling, showing a clear loss of all ventral and most intermediate 
and dorsal cell populations on the treated left hand side of the neural tube. (C) Lim 3 
labelling, showing a significant reduction in the number of cells especially the lateral 
aspect of the LMC. (D) Mnr2 labelling, showing a significant loss of cells. (E) 
Caspase3 labelling, arrows indicate the location of the dying cells. (F) pHistone3 
labelling. (G) In situ to PTP" showing an increase in RNA levels on the electroporated 
side, and sustained shortening and narrowing of the neural tube. (H) Schematic outline 
of the spinal cord to highlight the reduction in spinal cord area on the electroporated 
side. “e” denotes electroporated side of the spinal cord. Scale bar is 0.5mm. 
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Similar counts for Lim1/2 indicate a reduction of cells on average corresponding to a 
ratio of 0.61 (relative to 0.98)  (Fig 6.4, Chart B). Lim 3 positive cells also demonstrate 
a reduction of cell numbers representing a ratio of 0.64 (relative to 0.98) (Fig 6.4, 
Chart C). Overall, we see a consistent global reduction in the number of Lim-HD 
expressing cells following PTP" over expression. 
 
6.3.2  Further patterns at HH22 in IRES-PTP" treated embryos. 
 
Very few cells appear to undergo apoptosis and the number of progenitor cells at M-
phase of the cell cycle appear reduced as shown by phosphorylated Histone 3 
expression (Fig 6.3, Panels E & F). The mRNA distribution of PTP" confirms the 
persistent over expression of PTP" within the spinal cord tissue despite the reduction in 
overall spinal cord area on the treated side (Fig 6.3, Panel G). The truncation may arise 
as a result of a reduction in the mitotic activity of progenitors whereby the ectopic 
expression of PTP" in areas it is not normally expressed may disrupt the balance of 
normal gene expression and therefore neuronal development. 
 
Most of the affected embryos demonstrated a truncation of the spinal cord tissue on the 
treated side. However, in only one case we did see a displacement of cells within the 
lumen of the spinal cord. These cells were positive for Islet 1/2 (Fig 6.5, Panels A – 
C). The significance of this example is uncertain since this was an isolated 
observation, but it does look similar to what was found following PTP" knockdown. 
Nevertheless, it contrasts with the high frequency of ectopically-placed precursors 
following PTP" loss-of-function (Table 5.2). 
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Figure 6.4 Charts of LIM-HD expressing cell numbers at HH22 between IRES-GFP 
and PTP"-IRES-GFP treated embryos (A) Ratio of Islet1/2 cells between control and 
treated groups demonstrated a reduction in cell number amongst over PTP" expressed 
samples (n=19)(P<0.001; Student T test). (B) Ratio of Lim1/2 cells between control 
and treated groups showing a reduction in cell number amongst over PTP" expressed 
samples (n=8)(P<0.001; Student T Test). (C) Ratio of Lim3 cells between control and 
treated groups again showing a reduction in cell number amongst over PTP" expressed 
samples (n=11)(P<0.01; Student T Test) (Error bars show SD).  
 
 
 
 
 
 
 
 
   A 
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Figure 6.5 Immunocytochemical markers in transverse sections of HH22 chick 
brachial spinal cord in a PTP"-IRES-GFP treated embryo to (A) Islet 1/2, showing the 
ectopic expression of this marker within an island of cells in the ventricular lumen (B) 
Caspase 3, showing no cell death in serial sections of the same embryo and (C) 
pHistone3 in serial sections. Scale bar is 0.5mm.  
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6.4  PTP" gain-of-function does not lead to apoptosis. 
 
To gauge whether PTP" gain-of-function was triggering apoptosis, the number of 
apoptotic cells amongst our experimental groups at HH 22 were quantified using 
activated Caspase-3 as a marker for cell death. Within PTP"-IRES-GFP treated 
embryos, on average there were 0.38 and 0.32 cells observed between treated and non-
treated sides of the spinal cord respectively. Amongst control IRES-GFP treated 
embryos this value remained very low at 0.46 and 0.27 between treated and non-
treated sides respectively (Figure 6.6).  
 
Essentially there was no significant difference in apoptosis levels between sample sets, 
with each embryo having less than one apoptotic cell on average between the 3 
sections counted for each embryo. In conclusion, the over-expression of PTP" does not 
trigger apoptosis and the lack of apoptotic cells in any location at HH 20-22 reveals 
that cells, either in a radial glial state or as differentiating neurons, are not dying at a 
significant rate (Homma et al, 1994; Li et al, 1998).  
 
These findings lead us to ask a further question to account for the loss of spinal cord 
tissue and LIM HD positive neurons in tissue over-expressing PTP". If no cell death 
programme has been initiated one could either assume that a minority of LIM HD 
fated cells were not being born, or that the radial glial cells giving rise to such neurons 
were blocked at some stage of the cell cycle whereby they were not able to self renew 
or proliferate.  
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Figure 6.6 Chart – Average numbers of cells undergoing apoptosis as measured by 
Caspase3 between treated and non-treated sides of the spinal cord at HH22. IRES-GFP 
(n=6) (P<0.001; Student T test) and PTP"-IRES-GFP (n=23) (P<0.001; Student T test) 
samples compared, showing no significant change in the number of dying cells 
amongst the sample groups. The green bars represent the treated half of the spinal cord 
and the yellow bars the non-treated half of the spinal cord among the two experimental 
sets of embryos treated with IRES-GFP as a control and PTP"-IRES-GFP to drive the 
over expression of PTP" (Error bars show SD). 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Key : Green Bars denote the average number of cells on the treated sides of the spinal cord 
among control IRES-GFP  & PTP!-IRES-GFP sample groups. Orange Bars denote the 
average number of cells on the non-treated sides of the spinal cord among control IRES-
GFP  & PTP!-IRES-GFP sample groups. 
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6.5  Measuring the mitotic activity at HH22 
 
The mitotic activity of samples was measured at HH 22 using p-H3 as a marker of M-
phase of the cell cycle. Representative samples within the sets that demonstrated a 
reduction of motor neuron phenotype and high PTP" over expression levels were 
studied further to gauge the proliferation state of progenitor cells. (Figure 6.3, Panel 
F).  
 
Amongst 11 embryos at HH 22 treated with IRES-GFP and 15 embryos treated with 
PTP"-IRES-GFP, pH3 activity was reduced 25% in PTP" treated cases, compared with 
a 1% reduction in control samples (Figure 6.7). This finding suggests that the 
proliferative potential of LIM-HD fated neuronal progenitors was indeed decreased 
after PTP" gain-of-function.  
 
A significant reduction of cells undergoing mitosis is observed. This may favour a 
hypothesis that a number of radial glial progenitors are either arrested at a stage of the 
cell cycle, or that some other phase of the cycle is lengthened by high levels of PTP".  
 
6.6   PTP"  over-expression does not affect the rate of S-phase. 
 
Radial glial cells have a distinct morphology during S-phase of the cell cycle, whereby 
their nuclei shuttle back and forth in the mantle zone whilst synthesising DNA. 
Embryos injected with the BrdU tracer prior to harvesting will incorporate the 
molecule as they synthesise new DNA strands and this can be detected with an 
antibody against BrdU. 
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Figure 6.7 Chart Showing the ratio of cells detected with pH3 at HH22 between treated 
and non-treated sides of the spinal cord amongst IRES-GFP (n=11) and PTP"-IRES-
GFP (n=15) treated samples.  A slight reduction is evident in the number of cells at M 
Phase of the cell cycle between treated and control groups (P<0.0001: Student T Test) 
(Error bars show SD). 
 
 
 
 
Blue Bars denote ratio of cells between treated and non treated sides of 
the spinal cord among control IRES-GFP samples. Red Bars denote ratio of cells 
between treated and non treated sides of the spinal cord among PTP!-IRES-GFP samples.
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In a preliminary study, stage HH 10 embryos injected with IRES-PTP" were treated 
with BrdU for half an hour  prior to harvesting at HH 18. The treated side of the spinal 
cord revealed a reduction in the number of BrdU positive S-phase cells along with a 
corresponding reduction in the spinal cord area (Fig 6.8, Panels A-D). The BrdU 
labelled cells occupied the entire length of the spinal cord albeit in reduced numbers. 
The total number of cells and areas of the spinal cord were measured in Open Lab 
(Figure 6.9). The sample set at HH 18 consisted of 10 treated embryos over-expressing 
PTP" and 5 control Embryos expressing the IRES-GFP vector. Two to three sections 
from each embryo were measured and an average for each embryo was obtained. 
These values were then compared amongst the representative groups and an average 
number of cells and ratios obtained.  
 
The average number of BrdU and therefore S-phase cells was reduced to a ratio of 0.76 
(relative to 0.97). This was true when comparing the average ratio of cells on the 
treated and non-treated sides of the spinal cord within the PTP"-IRES-GFP and IRES-
GFP samples sets respectively (Figure 6.10, Chart A). The corresponding area of the 
spinal cord was also reduced by a ratio of 0.79 (relative to 1.04) (Figure 6.10 Chart B). 
Raising PTP" levels non-physiologically after HH10 and before its normal expression 
by HH18 may have an impact on the proliferative activity of the neural tube. 
 
When the ratio of cells on treated and non-treated sides amongst sample groups were 
corrected against the ratio of their corresponding areas, we obtained a value close to 1 
(Figure 6.10, Chart C), indicating that we were not observing proportionally less S-
Phase cells per unit area, despite the loss of tissue. Thus the process of DNA 
replication within progenitor cells seems unaffected at this embryonic stage. 
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Figure 6.8 BrdU labelling in transverse sections of HH18 chick brachial spinal cord 
treated with PTP"-IRES-GFP, labelled with BrdU prior to sectioning. 
Immunocytochemical staining of BrdU (A-D) Outline indicates boundary of the neural 
tube and the cells within this were quantified in four different examples. Scale bar is 
0.5mm. 
 
Figure 6.9 Screenshot of the Openlab software and method of counting the 
proliferating cells. The floor plate and roof plate regions were not counted. 
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Figure 6.10 Charts of LIM-HD BrdU positive cell numbers at HH18 between IRES-
GFP (n=6) and PTP"-IRES-GFP (n=10) treated embryos. (A) Ratio of cells during S-
phase between control and treated groups demonstrated a reduction in proliferating cell 
number amongst PTP" gain-of-function samples. (B) Ratio of spinal cord areas in 
corresponding samples between control and treated groups shows a reduction in the 
area of the spinal cord in PTP" over-expressed samples. (C) Ratio of proliferating cells 
corrected against the corresponding areas shows no chance in the overall number of 
cells undergoing S-Phase in sample sets (Error bars show SD). 
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6.7  Discussion 
 
The impact PTP" gain-of-function had on spinal cord tissues at HH20 and HH22 was 
determined through the expression on neuronal markers following PTP"-IRES-GFP 
treatment and electroporation of the neural tube. The results indicate that PTP" gain-
of-function led to a reduction in the total number of Lim1/2, Lim3, Mnr2 and Islet1/2 
cell populations through to HH22. The area of the spinal cord also appeared reduced in 
treated samples and this reduction was not thought to be a result of cell death as 
activated Caspase3 staining revealed no significant differences in cell death when 
compared to control samples. 
 
The mitotic activity, at M-Phase of the cell cycle within the sample groups was 
measured, revealing a decrease in the proliferative activity of neural progenitors as a 
result of PTP" gain-of-function. This suggested that the radial glial progenitors were 
either arrested at a particular point in the cell cycle, or that PTP" gain-of-function 
resulted in a lengthening of a phase of the cell cycle ultimately reducing the 
proliferative capacity of the spinal cord. Further preliminary studies using BrdU 
labelling to measure the number of cells undergoing S-Phase between control and 
PTP" gain-of-function groups revealed that the process of DNA replication within 
progenitors seemed unaffected. During PTP" gain-of-function, the gene acts in regions 
it is not normally expressed and proportionally affects a larger number of cells which 
maybe an important consideration. The role PTP" may have during the progress of the 
cell cycle and interaction with the cell matrix will be discussed further in the 
concluding chapter. 
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Chapter 7:  Silencing PTP$  
 
7.1  Introduction. 
 
A structurally different member of the PTP family to PTP", PTP$, has been implicated 
in neuronal development and its expression is localised on axonal growth cones and 
among spinal motor neurons (Stoker et al, 1995; Chaapveld et al, 1998; Chilton & 
Stoker 2000). In the mouse, PTP$ and its various isoforms have been shown to 
promote axon outgrowth and growth cone guidance (Ledig et al, 1999; Rashid-
Doubell, 2002).  
 
Ligands for PTP$ have been described in the chick, namely Heparan Sulphate 
Proteoglycans within the retinotectal system (Haj et al, 1999; Aricesu et al 2002; 
Sajani-Perez, 2003). These molecules have been shown to be required for motor 
neuron development and have been ascribed a role in the midline guidance of axons 
(Uetani et al, 2006; Inatani et al, 2003; Stepanek et al, 2005). A further ligand for 
PTP$ has also been described, Nucleolin, which is expressed in developing muscle 
tissue (Alete et al 2005).  
 
The PTP$ knock out in the mouse has highlighted its role during the proliferation and 
adhesiveness of neuronal cell types (Elchebly et al, 1999). These mice presented 
defects in pituitary gland development, reduced brain size and retarded growth patterns 
(Wallace et al, 1999).  
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7.1.1  PTP$ expression and RNAi 
 
PTP$ has a striking expression pattern in the early spinal cord, with areas of strong 
expression in the ventricular zone and mantle zone, where the various neuronal 
subtypes are generated, and in the lateral motor columns by E4 (Chilton & Stoker, 
2000). A lower level of expression is observed throughout the remainder of the cord. 
PTP$ expression remains within in the ventricular zone to E6 (Chilton & Stoker, 
2000). 
 
A recent study using dsRNAi in ovo to knock down the expression of PTP$ and other 
phosphatases during neurogenesis in the lumbar region has shown defects in the dorsal 
anterior iliotibialis nerve despite apparently normal development of the limbs 
(Stepanek et al, 2005). Combined RNAi targeting of two or more PTPs has shown less 
severe phenotypes than the silencing of single PTP implying a dose dependant 
function of PTPs during axonal outgrowth or a degree of functional redundancy. This 
also suggest that PTPs may work through mutual antagonism as is seen in drosophila 
studies (Desai et al, 1996). 
 
7.1.2  Aims. 
 
The expression and function of this gene in the chick has not been studied in the early 
spinal cord prior to HH18. In order to elucidate its function during neurogenesis, RNAi 
was used to transiently reduce PTP$ expression levels in this domain. In this section, I 
aimed to collect preliminary data on PTP$ function and generation of motor neurons 
from mitotically active radial glia, coincidentally the site of early PTP$ expression.  
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7.2  PTP$  loss-of-function constructs and in ovo electroporation. 
 
Six loss-of-function constructs were generated against PTP$ (Chapter 3.2.1). Based on 
in vitro experiments, the vector Sig5a was found to induce very effective PTP$ loss-
of-function due to its strong knock down in HEK 293T cells (Figure 3.5). This 
construct was injected into the neural tube at the brachial level to a final concentration 
of 1-2µg/µl at HH10 according to the same protocol as the PTP" silencing 
experiments. A control set of embryos treated with a control hairpin-encoding vector 
were harvested at HH18 following the onset of PTP$ expression, and treated in a 
similar way to PTP$ silenced embryos.  
 
7.3  PTP$  silencing has a general effect on LIM-HD expressing cells. 
 
Using in situ detection, PTP$ mRNA revealed a diffuse expression pattern within the 
ventricular and intermediate zones, with higher patterns of staining associated closely 
with the ventricular layer of mitotic cells (Figure 7.1 Panel G, N, U Arrows). Strong 
levels of expression were also detected amongst the floor plate cells (Figure 7.1 Panel 
G, arrow). 
 
Embryos electroporated with control vector showed a normal pattern of development 
as previous cell counts demonstrate (see Chapter 5). As the same control vectors were 
used for PTP" and PTP$ loss-of-function studies, these control experiments were not 
repeated here.  No significant apoptotic activity was observed and both the frequency 
and the distribution of mitotic cells appeared normal (Figure 7.1 Panels E & F). 
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Figure 7.1 Immunocytochemical and DIG-labelled mRNA in situ hybridisation in 
transverse serial sections of HH18 chick brachial spinal cord wild type (A-G), and two 
Sig5 treated embryos (H-N) & (O-U) to (A) Islet 1/2  (B) Lim 1/2, (C) Lim 3; (D) 
Mnr2; (E) Caspase3; (F) pHistone3 showing a reduced number of mitotic cells; (G) 
PTP$ arrows indicate stronger areas of expression in the ventricular zone and floor 
plate; (H) Islet 1/2  (I) Lim 1/2, (J) Lim 3; (K) Mnr2; (L) Caspase3; (M) pHistone3; 
(N) In situ to PTP$, arrow shows area of stronger PTP$ staining; (O) Islet 1/2  (P) Lim 
1/2, (Q) Lim 3; (R) Mnr2; (S) Caspase3; (T) pHistone3; (U) In situ to PTP$, red line 
represent neural tube midline, arrows show areas of strong PTP$ staining. Scale bar is 
0.5mm. 
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Amongst 12 embryos treated with Sig5a, a consistent and significant reduction in the 
number of LIM-HD expressing cells was evident in 9 out of 12 embryos (Figure 7.1 
Panels H-K and O-R, two examples shown). By in situ hybridisation, there was little 
evidence of a reduced RNA signal, however the PTP$ probe did not give as clean a 
signal as the PTP" probe. The shRNA could, however be reducing RNA translation of 
PTP$ (see Discussion) (Figure 7.1 Panels N & U).  
 
Cells counts were carried out on these cell populations as previously described and 
amongst a set of 9 PTP$ loss-of-function embryos, the ratio of Islet1/2 cells on the 
treated and non-treated sides of the spinal cord between control and PTP$ silenced sets 
reduced from 0.95 to 0.57 respectively (Figure 7.2). Lim1/2 demonstrated a similar 
trend, with a significant reduction in the ratios between embryos of 0.99 to 0.46 
(Figure 7.2). Lim3 cell numbers were down on average from a ratio of 0.95 to 0.63 and 
finally Mnr2 positive cells were reduced in number amongst silenced embryos by of 
0.97 to 0.51 (Figure 7.2). This demonstrates a broad reduction in the total number of 
LIM HD expressing cells by PTP$ loss-of-function at stage HH18. 
 
7.4 PTP$  loss-of-function triggers apoptosis of LIM HD fated progenitor motor 
neurons in the spinal cord. 
 
Observing the apoptotic activity of cells within the spinal cord amongst controls and 
PTP$ silenced embryos by Caspase-3 activity, a significant up-regulation of the 
apoptosis programme within the neural tube was seen. 
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Figure 7.2. Chart of LIM-HD positive cell numbers. Ratio of neurons compared 
between treated (Blue Bars) and non treated (Red Bars) sides of the spinal cord 
between control and PTP$ loss-of-function embryo sets at HH18. All four markers 
studied, Islet 1/2 (n=8)(P<0.001; Student T Test), Lim 1/2 (n=8)(P<0.0001; Student T 
test), Lim 3 (n=9)(P<0.001; Student T Test) and Mnr 2 (n=8)(P<0.0001; Student T 
Test) showed a significant reduction in their cell numbers in PTP$ loss-of-function 
groups (Error bars show SD).   
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Key: Blue Bars denote ratio of cells between treated and non-treated sides of the spinal 
cord among control shRNA samples. Red Bars denote ratio of cells between treated 
and non-treated sides of the spinal cord among PTP! loss of function samples. 
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This was less than 1 apoptotic cell on each section amongst controls to 3.4 cells on 
average on the treated side of PTP$ silenced embryos (Figure 7.3). These cells appear 
to be at different dorsoventral locations in the spinal cord and amongst our sample set 
of 9 embryos they appeared not to be restricted to any particular progenitor domain 
(Figure 7.1, Panels 7.1 L & S). We can conclude from these findings that neural tube 
cells at different locations undergo apoptosis after PTP$ loss-of-function, correlating 
with a ‘narrowing’ of the spinal cord area on the treated side of silenced embryos. 
 
7.5  PTP$  gain-of-function induces a reduction in the number of mitotically 
active radial glia. 
 
Further studies recording the mitotic activity of ventricular zone reveals a highly 
significant reduction in the number of proliferating cells along the ventricular zone 
associated with the lumen. Amongst 8 PTP$ loss-of-function embryos, the number of 
phosphorylated Histone 3 positive cells when compared to controls was reduced in 
number on average from a ratio of 0.93 to 0.60 (Figure 7.4) (Figure 7.1 Panels M & T). 
Amongst PTP$ loss-of-function embryos PTP$ mRNA expression appears slightly 
reduced, when compared to the control side, yet this maybe a result of the loss of 
neural tube tissue observed (Figure 7.1 N & U).  
 
These results show that a plausible explanation for the reduction of LIM HD 
expressing cells within treated samples, is that their progenitor populations are being 
depleted or are stalling at some stage of the cell cycle preventing normal entry to M-
Phase. The reduction in cell number can also be partly attributed to a triggering of the 
apoptosis programme evident from the caspase-3 staining within the spinal cord. 
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Figure 7.3 Chart of Caspase 3 positive cell numbers. Number of cells undergoing 
apoptosis between treated (Green Bars) and non treated (Red Bars) sides of the spinal 
cord between control and PTP$ loss-of-function embryo sets at HH18. The control 
embryos showed no significant change in the number of dying cells (n=6)(P<0.01; 
Student T Test) however this was significantly increased in PTP$ loss-of-function 
groups, observing 3 cells on average on the treated half of the neural tube 
(n=8)(P<0.001; Student T Test) (Error bars show SD). 
 
Figure 7.4 Chart of proliferating cell numbers. Ratio of cells undergoing proliferation 
between treated (Blue Bars) and non treated sides (Red Bars) of the spinal cord 
between control and PTP$ loss-of-function embryo sets at HH18 (n=8)(P<0.01; 
Student T Test) (Error bars show SD).  
 
 
 
 
 
  
Key : Green Bars denote the average number of cells on the treated sides of the spinal 
cord among control shRNA  & Sig5a sample groups. Red Bars denote the average 
number of cells on the non-treated sides of the spinal cord among control shRNA  & 
Sig5a sample groups. 
 
 
 
 
 
Key: Blue Bars denote ratio of cells between treated and non-treated sides of the spinal 
cord among control shRNA samples. Red Bars denote ratio of cells between treated and 
non-treated sides of the spinal cord among Sig5a shRNA PTP! loss of function 
samples. 
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7.6  Discussion. 
 
The data reveals a pattern of PTP$ gene expression within the sub-ventricular zone, 
mantle layer, floor plate and stronger expression proximal to the ventricular lumen, 
the site of mitotically active precursor cells. Reducing this activity along the 
dorsoventral aspect of the spinal cord leads at HH18 to a reduction in the number of 
cells fated with LIM-HD expression profiles. Further analysis using markers of 
apoptosis and proliferation show that the reduction in cell numbers is brought about 
by both cell death within the ventricular zone, and a reduction the proliferative 
capacity of radial glia at the ventricular surface.  
 
In comparison, no obvious defects were detected at HH18 amongst the PTP" loss-of-
function embryos attributable to the onset of this gene’s expression at around HH18. 
PTP$ is however expressed clearly by HH18 in the spinal cord, unlike PTP". This 
may explain why at stage HH18 Sig5a demonstrated an effect on the spinal cord 
whereas Si3 at this stage did not yield any phenotypes. Furthermore, amongst the Sig5 
treated samples studied at HH18, none displayed evidence of mislocated cells through 
their expression of LIM-HD expression factors. This is unlike the heterotopic 
phenotype observed with PTP" at later stages. 
 
Recent studies on the functions of PTP$ and PTP% in mice using double knockouts 
carrying a combination of alleles reveal a loss of motor neurons in the spinal cord and 
muscle dysgenesis. The single gene knockouts were, however, viable suggesting these 
genes may complement each other’s function. Moreover, these double mutants 
appeared normal at E13 when analysed using Islet-1. However, at E18.5 in the mouse 
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(approximately HH44 in the chick) a motor neuron deficit was detected and a single 
gene dose of PTP$ was sufficient for the survival of these motor neurons during axon 
extension (Uetani et al, 2006). PTP$ therefore makes an essential contribution to 
motor neuron survival at later stages of development in mammals. Our experiments 
further support a role for PTP$ in LIM-HD motor neuron development in the spinal 
cord from the mouse to the chick, however as PTP$ loss of function mutants in the 
mouse were viable (possibly due to functional redundancy with other RPTPs) in the 
chick this the loss of PTP$ may not be compensated.  
 
It would be interesting to determine the effects of double silencing directed against 
PTP$ and PTP" and moreover if PTP" overexpression is able to either enhance or 
rescue the early defects seen at HH18 amongst PTP$ loss-of-function embryos. The 
PTP$ loss-of-function experiments show that shRNAi can be used for another RPTP 
expressed in the spinal cord, and that PTP" and PTP$ may be involved in motor 
neuron proliferation during the early stages of neurogenesis. 
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Chapter 8:  Discussion 
 
The balance of phosphorylation states of proteins in cells during neuronal 
development gives rise to intricate patterns of neuronal connectivity, as previous 
studies into the function of the Ephrin and PTP receptors have demonstrated. 
Phosphorylation enables receptors to communicate, and is involved in the guidance of 
axons to their target sites. The function of numerous signalling pathways are 
dependent upon this very balance with PTKs and PTPs working to phosphorylate and 
dephosphorylate key protein interactors involved in cell proliferation and neuronal 
migration (den Hertog et al, 2008; Larsen et al, 2003). In this thesis I have shown for  
the first time that a receptor tyrosine phosphatase, PTP", can control proliferation and 
survival of neural tube progenitors. My data also suggests that PTP" influences the 
localisation of neural precursors  mediolaterally in the cord. 
 
PTP’s and PTK’s have been shown to be associated with adhesive sites that bind to 
the cell matrix. The neural tube following closure consists of exclusively radial glial 
cells attached to the ventricular surface at one end and to the pial surface through pial 
end feet at the other (Fujita 2003). The nuclei of these self-renewing cells shuttle back 
and forth through INM driven by microtubules and actin fibres, as the cell progresses 
through the cell cycle during growth and synthesis stages in the outer half of the 
ventricular zone. It is at the ventricular surface that cells undergo mitosis where they 
acquire information from their environment that specifies their fate. During mitosis 
the integrity of the adhesive junctions are temporarily compromised, allowing the 
radial glial progenitor cells at the midline to undergo division and proliferation, after 
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which time these junctions are re-established (Jacobson, 1991; Hartsock & Nelson, 
2007). Adherens junctions have Cadherins and Catenins both of which are controlled 
by tyrosine phosphorylation (Nelson et al, 2004; Lilien & Balsamo, 2005). 
 
At the end of mitosis, cells either decide to differentiate and migrate towards the pial 
surface, losing their connections at both ends, or re-enter the cell cycle and form 
adherens junctions and pial end feet. These events are governed by a complex series 
of phosphorylation and dephosphorylation controlled by cell-cell interactions and 
diffusible factors within the neural tube. (Fujita, 2003; McDermott, 2005; Orford & 
Scadden, 2008).  
 
Wnt signalling through the !-catenin pathway has been shown to regulate cell cycle 
progression, controlling the entry and exit of progenitor cells through this cycle. The 
transcriptional regulation of the Cyclin genes and balance of phosphorylation states 
have served as ‘start’ and ‘stop’ cues. Moreover !-catenin itself undergoes tyrosine 
phosphorylation (Brault et al, 2001; Megason & McMahon, 2002). The influences of 
the !HLH and LIM-HD genes then guide differentiated neurons to domain specific 
locations in the periphery guided along the radial glia parent cell (Lumsden, 1995; 
Hollyday, 2001; Wilcock et al, 2007). Tyrosine phosphorylation of proteins is 
therefore a post translational modification that regulates the signal propagation of 
receptors leading to proliferation, differentiation and communication with the 
neighbouring cells, cell matrix components and their associated adhesive properties 
(Burridge et al, 2006; Sallee et al, 2006).  
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The expression profiles of members of the RPTP family in the neural tube suggested 
they might have a specific function in the development of this tissue. A few studies to 
date have highlighted the role of members of the RPTP family in the spinal cord, but 
only during axon growth and guidance and motor neuron targeting and survival 
(Stepanek et al, 2005; Uetani et al, 2006). The aims of our study were to address the 
role of these receptors during earlier neurogenesis and spinal cord development, 
initially looking principally at PTP", but also PTP$ function (Chilton & Stoker, 2000; 
Gustafson & Mason, 2000).  
 
In the mouse, knock out studies of PTP" have not shed light on its potential function 
within the nervous system (Lamprianou et al 2006). A recent study has described the 
crystal structures of the carbonic anhydrase-like domains of PTP" and demonstrated 
their interaction directly with immunoglobulin subunits of members of the contactin 
family. These molecules are GPI anchored membrane proteins that can interact with 
extra cellular cues. They are involved in the construction of neural networks and this 
was the first report of potential ligands for PTP" (Bouyain & Watkins, 2010).  
 
To address the function of RPTPs in vivo, RNAi was considered an appropriate 
approach to silence RPTP genes. It could be used flexibly, both temporally and 
spatially, in order to analyse gene function, although few studies had used it in ovo 
when I started this project. I confirmed the efficiency of the loss-of-function shRNA 
constructs in culture, and showed these genes could be specifically targeted through 
RNAi. From the six silencing constructs generated for PTP", three provided a knock 
down of over 80% in in vitro studies using human carcinoma cell cultures. Using 
these vectors, the results of perturbing PTP" function in ovo demonstrated an effect 
 276 
on cell cycle progression, differentiation and lateral positioning of LIM-HD motor 
neurons and dorsal interneurons. 
 
8.1 PTP"  loss-of-function function disrupts neurogenesis in the chick. 
 
Knocking down PTP" in ovo initially gave us a range of phenotypes histologically. In 
severe cases, we observed heterotopia with a disruption of the ependymal cell layer 
and luminal ingrowths of neurons. When immunohistochemically stained with 
various antibodies, the cells within the ingrowths stained positive for Nkx2.2 and 
Islet1/2 and were therefore differentiating cells residing in ectopic locations. 
 
Milder phenotypic cases displayed a truncation of the spinal cord, in particular a 
dorsoventral shortening and mediolateral narrowing of the neural tube. There 
appeared to be no significant changes in the numbers of Islet1/2 positive cells 
between control and loss-of-function embryos at E5. However, a significant finding 
was that a large reduction was seen in the number of Lim1/2 positive cells on the 
electroporated side of the neural tube.  
 
The PTP" knockout mouse has been generated and presents no motor or interneuron 
specific spinal cord defects, yet it is worthy to note that the expression patterns of this 
gene are very different between species (Lamprianou et al 2006). In stark contrast to 
the chick, it was shown that PTP" is not expressed widely in the early mouse spinal 
cord (Chilton & Stoker, unpublished data).  Furthermore, Lamprianou and colleagues 
identified murine PTP" expression at low levels among oligodendrocytes and 
microglia within glial cultures. Murine PTP" expression was also seen in all the 
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sensory organs such as the eyes, ears and tongue suggesting a role for PTP" in sensory 
neurons.  
 
The murine expression profile of PTP" may thus suggest that the function of PTP" in 
the chick spinal cord may be replaced by another RPTP in the mouse, suggesting 
redundancy amongst the phosphatases across species. Future experiments may 
consider crossing two transgenic mouse lines to generate double knockouts with 
PTP", particularly RPTPs with similar expression patterns in order to address possible 
redundancy issues, namely double loss of function of PTP" with PTP$, PTP% and 
PTP*/! both in the mouse and chick (Chilton & Stoker, 2000). 
 
 
8.2 PTP"  function and Lim HD transcription factors 
 
  
A significant phenotype observed in the majority of successfully electroporated cases 
was a deficit in LIM HD expressing motor and interneurons, especially those 
expressing Lim1/2 in the LMC and more dorsal interneurons. Embryos observed prior 
to PTP" expression around HH18 appeared normal, and cellular deficits were only 
observed after HH20. The lateral aspect of the LMC appeared most affected as 
neurons only begin to populate this branch of the motor column at around HH18 
(Tsuchida et al, 1994). This suggests that Lim1/2-positive cells in the LMCl may be a 
specific target of PTP". The effects on Lim1/2 may be due to a specific functional 
requirement for PTP" during the development of these neural cell groups. Another 
more mundane possibility for the effect of PTP" loss-of-function on Lim1/2 cells, 
may be largely the temporal coincidence of PTP" expression and function with the 
birthdates of LMCl neurons. 
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The loss of neurons coincides with the onset of PTP" expression within the neural 
tube as it extends from its dorsal and lateral origins to more ventral locations. The 
smaller dorsal loss of Lim1/2 cells may suggest that other PTPs operate a certain level 
of functional redundancy that could compensate for the dorsal function of PTP". PTP" 
function may also be dose-dependent, where loss-of-function may not remove 100% 
of PTP" function and thus have more of an effect on low level expression within the 
pMN domain.  
 
The pMN domain was most sensitive to the mislocation of neurons seen and therefore 
appeared most readily affected, due to its lower PTP" expression compared to dorsal 
or lateral cells. It is also worthy to note that the effects of the shNRA vectors 
delivered by electroporation is likely to be transient and a certain level of recovery 
may ensue past HH20, as the shRNA expression becomes diluted away. 
 
Future experimental strategies may involve using either a retroviral or a lentiviral 
vector to deliver more stable RNA interference in order to circumvent the transiency 
of the RNAi effect. Here, the lentiviral system would ensure efficient, stable 
transduction of targeted cells. In addition, with the right type of vector, their RNAi 
dose can be modulated through doxycycline and the infected cells also traced through 
a bicistronic GFP-shRNA transcript (Amy Chen et al, 1999; Stegmeier et al, 2005; 
Snove & Rossi, 2006). Morpholinos could also be used in ovo, but these are likely to 
be diluted even faster than shRNA vectors 
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8.3  Ventricular zone activity and neural differentiation. 
 
 
Within the neural tube, one could assume that the loss of LIM HD expressing cells 
after knockdown of PTP", arises from the reduction in the motor and interneuron 
precursors that ultimately give rise to neurons occupying distinct levels of the 
dorsoventral spinal cord. The lateral motor columns appear to be particularly sensitive 
to these deficits. In the pMN domain where most motor neurons are generated, a loss 
of progenitor tissue was observed in PTP" silenced embryos, along with ectopically 
located motor neurons, some of which actually sat within the lumen of the spinal 
cord.  
 
Within this pMN region, Olig2 causes repression of Irx3 and other genes to regulate 
the expression of neuronal markers MNR2/Hb9, Lim3, Isl1/2, Lim1/2 and pan neural 
transcription factors Ngn2, NeuroM. Following PTP" loss of function, levels of 
NeuroM were largely unaffected (Figure 5.14, Panel N and Figure 5.16 Panel N). It 
would be interesting to check the levels of Neurogenin2 to see if this was affected. 
With PTP" loss-of-function, levels of Olig2 also remain unaffected as do levels of 
En1, indicating early actors upstream of Olig2 and En1 progenitors are unaltered, i.e. 
LIM HD expression as !HLH genes remain active in radial glial cells (Figure 1.4). 
Perturbation of PTP" did not appear to affect these early progenitor markers. 
 
An increase in the level of apoptosis seen in this region during PTP" shRNA 
treatment, suggests that cells were dying as they were moving away from the 
ventricular zone. However, cell death was observed dorsally and ventrally in the 
neural tube and was not specific to the pMN domain. The loss or exhaustion of 
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progenitor tissue may therefore result from premature differentiation of the precursor 
cells either directly or indirectly, rather than loss by cell death.  
 
The loss of tissue in the ventral neural tube and the ectopically located cells may point 
to a cell autonomous effect, or the migration of these cells may be directly influenced 
by PTP" through a contact mediated process. In order to delineate further which 
populations of neurons were effected by PTP" loss of function, future experiments 
should consider using markers that highlight, in the ventral neural tube, Evx1/2 for V0 
neurons. Furthermore, no real change in neuronal numbers were observed with En1 
for V1 neurons in PTP" loss of function neural tubes. The markers of V2 neurons 
Chx10 and Gata2/3 should be used in future experiments as well as Sim1 for V3 
neurons. It would also be worthwhile considering post mitotic markers of dorsal 
neuronal populations (dI6 to dI1) such as Lbx1 for dI4 to dI6, Islet1/2 for dI3, Foxd3 
for dI2 and finally Lhx2/9 for the dorsal-most neuronal dI1 population (Zechner et al, 
2007). This would give an accurate indication of which neuronal populations 
dorsoventrally, were specifically affected by PTP" modulation. 
 
One further possibility for the loss of tissue may arise from a negative progenitor 
feedback system where motor neurons feedback to their progenitors once they have 
differentiated and migrated laterally to their pool specific domains. PTP" may play a 
role in such feedback, directly or indirectly, whereby if PTP" acts non-autonomously, 
then the signals from the lateral glial cells bodies or neuroblasts could still be received 
medially. Although we have no evidence for this, such a potential negative feedback 
of motor neurons has been described in Islet1 deficient mice (Chitnis et al, 1995; Pfaff 
et al, 1996). 
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There is some controversy as to the extent that the RNAi technique itself can 
contribute non-specifically to the rate of apoptosis, and the contribution of normal cell 
death programmes within the chick (Li et al, 1998; Homma et al, 1994). Another 
group has demonstrated that RNAi hairpins may increase the apoptotic activity within 
tissues (Wakamatsu et al, 2007). Nevertheless, our controls did not reveal any 
significant increase in apoptosis. Our data reveals that some of the apoptotic cells in 
PTP" shRNA-treated embryos were located in distal locations away from the 
ventricular lumen suggesting that the cell death might be occurring either in 
differentiating neurons, or in progenitors outside of M-Phase. 
 
In the PTP" loss-of-function experiments, a reduction in the mitotic activity of cells 
was observed. The role that PTP" plays in the cell cycle is of particular interest and 
this has been touched on in a few studies from the proliferation of cancerous cells to 
the progression of the cell cycle where PTP" was found to act as a potential tumour 
suppressor gene (Liu et al, 2004; Cheung et al, 2008). When considering the functions 
of other RPTPs it is worthy to note that PTP( has been implicated in the proliferation 
of midline tissue and PTP$ has been shown to play a role in stem cell differentiation 
and function during neurogenesis (Badde & Schulte, 2008; Kirkham et al, 2006; 
Meathrel et al, 2002). PTP" could therefore be involved in controlling the cell cycle 
directly, or the balance between cycling cells and their post-mitotic, differentiating 
offspring. Of note also is a study in PC12 cells, where PTP" was shown to block 
morphological differentiation of these neuronal cells (Shintani et al, 2001) although 
an effect on the cell cycle was not determined. 
 
 282 
8.4   PTP"  gain-of-function. 
 
Within the spinal cord, PTP" gain-of-function resulted in gross dorsal and ventral 
retardation, unlike PTP" loss-of-function where the greatest effect was ventral. In 
order to gain more insight into which populations of neurons were affected by PTP" 
over expression, we studied the expression profiles of motor neuron markers and the 
states of proliferative activity and cell death from stage HH20. At this stage, of the 4 
neuronal markers observed, Islet1/2, Lim1/2, Lim3 and Mnr2, all consistently 
demonstrated a reduction in the total number of cells marked along with a significant 
shortening and narrowing of the spinal cord in many cases. These findings led us to 
ask a further question to account for the loss of spinal cord tissue and LIM HD 
positive neurons in tissue over-expressing PTP". If no cell death programme has been 
initiated one could either assume that a minority of LIM HD fated cells were not 
being born, or that the radial glial cells giving rise to such neurons were blocked at 
some stage of the cell cycle, whereby they were not able to self renew or proliferate. 
 
During PTP" over-expression, a significant reduction of cells undergoing mitosis 
were again observed, whilst the luminal length was not significantly affected by this 
gain-of-function. This may favour a hypothesis that a number of radial glial 
progenitors are either arrested in the cell cycle or in fact are slowed down during the 
G1 phase or another phase of the cell cycle by high levels of PTP". This would not 
favour the generation of neurons, nor the capacity for self-renewal, thus ultimately 
reducing the total pool of radial glial progenitors, resulting in a reduction in size and 
proliferative capacity of the spinal cord.  
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8.5        Knocking down PTP$  
 
Further preliminary experiments used the RNAi approach to knock down the function 
of another member of the RPTP family, PTP$, within the spinal cord. In situ 
hybridisation data on the expression profile of this gene at HH18 reveals a pattern of 
PTP$ gene expression within the sub-ventricular zone, floor plate and stronger 
expression proximal to the ventricular lumen, the site of mitotically active progenitor 
cells.  
 
PTP$ and PTP% loss of function mice reveal no neural tube defects nor any axon 
targeting defects indicating these genes maybe functionally redundant as they are both 
highly expressed in the spinal cord and more widely in the CNS. Double PTP$ and 
PTP% loss of function mice mutants however generate embryos that are paralysed 
with sever muscle dysgenesis along with a severe loss of motor neurons during motor 
axon extension within the spinal cord (Uetani et al, 2006).  
 
At earlier stages, however, E13 in the mouse, the populations of Islet1/2 positive 
motor neurons within the motor columns appeared largely normal in double PTP$ -/- 
and PTP% -/-  mutants, with a single gene dose of PTP$ (PTP$ +/- / PTP% -/- ) being 
sufficient to retain motor neuron survival similar to control levels. Further defects of 
the phrenic nerves were found along with targeting defects and stalling of motor 
neuron axons from the cervical spinal cord. This study concluded that PTP$ and 
PTP% complement each others function during normal development and this function 
was essential for the correct targeting of motor neuron axons and axonognesis (Uetani 
et al, 2006). 
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Reducing the activity of PTP$ in the chick along the dorsoventral aspect of the spinal 
cord again leads to a reduction in the number of cells fated with LIM HD expression 
profiles. Further analysis using markers of apoptosis and proliferation, show that the 
reduction in cell numbers is brought about by both cell death within the ventricular 
zone and a reduction in the proliferative capacity of radial glia at the ventricular 
surface. 
 
Furthermore, amongst the PTP$ loss-of-function samples studied at HH18, none 
displayed evidence of mislocated cells through their expression of LIM HD 
expression factors. However, this stage may be too early to physically see such events 
due to the small size of the cord and limited numbers of neurons born at this stage. 
This preliminary study on PTP$ therefore indicates that other RPTPs may also be 
playing important roles in early neurogenesis. This justifies future research to 
investigate this in more detail. 
 
8.6      The role of PTPs during the development of the neural tube. 
 
Recent studies have implicated PTP" in gastric and colonic cancers suggesting a 
potential role as a candidate tumour suppressor gene, supporting its activity in 
proliferating cells (Wang et al, 2005; Wu et al 2006). PTP" has been used to identify 
myeloid dendritic cells and macrophages whereby its expression is absent from 
infectious macrophages. However increased levels of PTP" are associated with a 
decreased ability to induce proliferation and interferon-" secretion of T-cells in the 
haematopoietic systems of cancer patients. Earlier studies have also shown PTP" to 
provide an inhibitory signal for neuronal outgrowth through modulation of the 
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p13suc1 complex where in PTP" expressing cell lines, MAP kinases and PKC were 
inactivated (Shintani et al 2001). PTP" may therefore have an impact on motor neuron 
proliferation as the results from perturbing the function of this gene indicate. This 
previous work indicates that PTP" influences proliferation and differentiation in other 
systems.  My data indicates that knockdown and over expression both suppressed 
proliferation within the neural tube. 
 
8.7      Cadherins, adhesion and migration. 
 
When considering the potential functions of PTP" within the neural tube, one 
possibility is that PTP" influences the molecular components and function of adhesive 
junctions in the neuroepithelium. These junctions are an important site for cellular 
signalling, and many phosphatases have been implicated in binding E, N and VE 
Cadherin family members and !-catenin. These binding partners also act as substrates 
to the RPTPs, which in turn bind either homophilically, or heterophilically (reviewed 
in Salle, 2006). It can be noted that the local concentration of PTPs at adhesive sites 
may be important when establishing a low level of phosphorylation at these crucial 
adhesive junctions, to maintain their integrity. Reducing the levels of PTP activity 
will increase the tyrosine phosphorylation of cadherins and catenins, thus breaking 
down the epithelial barrier function.  
 
Therefore, the effect of RPTPs on !-catenin signalling and the effect of tyrosine 
phosphorylation (either directly or indirectly by PTP" or PTP$) on adherens and tight 
epithelial junction must be looked at in more detail. This may ultimately have an 
effect on the radial glial population and the tightly associated daughter cells that give 
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rise to differentiated neurons. Furthermore there may also be an effect on the 
migration of neuronal precursors through cadherins (Lilien et al, 2002; Nelson & 
Nusse, 2004). Our group also has evidence that PTP" gain-of-function does support !-
catenin driven TCF signalling (Hashemi et al, 2011). 
 
Tyrosine phosphorylation of cadherins affect the stability of adherens junctions within 
epithelial cells (Lampugnani et al 1997). Treatment with a PTP inhibitor pervandate 
caused raised phosphorylation levels in adherens junctions and their consequent 
disassembly (Michalides et al 1994). This implicates PTP function early on in cell-
cell adhesion, later supported by studies with PTPµ and its role in the maintenance of 
junctional integrity (Sui et al, 2005). There may also exist functional redundancies or 
multiple isoforms of PTP" that are specific to different subtypes of ligand, which 
could rescue function later in development (Xiong et al 1996).  
 
A structurally similar phosphatase to PTP", PTP&/!, has been shown to bind 
Pleiotropin, a heparin binding protein that promotes the migration of neurons in the 
cortex, thereby inhibiting PTP&/! activity (Meng et al 2000). PTP&/! has been shown 
to interact directly with !-catenin, whose tyrosine phosphorylation regulates cell-cell 
adhesion via disassociation of cadherins from the actin cytoskeleton (Meng et al, 
2000; Stoker et al, 2005).  
 
Our studies show that not only did motor neurons mislocate to the progenitor zone, 
they effectively replaced this tissue in some cases. The most likely explanation for 
this is that the progenitor cells were depleted or pushed aside, leaving the motor 
precursors to differentiate in situ. Alternatively it is possible that adhesive defects in 
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these cells meant that they migrated medially rather than laterally, although I feel this 
is unlikely. The ingrowth of Isl1-expressing cells in some embryos looks almost 
neoplastic. However, we saw no evidence of increased mitoses in these regions and so 
it is more likely that they have arisen through the local generation of motor precursors 
that have failed to move away. Their failure to move laterally may thus have arisen 
through defective cadherin interactions, or other cell-autonomous defects in cell 
movement. 
 
8.8      PTP", !-Catenin and Wnt proliferation control. 
 
What role does PTP" play in the development of the spinal cord, and how could it 
cause a disruption in the LIM HD profile? If PTP" interacts with !-catenin, then this 
could explain some of the progenitor cell behaviours that have been observed, since 
!-catenin is closely involved in cell cycle control and adherens junctions (Kijiguchi et 
al 2007; Badde & Schulte, 2008). Our data indicates that PTP" may have a direct 
effect on motor neuron production or indirectly in the maintenance of progenitor 
pools. As we have suggested, a plausible role for PTP" interaction in the neural tube 
may be through Cadherins and !-catenin signalling (Price et al, 2002; Salle et al, 
2006). Here, !-catenin function has been attributed to phosphotyrosine signalling.  
 
It may be an interesting possibility as !-catenin is a transcription factor that controls 
neuronal proliferation through a Wnt gradient, and plays a role in the cell adhesive 
processes of epithelial cells through Cadherin modulation as previous studies suggest 
(Megason & McMahon, 2002; Lilien & Balsamo, 2005). In these !-catenin knock out 
studies in mice, a ventral loss of cell was observed in the spinal cord, not dissimilar to 
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the phenotypes observed with PTP" and PTP$. A number of phosphatases have been 
implicated in !-Catenin dephosphorylation interacting directly with other RPTPs and 
PTKs (Lilien & Balsamo, 2005; Nelson et al, 2004; Stoker, 2005.) !-catenin activity 
onset by Wnt signalling regulates the proliferation and terminal differentiation of 
progenitor cells via phosphorylation. (Megason & McMahon, 2002).  
 
As a regulator of proliferation and differentiation in the neural tube, the canonical 
Wnt/!-catenin signalling pathway is a plausible target of PTP". This pathway is 
activated by graded Wnt signals whereby !-catenin regulated cell-cell adhesion 
through cadherins at adherans junctions and further drives the transcriptional 
regulation of targets through complexes with TCF/LEF proteins. !-catenin itself has 
been shown to be regulated by tyrosine phosphorylation both at the nuclear and cell 
surface levels (Lilien & Balsamo, 2005). 
 
Previous studies in the chick neural tube blocking TCF/LEF function demonstrated 
similar phenotypes to our PTP" loss-of-function results (Megason & McMahon, 
2002).  Recent studies in our laboratory examined the effect of PTP" perturbation on 
the Wnt pathway through assessing TCF activity using a pTOPGFP and pTOPRFP 
reporter where GFP/RFP expression indicates binding of activated !-catenin-
TCF/LEF complex to consensus TCF/LEF binding sites in the GFP (or RFP) 
promoter. This vector demonstrated a steep dorsoventral gradient of GFP expression, 
which was unaffected in PTP" loss-of-function neural tubes. PTP" gain-of-function 
embryos however suppressed pTOPRFP expression by more than 80% across the 
entire neural tube (Hashemi et al, 2011). 
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!-catenin may serve as a possible target for PTP" as its tyrosine phosphorylation 
influences its transcriptional activity and adhesion to cadherins. In vitro experiments 
where the phosphorylation state of !-catenin at one of its regulatory tyrosine residues, 
Y654 would affect !-catenin complexes at its active site, nucleus and adherans 
junctions were carried out in our laboratory. The results indicated that spinal cord 
cells expressing !-catenin-GFP fusion proteins with Y654-F mutations that mimic a 
dephosphorylated state, such complexes localised at adherans junctions mainly, 
compared to WT !-catenin-GFP (Hashemi et al, 2011).  
 
However, !-catenin-GFP fusion proteins with Y654-E mutations that mimic a 
phosphorylated state resulted in the protein complex to localise in the nucleus and 
cytoplasm. This indicated that the tyrosine residue at Y654 of  !-catenin could 
regulate  its function, however this may not be sufficient to alter signalling as our 
group found that the Y654-E mutation should have a dominant-active phenotype that 
should induce tissue hypertrophy yet this failed to transpire. Further, PTP" was able to 
efficiently dephosphorylate !-catenin in vitro with tyrosine-phosphorylated !-catenin 
treated with purified catalytic domains of human PTP" (Hashemi et al, 2011). 
 
PTP" may therefore be participating in a signalling cascade that involves !-catenin. 
Indeed our lab had recently shown that PTP" interacts with !-catenin (Hashemi et al, 
2011). A recent study has also implicated another RPTP, PTP(, within the MHB as a 
negative modulator of Wnt1 expression in this region, and as an inhibitor of the 
canonical Wnt signalling pathway through sequestration of !-catenin (Badde & 
Schulte, 2008). In this study, PTP( over expression, PTP( being normally expressed 
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in a ring of cells anterior to the Wnt1 domain of expression at the MHB, inhibits 
Wnt1 expression here.  
 
Furthermore dose dependent Fgf8 signals from the MHB are required for the 
transcription of PTP( and Wnt1. The inhibition of Wnt1 by PTP( overexpression was 
specific to this gene within the MHB without affecting other markers in this region. 
Over expression of PTP( at the MHB a failure of Wnt1 upregulation was observed 
following further stimulation by Fgf8, however the MHB cells expressed En1, Pax2 
and Pax5. The group concluded that Wnt1 and PTP( border in expression domains 
rostrally where PTP( at the MHB may serve to act as a Ras-MAP Kinase feedback 
inhibitor restricting anterior expansion of the Wnt1 domain (Badde & Schulte, 2008).  
 
!-catenin has been previously shown to be dephosphorylated by PTP( in vitro, and 
over expression of PTP( in the MHB disrupted the canonical Wnt pathway whereby 
neuroepithelial proliferation was reduced along with a reduction in the activation of 
!-catenin responsive promoters. The group found further receptor tyrosine 
phosphatases expressed in the MHB, namely PTP&/! was expressed at the same time 
as PTP( and has been found to interact with the diffusion of Wnt/Fgf signals (Badde 
& Schulte, 2008). PTP" may therefore function in a similar way to PTP( and this 
could be investigated in future studies. A similar scheme for PTP" is proposed in 
Figure 8.1. 
 
Here, PTP" causes desphosphorylation of specific tyrosine residues on !-catenin, 
namely position Y654 (Kajiguchi et al, 2011) bound to p120, causing positive 
cadherin/catenin complex stability and integrity.  
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Figure 8.1 Scheme of possible PTP" interaction with the Catenin/Cadherin pathway. 
PTP" causes desphosphorylation of tyrosine residues on !-catenin, bound to p120, 
causing positive cadherin/catenin complex stability. Wnt signalling and RTK action 
negatively regulates the cadherin/catenin complex, through phosphorylation of !-
catenin tyrosine residues and allows !-catenin to enter the nucleus and activate 
transcription of target genes via the TCF/LEF pathway. !-cat - !-catenin; Fz – 
frizzled receptor; RTK – Receptor Tyrosine Kinase; Y-P, phosphorylated tyrosine of 
!-catenin. Adapted from A. Stoker (Personal Communication). 
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RTK action negatively regulates the cadherin/catenin complex, through 
phosphorylation of !-catenin tyrosine residues and allows !-catenin to enter the 
nucleus and activate transcription of target genes via the TCF/LEF pathway (Rhee et 
al, 2007). Furthermore, the migration of motor neuron precursors is controlled in part 
by cadherin regulated adhesive contacts and ultimately dependent on PTK and PTP 
regulation of !-catenin (Price et al, 2002).  Our proposed model suggests that PTP" 
regulates !-catenin tyrosine phosphorylation in balance with PTKs allowing some !-
catenin to translocate into the nucleus, both phosphorylated and non-phosphorylated 
forms (Kim & Lee, 2001). During overexpression of PTP", more !-catenin is 
dephosphorylated and associated with cadherin complexes. The is also a plausible 
adhesion effect of PTP" yet there maybe redundancy issues among the PTPs and 
along the cadherin/catenin pathway. 
 
8.9      PTP" and neural tube patterning 
 
In what ways does PTP" interact with protein complexes to bring about a loss of 
Lim1/2 cells? Transcriptional complexes control specific generation of motor neuron 
pools and clues could be provided in the E-box regulatory regions or enhancer regions 
of the Lim1/2 gene. Interestingly Islet1 itself is tyrosine phosphorylated when 
considering the role of cell-cell interactions as a potential mode of PTP" interaction 
(Hobert & Westphal, 2000).  
 
This is interesting as Islet1 is nuclear and PTP" is thought to be membrane-associated, 
it may be possible that PTP" is also cleaved and then travels to the nucleus for a 
possible interaction with Lim1/2 (Anders et al, 2006). However, it is more likely that 
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progenitor populations are affected through either cell death or disruption in the cell 
cycle through up and down regulation of PTP" activity. 
 
Further studies in our laboratory addressing whether PTP" function was upstream or 
downstream of Notch signalling demonstrated normal patterns of Hes5-1, Pax 6 and 
Nkx6.1 among PTP" loss-of-function embryos.  This indicates that PTP" functions 
occur downstream of Notch signalling independently of this signalling pathway. Our 
PTP" gain of function studies showed a reduction in motor neuron and interneuron 
numbers along, along with increased apoptosis, without affecting the expression of 
Pax3 or Nkx6.1 (Hashemi et al 2011). The loss of tissue arises partly from the 
reduction in mitosis without activating apoptosis. The reduction of mitosis and 
proliferative activity appears to be cell-autonomous through PTP" gain of function.  
 
Further experiments in our group also showed no difference in mitotic spindle  angle 
distributions through perturbing PTP" activity, indicating self-renewal processes and 
determination of neurogenic fate were possibly unaffected, although the relation 
between spindle orientation and neurogenesis has recently been called into doubt 
(Vilas-Boas et al, 2011; Das & Storey, 2012) . Loss of PTP" function also perturbs 
cell-cell adhesion in the neuroepithelial cells whose nuclei are normally well aligned 
increased the spread of angles and an increase in nuclei without random polarities and 
orientation (Hashemi et al, 2011). These findings point towards a cell autonomous 
effect of PTP" loss-of-function, where loss of progenitors occurs through apoptosis, 
along with a further defect causing displacement of motor neurons that fail to migrate 
laterally. Therefore PTP" function is needed for cell survival and correct cell-cell 
adhesion and migration of neuronal precursor cells (Hashemi et al, 2011). 
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PTP" loss of function resulted in a particular loss of pMN progenitor tissue and 
mislocation of motor neurons not observed with neurons in other ventricular zones. 
As they mature, motor neurons could provide feedback to progenitor cells deterring 
them from a motor neuron fate. Such a model has been suggested to Isl1  (Lee & Pfaff 
2003). The loss of Islet1 or Lim-1-expressing neurons here after PTP" loss, may 
affect motor neuron survival as the feedback system is lost, causing compensatory 
motor neuron production and progenitor exhaustion. The particular sensitivity at the 
pMN may be caused by the extinguishing of the already low levels of PTP" through 
its loss of function. Alternatively, it is possible that a specific cadherin-based function 
of PTP" is disrupted in this pMN region, or another regionalised substrate of PTP" is 
expressed in this region, causing the more extreme defects in tissue structure 
(Hashemi et al, 2011).  
 
8.10 Future Studies 
 
Future studies should look more closely at further analysing the effects of PTP" on 
neuronal populations within the neural tube at HH20, focussing on cell expressing 
Neurogenin2, Pax6, Olig2 and Nkx6.1 for example. This may provide insight into 
whether specific neuronal populations were being affected by PTP perturbation. 
Moreover, genes expressed within the LMC should be looked at further amongst the 
PTP" perturbed embryos to determine if the effects seen may be non-cell autonomous, 
in order to delineate the potential mechanisms for PTP" function during neurogenesis. 
Maintaining shRNA levels for longer, using viral delivery, may also reinforce the 
phenotypes observed and clarify their basis. 
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Examining the role of Catenins/Wnts and especially !-catenin as an interactor with 
PTP" should also be a high priority. As a potential candidate for PTP" interaction, !-
catenin loss of function (as with PTP" gain of function) both in the chick and the 
mouse results in a loss of ventral progenitor cells. Furthermore PTP" is able to 
suppress Wnt/!-catenin signalling via TCF and is able to dephosphorylate !-catenin 
in vitro. PTP( has also been shown to interact with !-catenin directly and affect CNS 
development. My preliminary study of PTPs also demonstrates a role in neurogenesis 
in the neural tube. These studies raise the critical issue of functional redundancy 
between RPTPs, making interpretation of gain of function studies and loss of function 
studies more difficult, since changes in PTP" may be compensated by other 
phosphatases under some but not all circumstances.  
 
Furthermore, other components of the Wnt/TCF pathway should be considered as 
interactors of PTP" here, as !-catenin phosphorylation may not be sufficient to drive 
TCF signalling. Namely the cadherin family, whose cell-cell adhesive functions are 
regulated by tyrosine phosphorylation (Price et al, 2002; Sallee et al, 2006).Thus these 
further experiments should address whether the function of PTP" is specifically 
directed through particular signalling pathways with its own specific substrates, or 
whether it acts upstream of the cadherin/catenin pathways with consequent, broad 
downstream consequences.  
 
My study has demonstrated for the first time that RPTPs control neurogenesis, 
neuronal patterning and positioning in the early chick spinal cord. It is likely that 
several further RPTP family members could also prove to be functionally relevant 
within this region, playing unique and overlapping roles. 
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APPENDIX A 
 
 
 
Neuronal Counts 
 
St20-Islet1/2 Si3 Con Ratio Negcon Con Ratio
Av 2 per Emb 8.57814E-05 Ttest 2T UEV 0.13837426 SD 0.105261579
a 19 29 0.66 28 27 1.03
b 12 26 0.46 30 31 0.97
c 9 21 0.43 29 30 0.97
d 12 22 0.55 26 29 0.9
e 12 20 0.6 22 19 1.16
f 18 26 0.69 23 20 1.15
g 21 28 0.75 26.33333333 26 1.03
h 26 29 0.9
I 8 14 0.57
j 16 27 0.59
k 10 21 0.48
l 12 21 0.57 1.01 0.61
m 8 20 0.4 n=6 n=13
14.07692308 23.38461538 0.588461538
St22-Islet1/2 Si3 Con Ratio Negcon Con Ratio
Av 2 per Emb 6.68772E-05 Ttest 2T UEV 0.104690019 SD 0.104578519
a 34 43 0.79 40 46 0.87
b 34 44 0.77 41 36 1.14
c 22 41 0.54 38 42 0.9
d 27 41 0.66 44 45 0.98
e 17.5 35 0.5 46 43 1.07
f 20 30.5 0.66 39 42 0.93
g 32 44 0.73 41.33333333 42.33333333 0.981666667
h 31.5 40 0.79
I 33 42 0.79 0.98 0.7
j 29 41 0.71 n=6 n=10
28 40.15 0.694
St20-Lim1/2 Si3 Con Ratio Negcon Con Ratio
Av 2 per Emb 0.000353167 Ttest 2T UEV 0.161993266 0.185013513
a 7 15 0.47 15 15 1
b 4 10 0.4 14 16 0.88
c 7 11 0.64 13 10 1.3
d 8 16 0.5 18 15 1.2
e 8 13 0.62 13.5 16 0.84
f 10 17 0.59 14 15 0.93
g 12 15 0.8 14.58333333 14.5 1.025
h 12.5 16 0.78
I 11 14 0.79 1.01 0.62
j 3 9 0.33 n=6 n=11
k 10 14 0.71
8.409090909 13.63636364 0.602727273
St22-Lim1/2 Si3 Con Ratio Negcon Con Ratio
Av 2 per Emb 5.66545E-08 Ttest 2T UEV 0.145693743 0.102111051
a 19 26 0.73 29 26 1.12
b 11 27 0.41 28 27 1.04
c 10 28 0.36 22 26 0.85
d 10.5 22 0.48 24 25 0.96
e 9 24 0.38 25 28 0.89
f 18 26 0.69 26 25 1.04
g 11 27 0.41 25.66666667 26.16666667 0.983333333
h 13 23.5 0.55
I 14 23 0.61 0.98 0.53
j 18 25 0.72 n=6 n=10
13.35 25.15 0.534
St20-Lim3 Si3 Con Ratio Negcon Con Ratio
Av 2 per Emb 0.000897405 Ttest 2T UEV 0.093464464 0.18622567
a 4.5 9.5 0.47 7 6 1.17
b 7.5 15 0.5 7.5 9.5 0.8
c 15 23.5 0.51 5 4 1.25
d 10 14 0.71 10.5 9.5 1.11
e 4.5 7.5 0.6 5 4 1.25
f 9.5 13.5 0.48 7 6.6 1.116
g 3.5 6 0.58
h 2 4.5 0.44 1.06 0.54
I 4 6.5 0.62 n=6 n=12
j 7.5 19 0.39
k 6.5 12.5 0.52
l 13 32 0.41
7.291666667 13.625 0.519166667
St22-Lim3 Si3 Con Ratio Negcon Con Ratio
Av 2 per Emb 0.000854047 Ttest 2T UEV 0.261298042 0.157056253
a 0 5 0 6 5 1.2
b 2 3 0.67 5 5 1
c 4 6 0.67 4 4 1
d 3 4 0.75 3 4 0.75
e 3 6 0.5 5 6 0.83
f 3 4 0.75 5 5 1
g 1 5 0.2 4.666666667 4.833333333 0.963333333
h 4 5 0.8
I 2 3 0.67 0.97 0.56
j 3 5 0.6 n=6 n=10
2.5 4.6 0.561
St20-MNR2 Si3 Con Ratio Negcon Con Ratio
Av 2 per Emb 0.003543041 Ttest 2T UEV 0.162095651 0.127226832
a 31 33 0.94 14 16.5 0.85
b 12.5 24.5 0.51 39 36 1.09
c 13 16 0.81 18.7 16.7 1.12
d 5 10.5 0.48 18.5 22.5 0.82
e 10.5 13 0.81 24 25 0.96
f 8 11 0.73 19 18 1.06
St20 Islet1/2
0
0.2
0.4
0.6
0.8
1
1.2
1 2
Series1
St22 Islet1/2
0
0.2
0.4
0.6
0.8
1
1.2
1 2
Series1
St20 Lim1/2
0
0.2
0.4
0.6
0.8
1
1.2
1 2
Series1
St22 Lim1/2
0
0.2
0.4
0.6
0.8
1
1.2
1 2
Series1
St20 Lim3
0
0.2
0.4
0.6
0.8
1
1.2
1 2
Series1
St20 Lim3
0
0.2
0.4
0.6
0.8
1
1.2
1 2
Series1
St20 MNR2
0
0.2
0.4
0.6
0.8
1
1.2
1 2
Series1
Ratio of motor neurons between 
treated and non treated sides of the 
spinal cord between control and 
silenced embryos at HH20
0
0.2
0.4
0.6
0.8
1
1.2
1.4
Islet1/2                Lim1/2                     Lim3                     Mnr2
g 18.5 20 0.93 22.2 22.45 0.983333333
h 13 17 0.76
I 25 31 0.81 0.99 0.78
15.16666667 19.55555556 0.753333333 n=7 n=9
St22-MNR2 Si3 Con Ratio Negcon Con Ratio
Av 2 per Emb 0.769875 Ttest 2T UEV 0.14399074 0.067354782
a 9 9 1 26 28 0.93
b 12 12 1 25 23 1.09
c 22 22 1 22 24 0.92
d 30 31 0.97 28 27 1.04
e 7 11 0.64 20 21 0.95
f 18 19 0.95 24 24 1
g 28 29 0.96 24.16666667 24.5 0.988333333
h 19 17 1.12
I 24 20 1.2 0.99 0.99
j 22 23 0.96 n=6 n=10
19.1 19.3 0.98
St20-C3 Si3 Con Negcon Con
Av 2 per Emb 3.21117193 0.369072765 SD 0.447213595 0.418330013
a 5.5 0 0 1
b 3 0 1 0
c 3.25 0.5 0.5 0.5
d 6.5 1 1 0
e 6.5 0 0.5 0
f 7 0.5 0 0
g 9 1 0.5 0.25
h 6.67 0
I 3.67 0
j 4 1
k 0 0.33
l 1 0 6.6648E-06 Ttest 1T EqV
m 0 0.33
n 12 0.25
o 9 0.25
p 3.5 0
q 3 0.5
r 4 0.67
4.866111111 0.351666667 0.5 0.25
n=18 n=6
St22-C3 Si3 Con Negcon Con
Av 2 per Emb 2.108475537 0.51877478 0.418330013 0.204124145
a 5 1.75 0 0.5
b 4.5 0.25 0 0
c 0 0 1 0
d 5.25 0.25 0 0
e 0 0 0 0
f 2 0 0.5 0
g 1.33 0 0.25 0.083333333
h 1.33 0
I 1 0 0.00284847 Ttest 1T EqV
j 0 0.33
k 4.33 0
2.249090909 0.234545455 0.25 0.08333333
n=11 n=6
St20 -H3 Si3 Con Ratio Negcon Con Ratio
Av 2 per Emb 0.001019906 Ttest 2T UEV 0.141562707 0.096626428
a 6 10 0.6 13 14 0.93
b 8 12 0.67 12 15 0.8
c 10 15 0.67 18 17 1.06
d 11 22 0.5 15 17 0.88
e 5 12 0.42 13 16 0.81
f 7 10 0.7 11 13 0.85
g 11 12 0.92 13.66666667 15.33333333 0.888333333
h 7 14 0.5
I 9 13 0.69
j 6 11 0.55
8 13.1 0.622 13.666667 15.3333333
n=10 n=6
E5 Islet1/2 Si3 Con Ratio Negcon Con Ratio
Av 2 per Emb 0.780083106 Ttest 2T UEV 0.183612228 0.102502033
a 163 185 0.88 133 137 0.97
b 118 124 0.95 101 92 1.1
c 110 137 0.8 114 125 0.91
d 101 110 0.92 164 186 0.88
e 131 136 0.96 122 109 1.12
f 145 194 0.75 141 153 0.92
g 265 183 1.45 129.1666667 133.6666667 0.983333333
h 227 213 1.07
I 178 130 1.37
j 186 149 1.25
k 92 97 0.95 0.97 1.03
l 104 86 1.21 n=6 n=19
m 75 88 0.85
n 92 93 0.99
o 87 91 0.96
p 145 147 0.99
q 126 123 1.02
r 145 129 1.12
s 124 123 1.01
137.5789474 133.5789474 1.026315789
E5 Lim1/2 UP Si3 Con Ratio Negcon Con Ratio
Av 2 per Emb 0.006787394 Ttest 2T UEV 0.274705076 0.133028819
a 31 41 0.76 39 44 0.89
St22 MNR2
0
0.2
0.4
0.6
0.8
1
1.2
1 2
Series1
Ratio of Islet1/2 Cells Between Control 
and Treated Groups E5
0
0.2
0.4
0.6
0.8
1
1.2
1.4
Control                                      Si3           
Ratio of Cells Undergoing Proliferation 
between control and silenced embryos 
at HH20
0
0.2
0.4
0.6
0.8
1
1.2
Control                                              Si3
Average Number of Cells undergoing 
Apoptosis between treated and non-treated 
sides of the spinal cord HH20
-2
0
2
4
6
8
10
Ratio of motor neurons between 
treated and non treated sides of the 
spinal cord between control and 
silenced embryos at HH22
0
0.2
0.4
0.6
0.8
1
1.2
1.4
Islet1/2                Lim1/2                     Lim3                     Mnr2
b 29 40 0.73 38 40 0.95
c 51 34 1.5 45 41 1.1
d 20 47 0.43 43 47 0.91
e 28 41 0.68 40 45 0.89
f 30 32 0.94 47 39 1.21
g 19 40 0.48 42 42.66666667 0.991666667
h 29 41 0.71
I 29 33 0.88
j 35 40 0.88 0.99 0.75
k 39 54 0.72 n=6 n=12
l 38 63 0.6
31.5 42.16666667 0.775833333
E5 Lim1/2 LO Si3 Con Ratio Negcon Con Ratio
Av 2 per Emb 0.000451441 Ttest 2T UEV 0.257478261 0.096626428
a 19 52 0.37 43 57 0.75
b 36 59 0.61 51 57 0.89
c 16 51 0.31 48 46 1.04
d 46 56 0.82 55 60 0.92
e 4 17 0.24 38 46 0.83
f 2 12 0.17 44 49 0.9
g 5 11 0.45 46.5 52.5 0.888333333
h 2 14 0.14
I 1 2 0.5
j 14 34 0.41 0.89 0.51
k 11 39 0.28 n=6 n=14
l 19 72 0.26
m 33 58 0.57
n 73 69 1.06
20.07142857 39 0.442142857
St18-Islet1/2 Si3 Con Ratio Negcon Con Ratio
Av 2 per Emb 0.819588581 Ttest 2T UEV 0.379598786 0.150166574
a 1 3.5 0.29 7 8 0.88
b 5 4 1.25 6.5 8 0.81
c 15.5 15.5 1 8 9.5 0.84
d 3.5 2.5 1.4 4 4 1
e 6.5 7.5 0.87 5.5 4.5 1.22
f 2 3.5 0.57 6 6.5 0.92
g 11 12.5 0.88 6.166666667 6.75 0.945
AV 6.357142857 7 0.894285714
n=6
St18-Lim1/2 Si3 Con Ratio Negcon Con Ratio
0.53258489 Ttest 2T UEV 0.324338154 0.197433533
a 2.5 2.5 1 3 3.5 0.86
b 7 5.5 1.27 5 5 1
c 3.5 6.5 0.54 5.5 4 1.38
d 1.5 2.5 0.6 3 2.5 1.2
e 2.5 4.5 0.56 4.5 4 1.13
f 4.5 3.5 1.29 4.2 3.8 1.114
g 3 3.5 0.86
AV 3.5 4.071428571 0.874285714 n=5
St18-Lim3 Si3 Con Ratio Negcon Con Ratio
0.314023769 Ttest 2T UEV 0.303342491 0.211021326
a 5 7.5 0.67 5 4 1.25
b 6 9.5 0.63 4.5 5.5 0.82
c 3 4.5 0.67 5 6 0.83
d 4 3.5 1.14 3.5 4 0.88
e 6 4.5 1.33 6 5 1.2
f 3 4.5 0.67 4.8 4.9 0.996
AV 4.5 5.666666667 0.851666667 n=5
St18-MNr2 Si3 Con Ratio Negcon Con Ratio
0.813267093 Ttest 2T UEV 0.120733867 0.133678719
a 5.5 6 0.92 6 5.5 1.1
b 4.5 5 0.9 5 5 1
c 5 6 0.83 5.5 5 1.1
d 3 3 1 4 4.5 0.89
e 4 3.5 1.14 5 4 1.25
f 6 5.5 1.1 5.1 4.8 1.068
AV 4.666666667 4.833333333 0.981666667
St22 c3 ires Con Ratio Negcon Con Ratio
0.33913249 Ttest 1T EqV
a 0 0.5 0.66 0
b 0 0 1 1
c 0.33 0.33 0 0.33
d 1.33 0 0.66 0
e 0 0 0 0
f 1 0 0.464 0.266
g 0 1
h 0.33 0.66 IRES-GFP
I 0 0
j 2 0.33 treated 0.464
k 0 0 non treated 0.266
l 0 0
m 0 0.33
n 0.66 0.33 IRES-PTPg-GFP
o 0.33 0.66
p 0 0 treated 0.375
q 0 0 Non teated 0.324
r 0.66 0.66
s 1 1
Average Number of Cells undergoing 
Apoptosis between treated and non-
treated sides of the spinal cord HH22
-0.40
-0.20
0.00
0.20
0.40
0.60
0.80
1.00
Ratio of motor neurons between treated 
and non treated sides of the spinal cord 
between control and silenced embryos at 
HH18
0
0.2
0.4
0.6
0.8
1
1.2
1.4
Islet            Lim1/2          Lim3             Mnr2
Ratio of Lim1/2 Cells in the dorsal third 
of the spinal cord Between Control and 
Treated Groups E5
0
0.2
0.4
0.6
0.8
1
1.2
Control                                     Si3
Ratio of Lim1/2 Cells in the ventral third of 
the spinal cord Between Control and Treated 
Groups E5
0
0.2
0.4
0.6
0.8
1
1.2
Control                                      Si3
t 0.33 0.33
u 0 0
v 0 0.33
w 0.66 1
0.375217391 0.324347826
SD 0.533989016 0.356151476 0.398677815 0.388618064
St22 h3 ires Con Ratio Negcon Con Ratio
6.92058E-05 Ttest 2T UEV 0.107135873 0.091800178
13 9 0.69 17 15 1.13
12.5 9 0.72 15.5 15 1.03
13.5 7 0.52 14.5 15 0.97
11.5 8 0.7 12.5 13.5 0.93
10.5 10 0.95 14 12.5 1.12
12.5 9 0.72 11.5 11 1.05
14 10 0.71 13.5 16 0.84
14 10.5 0.75 16 17 0.94
18 14.5 0.81 15 17 0.88
15 12.5 0.83 16.5 16.5 1
10 8 0.8 10 10.5 0.95
14 9 0.64 14.18181818 14.45454545 0.985454545
12.5 9 0.72
13.5 12.5 0.93 Ires-gfp 0.99
13 10 0.77 sd 0.092
13.16666667 9.866666667 0.750666667
0.75
sd 0.107
St18 brdu ires Con Ratio Area ires Area con Ratio
0.024647283 Ttest 2T UEV 0.080062476 0.182211721
69 81.7 0.84 1.1632 1.5261 0.76
45 54 0.83 1.3329 1.7404 0.76
46 73.5 0.63 0.8124 1.3491 0.6
49 69 0.71 0.8051 1.4561 0.55
79.5 103.5 0.77 2.371 2.3873 0.99
67.5 105.5 0.64 1.3173 2.507 0.53
69 90 0.76 2.2264 2.7732 0.81
97 128 0.76 1.9686 2.0123 0.98
62 71 0.87 1.3727 1.5814 0.87
61 78 0.78 1.7121 1.6759 1.02
av 64.5 85.42 0.759 1.50817 1.90088 0.787
0.090719347 0.048166378
control 78 93 0.96 3.1465 2.856 1.1
107 112 0.84 2.4104 2.4586 0.98
95 94 1.01 1.5853 1.5203 1.05
83 76 1.09 1.7956 1.6987 1.06
68 70 0.97 2.3722 2.3719 1
av 86.2 89 0.974 2.262 2.1811 1.038
ratio of cells Ratio of areas
ires-gfp 0.97 ires-gfp 1.04
sd 0.09 sd 0.05
ires-gamma 0.76 ires-gamma 0.79
sd 0.08 sd 0.18
CORRECTED VALUES
cells 0.78
area 0.76
St22 islet ires Con Ratio Negcon Con Ratio
0.000707109 Ttest 2T UEV 0.096947565 0.088185411
8.5 13.5 0.63 18 22 0.82
10 19 0.53 33 36 0.92
16 24 0.67 13 14 0.93
8.5 11.5 0.74 28 32 0.88
11.3 18 0.63 43 49 0.88
6.5 11 0.59 42 39 1.08
16 22.5 0.71 29.5 32 0.918333333
40.5 81.5 0.5
5 9.5 0.53
4.5 9 0.5 islet1/2
17.5 24 0.73
6.5 13 0.5 IRES-GFP 0.918
7 14 0.5 sd 0.0881
5.5 10.5 0.52
9 13.5 0.67 IRES-PTPg-GFP 0.6089
89 115.5 0.77 sd 0.0969
5.5 11 0.5
7.5 12 0.63
83 116 0.72
av 18.80526316 28.89473684 0.608947368
St22 Lim1/2 ires Con Ratio Negcon Con Ratio
0.001635473 Ttest 2T UEV 0.203171286
2.5 7 0.36 33 37 0.89
11 29 0.38 46 44 1.05
36 54.5 0.66 24 28 0.86
36 43.5 0.83 58 53 1.09
26 33.5 0.78 47 51 0.92
33 51.5 0.64 35 32 1.09
32.5 38.5 0.84 40.5 40.83333333 0.983333333
16.5 40.5 0.41
av 24.1875 37.25 0.6125 Lim1/2
IRES-GFP 0.98333
sd 0.105
Ires-PTPg-gfp
Ratio of Cells During S-Phase HH18
0
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0.4
0.6
0.8
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1.2
IRES-GFP     IRES-PTPg-GFP
Ratio of Areas During S-Phase HH18
0
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IRES-GFP       IRES-PTPg-GFP
Ratio of Cells Corrected Against 
Corresponding Areas
0
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0.8
1
IRES-GFP   IRES-PTPg-GFP
Ration of Cells Undergoing Mitosis 
Between Control and Experimental 
Groups HH22
0
0.2
0.4
0.6
0.8
1
1.2
IRES-GFP      IRES-PTPg-GFP
Ratio of Islet1/2 Cells Between Control 
and Treated Groups HH22
0
0.2
0.4
0.6
0.8
1
1.2
IRES-GFP                      IRES-PTPg-GFP
Ratio of Lim1/2 Cells Between Control and 
Treated Groups HH22
0
0.2
0.4
0.6
0.8
1
1.2
IRES-GFP                        IRES-PTPg-GFP
IRES-PTPg-GFP 0.6125
sd 0.203
St22 Lim3 ires Con Ratio Negcon Con Ratio
0.002232879 Ttest 2T UEV 0.156553796 0.206663978
30 51.5 0.58 22 26 0.85
5.5 11 0.5 8 11 0.73
33 40 0.83 25 20 1.25
15 45 0.33 39 41 0.95
4.5 7.5 0.6 6 5 1.2
3.5 5.5 0.64 13 15 0.87
17 22 0.77 18.83333333 19.66666667 0.975
31.5 44 0.72
8 16 0.5 Lim 3
33.5 42 0.8
39 50 0.78 IRES-GFP 0.975
20.04545455 30.40909091 0.640909091 sd 0.206
IRES-PTPg-GFP 0.641
sd 0.156
St18 Islet 1/2 Sigma sig 5a Con Ratio Negcon Con Ratio
0.000835941 Ttest 2T UEV 0.57375 0.91357
6 8.5 0.71 7 8 0.88
5 7 0.71 6.5 8 0.81
3.66 8 0.46 8 9.5 0.84
4 5 0.8 4 4 1
6 9 0.67 5.5 4.5 1.22
3.5 6 0.58 6 6.5 0.92
2.5 7.5 0.33 SD 0.150166574
2 6 0.33
0.181023874 SD
St18 Lim3 Sigma sig 5a Con Ratio Negcon Con Ratio
0.002533307 Ttest 2T UEV 0.62666667 0.996
8 12 0.67 5 4 1.25
8 11 0.73 4.5 5.5 0.82
7.5 11.5 0.65 5 6 0.83
5 13.67 0.37 3.5 4 0.88
7 7.5 0.93 6 5 1.2
1.5 3.5 0.43 0.211021326
5.5 8 0.69
3 6 0.5
4 6 0.67
0.170146995 SD
St18 Lim1/2 Sigma sig 5a Con Ratio Negcon Con Ratio
4.59756E-05 Ttest 2T UEV 0.45575 1.114
3 7 0.429 3 3.5 0.86
1 4 0.25 5 5 1
2.5 4.5 0.556 5.5 4 1.38
5 7 0.714 3 2.5 1.2
1 3.5 0.286 4.5 4 1.13
1.5 5 0.3 0.197433533
3 4.5 0.667
2 4.5 0.444
0.176323364 SD
St18 Mnr2 Sigma sig 5a Con Ratio Negcon Con Ratio
1.66639E-05 Ttest 2T UEV 0.505 1.068
13.5 21.5 0.62 6 5.5 1.1
6.5 14 0.46 5 5 1
6 10.5 0.57 5.5 5 1.1
5 11 0.45 4 4.5 0.89
6 9 0.66 5 4 1.25
0.5 4 0.125 0.133678719
9 13 0.69
4.5 10.5 0.43
6 11 0.54
0.170293864 SD
St18 C3 Sigma sig 5a Con Ratio Negcon Con Ratio
0.000582305 Ttest 1T EqV 0 0
3.5 0 0 1
4 0 1 1
1 0 1 0
3 1 0 0
2 0 1 1
4 0 0.5 0.5
3 2
7 2
Av 3.4375 0.625
SD 1.761442185 0.916125381 0.547722558 0.547722558
St18 H3 Sigma sig 5a Con Ratio Negcon Con Ratio
0.005156422 Ttest 2T UEV 0.6075 0.95
4 7.3 0.55 12 15 0.8
3.5 10 0.35 14 11 1.27
4 11.5 0.35 10 12.5 0.8
4 9 0.44 9.5 9.5 1
6 5.5 1.09 12 13.66 0.88
7 12 0.58 0.196723156
3 4.5 0.67
5 6 0.83
0.253813767 SD
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0
0.2
0.4
0.6
0.8
1
1.2
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Islet1/2                Lim1/2                     Lim3                     
Mnr2
Western Blot Raw Data - PTPgamma
exp 1 od luciferase od/luciferase E / y14 average av si3
si3/y14 0.15 327302 4.58292E-07 0.103633647 0.128571418
0.05 0.164139494
si3/gfp 0 200665
gfp/y14 1.2 271356 4.42223E-06 1 1
0.27
si3/y14 0.21 309345 6.78854E-07 0.153509189
0.06
exp 2
si3/gfp 0 132108
si3/y14 0.17 79832 2.12947E-06 0.104237649
0.07
gfp/y14 1.28 62656 2.0429E-05 1
0.2
si4/y14 1 122898 8.13683E-06 0.398297775
0.27
si5/y14 0.74 92583 7.99283E-06 0.391248933
0.14
exp3
si3/y14 0.41 327302 1.25267E-06 0.298174003
0.38
si3/gfp 0 200665
0.64
gfp/y14 1.14 271356 4.20112E-06 1
0.62
si3/y14 0.39 309345 1.26073E-06 0.300093151
0.61
exp4
gfp/y14 2.06 85036 2.4225E-05 1
1.09
si3/y14 0.2 65745 3.04206E-06 0.125574908
0.1
si6/y14 0.15 68571 2.18751E-06 0.090299715
0.03
si3/gfp 0 79082
degly exp
gfp/si3 w-enz 0 79082
gfp/y14 w-enz 0.11 85037 1.29355E-06
0.07
gfp/si3 w/o-enz 0 79082
gfp/y14 w/o-enz 0.19 85037 2.23432E-06
0.09
Western average
si3 0.12857142 si3 0.164481995 16.4481995 4.5
0.10423765 gamma 1 100 0
0.299544 si4 0.39829778 39.829778 0
0.12557491 si5 0.39124893 39.124893 0
0.090690788 si6 0.09029971 9.029971 0
gamma 1 1
1
1
1
si4 0.39829778
si5 0.39124893
si6 0.09029971
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